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Abstract
Post-myocardial infarction arrhythmias are a leading cause of death in developed coun-
tries, motivating research to improve treatment strategies. Ischemic damage occurring due
to a myocardial infarction results in the formation of inexcitable infarct scars. Electrical
activation waves circumvent these structural barriers and can propagate in perpetual reen-
trant circuits giving rise to ventricular tachycardia. The success of reentrant propagation
depends on the wavelength of the activation wave with respect to the physical path length,
determining the extent of wavefront-waveback interactions.
A wide variety of animal and computational models are used to perform research how-
ever, the optimal species for studying clinical arrhythmias is unknown. One aim of the
research in this Thesis was to suggest a species model which most closely replicates clinical
arrhythmia dynamics. Computational models were utilised to compare the susceptibility
to reentry, by calculating the effective electrical size of the heart, which takes into consider-
ation both the size of the wavelength and the physical size of the heart. Results suggested
that species differences in effective size exist between human and animal models. However,
the effective size of the rabbit model was most similar to the human. This conclusion was
utilised to formulate methodologies for the following studies.
Current techniques employed to locate ablation lesion sites during radiofrequency
catheter ablation are inaccurate, leading to insufficient procedure success rates. Here,
a method to accurately locate optimal ablation lesion targets was investigated utilis-
ing computational models. Quantification of wavelength permitted the observation of
wavefront-waveback interactions to predict susceptibility to reentry. The clinical appli-
cation of the methodology was modelled to ensure that ablation of the susceptible tissue
could terminate reentry and that the limitations of clinical data acquisition did not in-
validate the technique. The method accurately located a region of tissue where reentry
could potentially occur and ablation of the region terminated reentry even when clinical
protocol was simulated.
This research suggests the most suitable species models to research ventricular tachy-
cardia, guiding further in vivo and in silico methodologies. Additionally, a protocol to
improve the success of the ablation procedure has been further investigated. Clinical
implementation of this technique could vastly improve the treatment of post-myocardial
infarction arrhythmias.
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i Intracellular
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Cm Membrane capacitance
E Equilibrium potential/Nernst potential
g Conductance of the membrane
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Im Transmembrane current (in cable theory Im = Iion + Ic)
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Iion Total transmembrane current
IK1 Inward rectifying potassium current
IKr Rapid delayed rectifying potassium current
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INa Sodium current
Istim Stimulus current
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Non-communicable diseases are an increasing health concern as the average life expectancy
increases alongside escalating risk factors such as high cholesterol, diabetes and obesity.
Heart disease is a non-communicable disease which currently accounts for approximately
a quarter of all deaths in the UK and costs the National Health Service in the region of
£6 billion each year1. These statistics illustrate the necessity for research into the causes,
pathologies and possible treatment strategies of heart disease to lessen the health and
economic burdens imposed on society by the related disorders.
In particular, sudden cardiac death (SCD) is the cause of approximately 100,000 deaths
in the UK each year2 and is characterised by a sudden loss of cardiac function. The most
common cause of SCD is the occurrence of an abnormal heart rhythm. The function of the
heart is to pump blood around the body to supply vital oxygen to the tissues as a result of
its consistent, rhythmic, mechanical contraction. A disruption of the rhythm may cause
insufficient oxygen to be supplied to the heart and the brain, resulting in death within
minutes.
Ventricular tachycardia (VT) is a disturbance of the heart rhythm, otherwise termed
an arrhythmia, in which the heart rate is increased. Electrical activation waves propagate
across the walls of the heart and generate mechanical contractions. The regular, syn-
chronous propagation of the activation waves ensures that the contractions are rhythmic,
thus maintaining efficient cardiac function. VT occurs due to alterations to the physi-
1Source: British Heart Foundation https://www.bhf.org.uk/publications/statistics/cardiovascular-
disease-statistics-2014
2Source: National Health Service http://www.nhs.uk/Livewell/Healthyhearts/Pages/Arrhythmias.aspx
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cal path along which the waves propagate, in turn altering the rhythm of contraction.
The disruption and increased rate of wave propagation which occurs during VT can be a
precursor to more serious arrhythmias such as ventricular fibrillation (VF). In VF, wave
propagation further destabilises as a result of the increase in activation rate during VT,
causing the wavefronts to break up. Instead of one homogeneous wavefront propagating
over the walls of the heart to produce synchronous contractions, many small dynamically
changing wavefronts exist, causing rapid, irregular contractions. This leads to severly
impaired cardiac function and unless treated, SCD (Weiss et al., 2000).
A common cause of VT stems from the prior occurrence of a heart attack, otherwise
known as a myocardial infarction (MI), in which a lack of blood supply to parts of the
heart causes scar tissue to form there as a result of ischemic injury. In fact, approximately
125,000 heart attacks occur each year in the UK3 and contribute to ischemic heart disease
being a leading cause of death in the country4. As a result of an MI, regions of infarct
scar tissue lose the essential electrical properties of the myocardium and become unable
to conduct the electrical activation waves. Therefore, wavefronts are diverted around scar
tissue, altering the path of wave propagation. Waves are only able to propagate through
surviving tissue around the scar which often results in circuitous paths of activation.
Crucially, wave propagation around a region of scar can be sustained in what is termed
a reentrant circuit which, due to the short path length of the circuit, increases the heart
rate as contraction follows the pattern of disturbed activation.
1.2 Cardiac Excitation Wavelength
The electrical property of cardiac function is conferred on the myocardium due to a po-
tential difference being invoked by the movement of ions into and out of the cells. Broadly
speaking, when the movement of ions in a region of tissue produces a deflection in the
potential difference, the tissue is said to be activated. Activation of the tissue occurs as the
ions move across the myocardium, producing waves of electrical activation which spread
throughout the tissue. A fundamental parameter of an activation wave is the wavelength
which is defined as the length of tissue which is activated at a particular moment in time.
An important control mechanism of cardiac function ensures that only tissue which is in-
active can be activated, so that waves can only propagate into a region which is inactive.
3Source: Heart Rhythm Institute http://www.hriuk.org/about-heart-disease/heart-facts/
4Source: Office for National Statistics http://www.ons.gov.uk/ons/dcp171778 381807.pdf
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Considering that the wavelength of a wave describes an activated region of tissue, it is con-
ceivable that the wavelength can determine the success of wave propagation throughout
the tissue. A wave travelling across the myocardium will be terminated or diverted if it
collides with tissue which is already activated, or a structural obstacle, ultimately altering
the dynamics of wave propagation (Hayden et al., 1967; Azene et al., 2001). Moreover,
wavelength is rate-dependent due to time-dependent mechanisms which control the cellu-
lar flux of ions, and varies with varying heart rate, dynamically altering the conduction
of waves across the myocardium (Smeets et al., 1986; Girouard and Rosenbaum, 2001;
Matthews et al., 2013). Theoretically, in the most simplified examples, a larger wave-
length will produce more wavefront-waveback interactions resulting in a disruption of the
normal wave patterns. However, the many variables affecting wave propagation dynamics
may interact in complex ways producing a variety of outcomes.
At the turn of the 20th century, a pioneering electrophysiologist, George Mines, was
conducting some of the first experiments which would uncover how the activation wave-
length could determine the progression of complex wave patterns in the heart (Mines,
1913, 1914). Initally, his experiments showed that the nature of the heart beat changed
in response to a change in the frequency of the stimulation of the heart. This observa-
tion prompted Mines to further investigate the impact of the rate dependency of the heart
beat on wave propagation. Using simple heart tissue ring preparations from rays, dog-fish,
frogs, tortoises, cats and dogs, Mines stimulated the preparations at varying frequencies
and observed that, at a particular, relatively fast frequency of stimulation, the excitation
wave propagated around the ring of tissue in a self-sustaining circuit, re-activating the
ring without further external stimuli. These experiments highlighted the importance of a
short and slow activation wave, occurring due a change in stimulation frequency, in order
for the wave to continue to re-excite the tissue within the circuit without terminating due
to wavefront-waveback interactions. Mines proposed that this reentrant activation could
cause the observed pathologies of tachycardia and fibrillation.
It is vital to understand the mechanisms which underlie reentrant propagation in order
to be able to further investigate these arrhythmias and potential treatment strategies. In
particular, using metrics of wavelength can elucidate the nature of wave propagation and
can be used to infer the propensity of the tissue to reentry.
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1.3 Computational Modelling of Cardiac Arrhythmias
Implementing research to study cardiac electrical activity in patients is fraught with diffi-
culties. Research conducted on patients is subject to strict ethical constraints. Specifically,
the research must not cause any undue negative impact on the patient (Taggart et al.,
2014). In fulfilling this requirement, research is often carried out during prerequired pro-
cedures. As a result, investigations must be performed within the limited time frame of
the procedure and must utilise techniques which do not increase the invasiveness or danger
of the procedure. Due to these restrictions, sample sizes of clinical research remain small,
limiting the validity of the results. In all, whilst ethical review is essential for maintaining
high standards of patient care during research activities, it limits the scope of clinical
research. Despite these constraints, ventricular arrhythmias are studied in patients, usu-
ally by acquiring electrical activation data from the surface of the heart during cardiac
surgery, utilising techniques that are no more invasive than the surgery being carried out
(Nanthakumar et al., 2004; Nash et al., 2006). The dynamic nature of wave propagation
and the progression of arrhythmias across the myocardium require the acquisition of data
at multiple sites to sample the transit of the waves in order to be able to effectively study
arrhythmias (Taggart et al., 2014). However, acquiring adequate data for this purpose is
not without difficulty. In order for the data to adequately represent wave propagation, it
is necessary to record a vast amount of data. Consequently, storing and processing such
quantities of data becomes a limiting factor in clinical research. Significant expertise and
skill is necessary to manipulate the recording device to sample data from the correct loca-
tions and avoid acquiring very noisy data. In addition, recording the data from a patient
is a time consuming process and must be performed within the procedure time frame,
reducing the amount of data which is able to be recorded. It is inevitable that with the
limitation imposed by the manual manipulation of the recording device and the relatively
short time frame, the spatial resolution of recorded data is limited and may not faithfully
represent all wave propagation dynamics. Crucially, electrical activation waves propagate
throughout the myocardial wall which also requires sampling if wave propagation is to
be thoroughly and reliably investigated. However, temporal data of electrical activation
waves are only routinely recorded from the surface of the heart in the clinic, hindering the
ability to observe transmural propagation which could be vital to understand the initiation
and mechanism of clinical arrhythmias.
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Investigating arrhythmias in animal models reduces some of the limitations imposed by
the ethical review of clinical research, although animal research is also regulated by ethical
legislation. As such, animal models are often used to investigate arrhythmias with tech-
niques which are not available in the clinic. For example, voltage-sensitive dyes are used to
image wave propagation across the myocardium in real-time, with very much higher spa-
tial resolution than is permitted by clinical data recording (Gray et al., 1998; Chen et al.,
2000; Wu et al., 2004). Such data can provide exceptionally detailed information about
the initiation, maintenance and termination of arrhythmias without requiring the degree
of computational data storage and analysis demands which clinical investigation requires.
However, the methodology used is still only confined to acquiring data on the surface of
the heart, again potentially omitting vital information about the propagation of the dis-
turbed activation waves throughout the myocardium. Moreover, significant differences in
both the anatomy and electrophysiology occur between animals and humans rendering it
difficult to extrapolate reliable conclusions from animal models to inform clinical scenarios
(Coronel et al., 1997; Fink et al., 2011; O’Hara and Rudy, 2012) as both factors may play
important roles in the mechanism of an arrhythmia. Additionally, ethical and financial
burdens of animal research are not neglible and need to be taken into consideration when
proposing methodological protocols (Mirams et al., 2012; Taggart et al., 2014). Although
animal models are able to provide important data which can be used in investigating ar-
rhythmias, significant drawbacks remain, motivating the use of alternative investigative
approaches.
In light of the problems encountered by using patient and animal model data, compu-
tational models have been developed, utilised and thoroughly validated over the past few
decades. Further, in silico models can provide novel insight into arrhythmia mechanisms
which are otherwise unattainable from in vivo investigation. Of great importance is the
ability to simulate cardiac function over multiple scales, from the cellular biophysics un-
derlying the electrical properties, to the whole heart activation and contraction patterns
(Clayton and Panfilov, 2008; Trayanova and Rice, 2011; Trayanova, 2011). The ability
to model the system in a multiscale framework, provides the opportunity to investigate
the mechanisms of a phenotype involved in arrhythmia dynamics as part of the integrated
physiology of the heart (Evans, 2000; Lee et al., 2009; Niederer et al., 2009). In certain cir-
cumstances, experimental data alone cannot elucidate the detailed mechanism behind an
observed feature, but when integrated into a multiscale modelling framework, the mech-
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anism is contextualised and may be understood (Collins et al., 2003; Deisboeck et al.,
2009; Niederer and Smith, 2012). However, in such complex models, it may be difficult to
tease out individual components and draw conclusions about the mechanisms involved at
a particular scale. Computational models can also be utilised to study single components
of cardiac function, in order to reduce complexity of the models and identify detailed
mechanisms giving rise to the arrhythmia. These models can also be predictive and so
can prove invaluable in supplementing clinical research, for example to reduce performing
unnecessary experiments in the clinic (Yang and Saucerman, 2011). Moreover, due to
the limitations of clinical research, in silico models enable investigations which cannot be
performed in the clinic (Yang and Saucerman, 2011). One important example of this is
that clinical protocol only allows recording of electrical activation data from the surface
of the heart, whereas computational models can be utilised to observe transmural propa-
gation dynamics, providing insight into the complex 3D nature of arrhythmias. Likewise,
the spatial and temporal resolution of data available from in silico modelling can be used
to research the fine-scale details of wave propagation which may be missed by clinical
recording techniques. Computational models therefore, provide a mechanism for studying
arrhythmia dynamics in much more detail than can be done in patients, without such
ethical and financial demands as encountered during clinical research.
Mathematical models of electrophysiology are used in in silico modelling studies to sim-
ulate the ion flux within a single cell which drives the electrical activation. Species specific
models of electrophysiology are available including human and a variety of mammalian
species models (Rudy and Silva, 2006; Clayton and Panfilov, 2008; Fenton and Cherry,
2008; Holzem et al., 2014). Studies which simulate cardiac function at the organ level
require an electrophysiological component which simulates ion flux over the whole tissue,
a mechanical contraction component, and a detailed anatomical model. Such models are
also available for different species (Clayton and Panfilov, 2008; Trayanova and Rice, 2011;
Trayanova, 2011) and have been utilised to investigate arrhythmias (Panfilov and Keener,
1995; Plank et al., 2008; Trayanova, 2011; Holzem et al., 2014; Trayanova and Rantner,
2014). The variety of models available make it possible to research arrhythmias in differ-
ent species on many scales of complexity. As previously discussed, if possible, modelling
human physiology is preferable to draw conclusions which may be of use in the clinic due
to physiological differences between species. However, modelling the human heart, partic-
ularly in a multiscale framework, is exceptionally demanding in terms of computational
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data storage and analysis, and requires the use of high-performance computing which is
both costly and not universally available. As a consequence, computational models of
animal species are used to study arrhythmias with reduced computational demands. In
addition, in silico animal models are useful in order to determine how conclusions from in
vivo animal studies may relate to the clinical scenario and to validate such conclusions.
1.4 Thesis Goal
The research in this Thesis uses a computational modelling approach to study how wave-
length can be used to determine the susceptibility of the tissue to reentrant propagation.
Metrics of wavelength are used to investigate species differences in arrhythmia dynamics as
well as, in the context of scar-related arrhythmias, to investigate a novel method to locate
a reentrant circuit in order to guide the ablation procedure. The concepts investigated are
of significant interest as they may contribute directly to guiding arrhythmia research and
clinical treatment strategies.
Animal models are extensively used to research arrhythmias and the conclusions are
often extrapolated to the clinic. However, due to the physiological differences between
species, some animal model studies may not be able to replicate clinical arrhythmias and
hence, the resulting conclusions which may be drawn upon in the clinic, should be regarded
with caution. The first aim of this Thesis is to investigate which species model most closely
replicates the arrhythmia dynamics observed in the clinic, for the purposes of suggesting
the most useful animal model to use in future research pertaining to VT arrhythmias.
Both wavelength and heart size are critical determinants of wave propagation patterns
and vary between species, suggesting that as a result, arrhythmia dynamics also vary sig-
nificantly between species. A metric called the effective electrical size of the heart (which
takes into consideration both the wavelength and the heart size) has been suggested to
determine the similarity between species in terms of VF dynamics (Panfilov, 2006). Here
we extend the previous study by observing how species differences in electrophysiological
properties during conditions indicative of VT, combine to affect the wavelength of each
species. Moreover, we investigate the species differences in the rate-dependency of wave-
length, in order to determine whether each species displays similar rate-dependent effects
on wavelength, or whether the differences in arrhythmia dynamics between species may
increase with varying physiological parameters. The effective size calculation is performed
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to study the combined effects of rate-dependent wavelength and the size of the hearts of
different species to quantify the potential similarities in VT arrhythmia dynamics. Cru-
cially, VT often occurs as a result of reentrant propagation around infarct scars caused
by ischemic damage to the tissue. Ischemia also alters the electrophysiological properties
of the myocardium, and hence wavelength, in the surviving tissue surrounding the infarc-
tion. The effective size calculation is used to determine whether species differences occur
in effective size as a result of ischemic damage, in order to suggest whether a particular
species model can replicate wave propagation dynamics of the human in both health and
disease.
The second aim of this Thesis is to investigate the possibility of improving the treat-
ment of post-MI VT utilising metrics of wavelength to determine the success of reentrant
propagation. Currently, ablation therapy seeks to disrupt the physical path along which
reentrant waves propagate to form reentrant circuits resulting in VT. As it stands, the lack
of a sufficient methodology for locating the optimal region to disrupt the circuit results
in poor treatment success rates and requires the induction of VT, which increases the
risk of the procedure. A previous methodology utilised metrics of wavelength to deter-
mine whether reentry could occur around a simple circuit based on wavefront-waveback
interactions in a porcine in vivo model. We utilise the fundamental concept to investigate
whether the technique can be built upon and used to accurately locate reentrant circuits
in the clinic without the danger to the patient of inducing VT. In addition to studying this
technique in a human in silico model over a range of physiological conditions, including the
addition of infarct scar obstacles into tissue level models, we aim to thoroughly examine
the potential use of the technique in the clinic and optimise the algorithm by performing
sensitivity analyses of the parameters implemented in the calculation. In particular, we
determine whether the technique remains accurate when only data from the surface of
the heart are available. In addition, we observe the impact that low resolution clinical
recording has on the ability to locate the critical circuit in order to be able to conclude
whether the technique could be of significant use in the clinic.
1.5 Thesis Outline
The Thesis begins with the presentation of the fundamental background information on
cardiac physiology in Chapter 2, describing cardiac anatomy and in particular, outlining
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how the movement of ionic particles causes the fundamental electrical activity of the my-
ocardium at the single cell level. The chapter progresses with an account of the mechanism
behind tissue level excitation leading to wave propagation. Both the characterisation and
implication of the rate-dependency of electrophysiological properties are discussed. Back-
ground information is then presented on how data are recorded in in vivo studies and in
the clinic. Following that account, the methodology behind representing single cell elec-
trophysiology and activation of cardiac tissue with mathematical equations is explained.
Importantly, an account of the pathology of MI is discussed, including the causes and
progression of the disease in relation to VT and the chapter concludes with an overview
of the ablation therapy used to treat VT.
A review of the relevant literature is presented in Chapter 3, beginning with an ac-
count of the work which reports and describes the mechanisms behind the occurrence of
Post-MI VT. An outline of previous studies which have utilised animal models to study
arrhythmias is then given, followed by a review of in silico models which have been utilised
to investige arrhythmias. A presentation of the foundational study which implied that the
effective size could determine the most suitable model to replicate clinical arrhythmias
follows. We present an account of past and present ablation treatment strategies and
their downfalls with a mention of how the procedure could be improved. An overview of
the work which preceeds the research in Chapters 5 and 6, illustrating how measures of
activation wavelength in a potential reentrant circuit can predict the success of reentry
is then presented. The literature review ends with a discussion about where further re-
search could enhance the literature which has been acknowledged in this chapter, further
motivating the research presented as part of this Thesis.
Chapter 4 constitutes the first research chapter of the Thesis. The work in this chapter
builds upon previous research suggesting that calculating the effective size of the heart
can quantify species differences in wave propagation dynamics based upon wavelength and
heart size. We use a simplified 2D geometrical model to simulate the electrophysiology
of four small animal species using existing mathematical models. Observations of rate-
dependent electrophysiological properties and their effects on wavelength are studied in
order to investigate the rate-dependent species differences in effective size. Additionally,
electrophysiological alterations as a result of MI are incorporated into the models, in order
to observe their effect on the effective size of the hearts of different species.
In Chapter 5 we begin our research investigating the possibility of improving the ac-
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curacy and success rates of the ablation procedure, by utilising metrics of wavelength to
locate regions of tissue susceptible to reentry. We validate the technique in a simple 2D
geometrical model using a human model to simulate cardiac electrophysiology. In this
chapter we investigate whether the proposed technique is robust in the human model,
across varying physiological conditions and considering the limitations imposed by clinical
data recording, such as decreased resolution of the data. Crucially, we introduce a simpli-
fied obstacle to represent an MI scar and model the wave propagation around the scar to
observe whether the technique can locate regions susceptible to reentry in more complex
clinical scenarios.
The final results chapter (Chapter 6) presents the research conducted to thoroughly
investigate the potential use of the technique to improve the ablation procedure in the
clinical scenario. As such, a highly detailed geometrical model of the rabbit ventricles
was utilised to minimise computational demand in return for the ability to conduct many
simulations testing a variety of variables. We study the ability of the technique to locate
regions of the heart susceptible to reentry utilising varying simplified scar geometries
to simulate patient variation. Again, we investigate the impact of low resolution data
recording on the surface of the heart in the clinic. The research presented in this chapter
determines whether the technique to locate regions susceptible to reentry can guide the
ablation procedure with increased accuracy and success rates.
Chapter 7 concludes the Thesis by presenting a summary of the results of the research
conducted here, highlighting the impact of the results on the clinical treatment of post-MI
VT. Following the summary, possible future directions to further validate and investigate




Presented in this chapter are the fundamental concepts of the structure and function of
the heart in health and after an MI. Particularly, the excitability of the heart is described
in sections which discuss the cellular mechanisms of the cardiac action potential and the
action of excitation wave conduction across the myocardium. In addition, a discussion of
the methodology behind both single cell and tissue level computational modelling is given.
Following that, pathological alterations in cellular function and the subsequent disruption
of the heart rhythm as a result of an MI are discussed. The chapter concludes with a
description of radiofrequency catheter ablation therapy employed in the treatment of MI.
2.1 Cardiac Function
The function of the heart is to pump blood around the body, transporting oxygen and
nutrients to cells which are required ubiquitously for maintaining cellular function and re-
moving the by-products of cellular metabolism. Within one heartbeat, oxygenated blood
is transported systemically to deliver oxygen and nutrients to the tissues and deoxygenated
blood is returned to the heart to be pumped into the lungs for reoxygenation. The con-
stant transportation of oxygenated blood throughout the circulatory system is essential
to maintaining life, for in its absence, loss of consciousness and cardiac arrest, or SCD,
occurs within minutes.
The heart must beat synchronously in order to maximise its efficiency. The myocar-
dial wall contracts during systole to force blood out of the heart, to the lungs via the
pulmonary system and around the body via the systemic system. Relaxation of the cham-
bers occurs during diastole to allow blood to flow back into the heart. In the event that
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contraction of the heart muscle becomes desynchronised, and the chambers contract out
of phase with each other, the cardiac output (CO) of the heart is compromised due to
insufficient presystolic filling. Thus, maintenance of the heart’s function must be sustained
and consistent throughout a lifetime, representing a vast amount of physical work and re-
quiring sophisticated protective mechanisms. In health, the CO is maintained throughout
varying physiological conditions to fulfil systemic oxygen demand.
2.2 Cardiac Anatomy
2.2.1 Gross Anatomy
The heart measures approximately 12cm from the apex (inferior) to the base (superior),
8cm in the lateral direction and 6cm in the anteroposterior direction. Figure 2.1 depicts
Figure 2.1: Diagram of the heart.
the gross geometry of the heart and its vessels. The compartmentalisation of the heart
into four chambers facilitates the separation of oxygenated and deoxygenated blood and
maintains the differentiated pressure gradients, required for the simultaneous transport of
blood through the systemic and pulmonary circulatory systems. Valves separate the basal
atria from the apical ventricles to maintain pressure gradients and ensure one-directional
flow. Blood leaves the heart via the aorta and pulmonary artery and returns to the
heart through the vena cava and pulmonary veins. The right and left ventricles (RV &
LV respectively) are separated by myocardium named the interventricular septum which
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forms part of the LV chamber. LV wall thickness increases from the apex to the base with
an average depth of approximately 1cm. A thickened LV wall is required to withstand
high pressures generated for the systemic transportation of blood. The inner surface of
the heart chambers is termed the endocardium and the outer surfaces are termed the
epicardium.
2.2.2 Cellular Anatomy
The myocardium is primarily comprised of electrically excitable, contractile myocytes.
A fluid mosaic lipid bi-layer membrane called the sarcolemma, separates the myocytes
from both each other and the extracelluar space. The sarcolemma forms due to the
polar nature of phospholipid molecules which constitute the membrane. Ion channels and
active transport pumps are incorporated into the sarcolemma and span the membrane,
connecting the intracellular and extracellular spaces. Either subunits or single polypeptide
chains make up the ion channels, which arrange to form pores through the membrane. It
is the flux of ions through these membrane proteins which confers on the myocardium its
electrical property. Selectivity to ion species is crucial for the electrical activity of the cell
and is inferred either by the physical size of the pore, or by the charge or size of amino
acids surrounding the pore. The protein molecules forming the ion channels are allosteric
proteins which can attain open, closed or inactivated states. Conformational changes of
the amino acid residues serve to either open or occlude a given channel in response to
changes in voltage or time. Similarly, conformational changes in active transport pumps
facilitate the uptake and release of ions at either side of the membrane. In Section 2.3,
the importance of the mechanisms controlling the flux of ions across the membrane will
be discussed as they are essential characteristics of cellular electrical activity.
Within the sarcoplasm of each cell, the units responsible for generating contractile
force, the sarcomeres, are arranged to form long strands called myofibrils (Figure 2.2
(left, top and middle)). Sarcomeres contract longitudinally and so due to their intracel-
lular arrangement, contractile force is generated in the direction parallel to the myofibrils.
The importance of this property is contextualised in the following paragraph which de-
scribes how myocytes arrange to form cardiac tissue.
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Figure 2.2: Structure of the myocardium. Left, top to bottom - Sarcomeres join to form
myofibrils within the myocytes, and myocytes join to form longitudinal fibres. Right, top
- Gap junctions within intercalated disks adjoin neighboring myocytes . Right, bottom -
Myocyte fibres form laminar sheets with orthogonal fibre axes.
2.2.3 Myocardial Structure
Myocytes arrange end-to-end into longitudinal fibres (Figure 2.2 (left, bottom)), the direc-
tion of which determines the contractile strength of the myocardium. These fibres coalesce
to form laminar sheets of myocardial tissue, a few cells thick (Figure 2.2 (right, bottom)).
Importantly, the arrangement of the myocyte fibres within the myocardial wall, play a role
in not only the anisotropic strength of contraction but also the anisotropic conduction of
electrical activation waves through the myocardium, which will be discussed further in
Section 2.3. The myocardium can be described as an orthotropic material with an axis
parallel to the longitudinal fibre direction, an orthogonal axis in the transverse fibre di-
rection in the plane of the sheet and a third orthogonal axis in the sheet normal direction.
The angle of the fibres with respect to the apex-base axis of the heart is called the helix
angle. The helix angle of the fibres varies from the epicardium to the endocardium, with
the angle at the epicardium approximately tangential to the wall at −60◦, transitioning
through 0◦ in the midmyocardium to +70◦ and tangential to the endocardial wall at the
endocardium.
2.2.4 Intercellular Coupling
Neighbouring myocytes are coupled together via gap junctions in the sarcolemma (Figure
2.2 (right, top)), forming a syncytium in which the sarcoplasms of the myocytes are
continuous. The continuity of the sarcoplasms plays a role in the conduction of electrical
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activation waves throughout the tissue (see Section 2.3). Regions of the sarcolemma of two
adjacent cells come into close proximity to each other (approximtely 2nm) at sites called
intercalated disks. Gap junctions occur at the intercalated disks forming small pores called
connexons which span from the sarcoplasm of one cell, through the extracellular space,
into the sarcoplasm of an adjacent cell. The structure of the pore is formed by six integral
membrane proteins called connexins (Connexin-43 (Cx43) predominates in the ventricles)
and has a surface area of approximately 0.005µm. The pore of the gap junction allows
molecules such as ions to flow from the sarcoplasms of adjacent cells whilst remaining
discontinuous with the extracellular medium, forming a path of low resistance between
myocytes.
On average, 11 myocytes are connected to each other via intercalated disks. Approxi-
mately 50% of gap junctions in a cell membrane are located at the ends of the myocyte and
50% are located along the edges (Saffitz, 1994). However due to the elongated cylindrical
shape of the myocytes, a greater density of gap junctions occurs within the smaller surface
areas of the ends than at the side edges. Gap junctions are dynamic structures within the
sarcolemma whose connexin subunits are deposited and degraded every few hours. This
high turnover of gap junction proteins facilitates the relocation and altered regulation of
the gap junctions within the myocyte, in states of disease.
2.3 Cardiac Electrophysiology
The electrical property of cardiac tissue underlies the contractile mechanism of the heart
and is therefore vital to cardiac function as a whole. The research presented in Chapters
4, 5 and 6 involves modelling electrical activity at the single cell and tissue level and so
an understanding of the generation and propagation of electrical signals in the heart is
essential and is discussed in this section. In addition, we consider how electrical signals
generate cardiac contraction and lastly, look at a protective mechanism, cardiac restitution,
which ensures that, despite an increase in heart rate, the heart maintains its functional
capability.
2.3.1 The Membrane Potential
The phospholipid bilayer structure of the sarcolemma (discussed in Section 2.2) renders
the membrane impermeable to ions, with ion channels facilitating transport of ionic species
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into and out of the cell, conferring a selective permeability on the membrane. The con-
formational changes in the ion channels, commonly referred to as the gating mechanism,
alters the permeability of the sarcolemma to specific ions. The regulated transportation
of cations across the sarcolemma produces a difference in ionic concentration between the
intra- and extracellular spaces, causing a potential difference which evokes the electrical
property of the myocardium.
The diffusion of ions through species-selective gated ion channels is controlled by elec-
trochemical gradients of the ions across the membrane. A specific species of ion diffuses
across the sarcolemma through ion channels from a region of high concentration of that
ion, to a region of low concentration of that ion, to balance its electrochemical concen-
tration across the membrane. Differences in concentration of charge across a membrane
occur, due to the permeability of the membrane to that ion and the ion’s flux, causing a
potential difference. When the electrical gradient is large enough to cause the net move-
ment of the ion across the sarcolemma to cease, electrochemical equilibrium is reached.
The potential difference across the membrane required to maintain this equilibrium is
called the equilibrium potential (E). The Nernst equation (Equation 2.1) describes the
equilibrium potential for a single ionic species (Eion) where [ion]o denotes the extracellular
concentration of the ion, [ion]i is the intracellular concentration of the ion, R is the gas








An extension of the Nernst equation gives the Goldman equation (Equation 2.2) which
produces the potential difference across the membrane, the membrane potential (Vm),
considering that the membrane is permeable to more than one ion. In the case of cardiac










PK [K+]i + PNa[Na+]i + PCl[Cl−]o
) (2.2)
where P is the permeability of the membrane to the ionic species. In contrast to ion
channels which allow the passive diffusion of ions down the electrochemical gradient, active
transport pumps transport particles across the membrane against the electrochemical
gradient and require adenosine triphosphate (ATP) to do so.
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2.3.2 The Cardiac Action Potential
The membrane potential of the cell at rest (Vrest) is approximately −80mV. At rest, the
membrane is most permeable to K+ and relatively impermeable to other cations. As such,
Vm approaches the equilibrium potential of K
+ (EK) at −85mV. However, Vm is slightly
more positive than EK due to a small inward potassium current through potassium leak
channels, referred to as the inward rectifier current (IK1).
Depolarisation of the cell membrane from Vrest constitutes an action potential (AP),
the electrical signal that is transmitted across the heart to stimulate contraction. Figure
2.3 displays an AP and highlights the occurrence of four distinct phases caused by different
ionic currents. As a positive current from a neighbouring cell depolarises the membrane
Figure 2.3: Diagram of a cardiac AP. EK and the flux of ion concentrations driving
the membrane potential are indicated. Approximate representations of ERP, APD50 and
APD90 are labelled on the diagram.
from Vrest to approximately −65mV, the voltage gated sodium channels open, allowing
an influx of Na+ into the cell (red). This sodium current (INa) rapidly depolarises the
cell membrane during the upstroke phase of the action potential. A second inward current
of Ca2+ (ICaL), initiated by the voltage-dependent gating of the ion channels at approx-
imately −45mV, also contributes to the upstroke of the AP which terminates when Vm
reaches its peak at approximately +25mV. Both INa and ICaL inactivate after specific
time periods. The plateau phase (blue) is a major contributor to the refractoriness of
the tissue, a property which is vital in maintaining the regular contraction of the heart.
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The initial part of this phase of the AP is due to ICaL but this current plays another
important role in the plateau phase. The influx of Ca2+ due to ICaL causes the release
of Ca2+ from intracellular stores within the sarcoplasmic reticulum (SR), maintaining the
positive Vm at approximately 0mV. Also contributing to the plateau phase is the reduced
permeability of the membrane to K+ at higher Vm and the net influx of Na
+ through the
sodium-calcium exchange pump (NCX), which extrudes one Ca2+ in exchange for the in-
flux of three Na+. Repolarisation of the membrane (green) occurs as sarcoplasmic calcium
is taken up into the SR. Time-dependent potassium channels open causing an outward
potassium current. In addition, the permeability of the membrane to K+ increases as Vm
falls, further repolarising the membrane until it reaches Vrest.
Refractoriness is the property of the tissue which ensures that ectopic stimulation (an
abnormal stimulus occurring out of normal rhythm) of the membrane cannot elicit an
AP. This feature safeguards the heart from possible ectopic beats and hence irregular
or tetanic contractions which would cause inefficient cardiac function and impaired CO.
During sinus rhythm, the action potential duration (APD) from the upstroke to repolar-
isation, is approximately 200 − 400ms and is contributed to by the large plateau phase
of the human cardiac AP. The effective refractory period (ERP) is described as the pe-
riod in which no amount of further stimulation of the membrane can elicit another AP
and ends slightly before total repolarisation of the membrane. The relative refractory
period denotes a period of time after the ERP when the membrane is not at rest, but an
AP can be initiated under the right circumstances. The time-dependent inactivation of
sodium channels ensures that further APs cannot be initiated whilst these channels are
inactive. The period of sodium channel inactivation produces the ERP and lasts until
the membrane is nearly fully repolarised, when inactivation of the voltage-gated sodium
channels ceases. The relative refractory period is produced by the voltage-dependence of
the sodium channels, which must see a rise of approximately 15mV from Vrest before an
AP is initiated. Hence, a large influx of positive current must occur during the relative
refractory period in order to elicit an AP.
2.3.3 Conduction of Electrical Signals
Having described the mechanism of initiating an electrical potential at the single cell level,
it is important to consider how these APs are conducted to produce waves of excitation
which travel across the heart and cause mechanical contractions. Initially, we focus on
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how the electrical potential is initiated in the pacemaker cells of the heart and go on to
consider how that potential is conducted across the tissue.
Impulse Initiation
Initial electrical potential is conferred on the heart by the spontaneous activity of the
autorhythmic cardiac pacemaker cells in the sinoatrial node. An electrical potential is
initated across the membrane of these myocytes due to changes in the membrane conduc-
tance of ions. The autorhythmycity of these cells ensures the essential continuous rhythmic
contraction of the heart, but the rate of autorhythmicity of the cells is controlled by the
autonomic nervous system which alters membrane conductance, due to the stimulation of
either β-adrenergic (excitatory) or nicotinic (inhibitory) receptors. The electrical poten-
tial then propagates across the atria, causing contraction of the atria, forcing blood into
the ventricles. The electrical signal then reaches the atrioventricular node at which point,
the activation spreads along fast-conducting impulse pathways down the bundle of His
(4 − 5m/s−1) to the apex of the heart and into the Purkinje system, from which homo-
geneous propagation of the ventricles begins simultaneously across the heart (0.5m/s−1),
forcing blood out of the ventricles. However, the Purkinje network is connected to the en-
docardium so that propagation of the electrical wave occurs primarily at the endocardium,
spreading towards the epicardium in an apical-basal direction.
Electrotonic Current
The structure and location of gap junctions connecting the sarcoplasms of adjoining cells
into a syncytium has already been discussed in Section 2.2. Their function is to electrically
couple myocytes together, providing a low resistance pathway for ionic species to travel
between cells. This continuity between cells allows the rapid transmission of electrical
signals which enables synchronous depolarisation and contraction across the tissue. Gap
junctions are gated via a complex voltage and time dependent mechanism, opening when
the voltage across the gap junction is near to 0mV and closing at very positive or very
negative voltages. When gap junctions are open, cations flow from the depolarised cell
to neighbouring hyperpolarised cells, initiating an AP in adjacent cells. This flow of
cations through gap junctions is called the electrotonic current, the magnitude of which is
dependent on the number of gap junctions and gap junctional conductivity. An increase
in electrotonic current increases the conduction velocity (CV) of the electrical signal. The
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voltage sensitivity of the gating mechanism facilitates the flow of ions in one direction,
ensuring that the propagation of the electrical signal flows in one direction. Thus, the flux
of cations through the syncytium causes an electrical activation wave to propagate across
the tissue with a largely homogeneous wavefront.
Electrical current is only transferred between cells through gap junctions and so the
position of the gap junctions throughout the myocardium affects the shape of the wave as
it propagates throughout the heart. Due to the higher concentration of gap junctions at
the ends of the cylindrical myocytes and the more diffuse gap junctions positioned along
the edges of the myocyte, electrotonic current flows faster longitudinally along the direc-
tion of the fibre than transversely between the edges of the myocytes. The anisotropic
conductivity across the myocardium causes the CV in the longitudinal direction to be
approximately three times faster than in the transverse direction. As a result of this
anisotropy, the direction of the fibre affects the morphology of the wavefront. Due to
the increased helix angles at the epi- and endocardium where fibre direction is approxi-
mately tangential to the wall, CV in the apical-basal direction is faster here than at the
midmyocardium because of the preferential conduction along the fibre.
The success of the wave propagation is determined by the so-called source/sink rela-
tionship. The source is the current of the electrical signal and is provided by the influx of
cations into a myocyte. The sink is the tissue which the source could potentially excite.
A large source (whether it is a large current or current stemming from a large volume of
tissue) and small sink will ensure safe and fast propagation of the electrical wave through
the myocardium. Whereas large sinks and a small source (either a small current or current
emanating from a small volume of tissue) will slow CV and possibly terminate the wave.
In addition, resistance to the source current through the sarcoplasm and the gap junctions
affects the sink and alters wave propagation success. These source/sink effects ultimately
determine the shape of the propagation wave, the speed of conduction and the success of
propagation.
2.3.4 Electromechanical Contraction
Blood is able to be actively pumped out of the heart because it is a muscle, contracting to
force blood out of the ventricles in systole and relaxing to allow blood to flow back into the
heart in diastole. As electrical signals propagate across the heart, each myocyte contracts
due to a rise in intracellular calcium. The subcellular units responsible for generating
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contractile force, the sarcomeres, are composed of actin filaments interspersed with myosin
filaments which are held together by cross bridges. Contraction occurs when the myosin
filament slides along the actin filament, shortening the length of the sarcomere. In a
relaxed state, steric hindrance occurs between the actin and myosin filaments, preventing
cross bridges forming. Calcium ions are able to relieve the steric inhibition allowing cross
bridges to form between the filaments and the sliding mechanism which generates the
contraction can occur. Sarcoplasmic concentration of calcium is very low when the cell
is at rest so a rise in calcium is required for the initiation of contraction. This rise in
calcium occurs during an AP, when the sarcoplasmic concentration of calcium is increased
by in the influx of Ca2+ via ICaL and via the release of Ca
2+ from the SR, enabling the
initiation of contraction.
2.3.5 Cardiac Restitution
Cardiac restitution is a cardio-protective mechanism which ensures regular contraction of
the heart as the heart rate (synomymous with stimulation frequency) varies, maintaining
efficient CO. The research presented in Chapters 4, 5 and 6 of this Thesis focuses on ar-
rhythmias, a physiological condition which arises due to a disruption of the heart rhythm.
Although this can be brought about by varying causes, increases in heart rate often fa-
cilitate the occurrence of arrhythmias. As will become evident in this section, APD, CV
and wavelength all decrease as heart rate increases in order to preserve cardiac function.
However, a concept which is fundamental to this Thesis and is discussed in Sections 2.6
and 3.2 and in Chapters 4, 5 and 6, is that a decrease in wavelength due to restitution
effects increases the likelihood that an arrhythmia will occur. Therefore, an understanding
of the mechanism and the implications of cardiac restitution is necessary to contextualise
the research presented here.
Restitution is defined as the relationship between the APD and the interval between
APs, the diastolic interval (DI). The APD is defined as the time between the upstroke
and repolarisation of the AP. The upstroke occurs over a very short time period, typically
a few milliseconds, whereas the repolarisation phase is longer. As such, it is possible to
define repolarisation at different times, such as at 50% or 90% of repolarisation. Thus,
the APD can be defined as the time between the upstroke and the time it takes to reach
50% of repolarisation (APD50) and can also be defined as the time between the upstroke
and the time it takes to reach 90% of repolarisation (APD90). The DI is the interval
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between APs during which the membrane is at rest and the heart is relaxed. The DI can
be governed by the duration of time between stimuli, otherwise referred to as the basic
cycle length (BCL) and so in terms of restitution, the relationship between APD and DI
is analagous to the relationship between APD and BCL.
Restitution Pacing Protocols
Restitution protocols are performed to analyse the restitution relationship, the relationship
between APD and DI, with varying pacing frequency. Two primary protocols are utilised
to investigate the relationship; the dynamic and the S1S2 protocol.
The dynamic pacing protocol implements a gradual change in frequency and is illus-
trated on the right of Figure 2.4. Typically, x number of beats are paced at a certain
Figure 2.4: Restitution pacing protocols. Left - S1S2 pacing protocol. Right - dynamic
pacing protocol. Each vertical line represents a stimulus. BCL decreases from top to
bottom. Stimulus from which AP data are recorded is shown in red.
BCL before the BCL is reduced. Another x number of beats are paced at the new BCL,
and the pattern is repeated, decreasing the BCL each time. The APDs used in restitution
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analysis are sampled at the end of each train of beats at a particular BCL, just before the
stimulus train at a new BCL begins.
The S1S2 pacing protocol provides a more sudden change in pacing frequency and is
illustrated on the left of Figure 2.4. The S1 stimulus constitutes pacing at a long BCL
for x number of beats, shown in blue in the figure. A single, premature beat that is paced
at a shorter BCL (red) is the S2 stimulus. The S1 phase is repeated with the intervening
S2 beats paced at decreasing BCLs. The APD data are recorded from the premature S2
beats.
APD Restitution
APD displays rate dependency. As BCL decreases, the APD decreases ensuring that com-
plete APs occur, to maintain efficient contraction of the myocardium and hence, cardiac
function. Ion channels involved in an AP are controlled by complex gating mechanisms.
Many channels such as the sodium channels, proceed to an inactive state after the open
and closed states have taken place. The inactivation phase is time-dependent and hence,
a particular period of time is required for the channels to recover from inactivaion before
another AP can occur. Thus, the APD is dependent on the length of the previous DI. If a
preceding DI is short, the subsequent APD will also be short due to insufficient recovery
of the ion channels from inactivation. At very short BCLs, after a shortened AP, the
DI may be slightly longer due to the premature repolarisation of the previous beat and
so the subsequent AP occurring after the lengthened DI may be longer. The cycling of
long-short-long-short APs is termed alternans. Calcium plays an important role in initiat-
ing and maintaining alternans. Due to the calcium-induced-calcium-release from the SR,
a decrease in ICaL decreases the release of SR calcium, decreasing the calcium transient
which maintains the plateau phase of the AP and so decreases the APD. The instability
of the calcium transient underlies the occurrence of APD alternans. The monotonic rela-
tionship between APD and BCL (left, top) and the occurrence of alternans (right, top) is
displayed in Figure 2.5 during trains of APs stimulated at decreasing BCLs. As displayed
on the left of the lower panel in Figure 2.5, a graph of APD against BCL or DI produces
a restitution curve which displays the monotonic decrease in APD with decreasing BCL.
Graph bifurcations at small BCLs indicate that the APD varies between two beats and
signifies the presence of alternans.
Alternans can be spatially discordant throughout the tissue. In some regions APD may
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Figure 2.5: Cardiac restitution. AP traces display decreasing APD as BCL decreases
(left, top) and APD alternans at short BCLs (right, top). The lower panel displays
an APD restitution curve for two subsequent APs shown in blue and red, and CV and
wavelength restitution curves.
be long, whilst in other regions APD may be short. This heterogeneity results in wave
break and fibrillation. Nolasco and Dahlen (1968) proposed a graphical representation
to predict the occurrence of alternans at fast pacing freqencies. They concluded that if
the restitution graph has a slope greater than 1, the system becomes unstable leading to
alternation in APD which can lead to wave break. A restitution graph with a slope less
than one predicts stable APD values and stable propagation.
CV Restitution
CV of the excitation wave also varies as the frequency of stimulation varies. The CV de-
creases as the rate of stimulation increases (Figure 2.5 (middle, bottom)) due to the time
it takes the sodium channels to recover from inactivation. As electrotonic current passes
into the cell, if sodium channels remain inactivated, an AP will not occur and conduction
through the myocyte will be delayed until the sodium channels have recovered from inac-
tivation. Therefore, at short BCLs, sodium channels are more likely to be inactive due to
the short preceding DI and so CV decreases. Decreasing CV enables previously activated
tissue to recover before the current activation wave arrives. In situations of irregular prop-





The activation wavelength is the length of tissue in which all myocytes are depolarised.
However, not all myocytes are depolarised to the same degree. In Figure 2.6, the AP from
Figure 2.6: Wave propagation across a tissue model.
the front of the wave illustrates that myocytes in this region are only just being depolarised
by the electrotonic current of the neighbouring activated cell and are at the beginning of
the upstroke phase of the AP. In the same instant, cells at the back of the wave are very
nearly repolarised and ready to be reactivated by the next wavefront. Wavelength (λ) is
described by the equation,
λ = ERP × CV (2.3)
the ERP determining when the tissue is able to be reactivated. In most circumstances,
the ERP, occurring during the repolarisation phase of the AP, is very similar to the APD.
However, in certain circumstances, the ERP is sustained after the cell has repolarised back
to Vrest. This post-repolarisation-refractoriness may occur in cells which have been altered
by ischemia. Due to the similarity between the APD and ERP prevailing in most cases,
the equation for λ is often defined as
λ = APD × CV (2.4)
(Lou et al., 2012; Weiss et al., 2000; Matthews et al., 2013; Garfinkel et al., 2000; Girouard
and Rosenbaum, 2001), so that λ can be calculated without requiring data on the recovery
of sodium channels from inactivation which determines the ERP. Due to the frequency
dependence of both APD and CV, wavelength also varies as a function of stimulation
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frequency. As stimulation frequency increases, both APD and CV decrease so wavelength
decreases also (Figure 2.5 (right, bottom)). This decrease in wavelength due to increased
pacing frequency facilitates propagation of unsynchronised, disruptive waves leading to
cardiac dysfunction.
2.4 Acquisition of Electrophysiological Data
In Chapter 1, the use of in vivo research in both the clinic and animal models, as well
as the use of in silico models to research arrhythmias was discussed. Irrespective of
the medium, in many cases, acquisition of electrophysiological data is required to carry
out research pertaining to single cell ionic mechanisms and tissue level electrical wave
propagation during arrhythmias. The research presented in Chapters 4, 5 and 6 rely upon
mathematical models which have been formulated based upon animal data. The research
in Chapter 6 has a significant clinical application and indeed, comparisons are drawn
between this modelling study and relevant clinical studies. Understanding the acquisition
of electrophysiological data from both patients and animal models, the characteristics
of the data and their limitations is important in order to be able to fully understand
the results of the modelling studies presented in this Thesis and crucially, to be able
to compare these results to clinical studies, which is particularly relevant to the work
discussed in Chapter 6.
2.4.1 Animal data
Single Cell Electrophysiological Data
Measurements of cellular ionic mechanisms are often obtained from isolated animal hearts.
The membrane potential can be measured using microelectrodes in intracellular recordings.
Microelectrodes are approximately a micron in diameter and are filled with a conducting
buffer solution. One of the microelectrodes is inserted into the sarcolemma and a tight seal
is reformed around the electrode. The other microelectrode is placed in the extracellular
space and the potential difference is measured across the membrane to provide a measure
of Vm. Current flow through a specific ion channel can be measured using patch clamp
recordings in which a strong suction seal is created, rupturing the membrane around
a single ion channel so that flux of ions through the channel can be measured. Both
membrane potential and ionic current data are invaluable to electrophysiological research,
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as such in vivo measurements can provide information about cellular APs, restitution
effects and even the biophysical mechanisms underlying such phenomena.
Isolating the heart to obtain the required measurements involves administering anal-
gesics and tranquilisers such as ketamine and azaperone which are antagonists of neu-
roreceptors. In addition, animals are anaesthetised with drugs such as pentobarbital and
isoflurane which are agonists of inhibitory neurotransmitters and lower the heart rate.
These drugs affect the heart via multiple mechanisms, all of which are not fully under-
stood. As such, it is important to consider that the cocktail of drugs administered to the
animal before acquistion of the data may affect the resulting data.
The process of rupturing the cell membrane during intracellular recording causes the
release of intracellular calcium stores. A buffer solution is required to diminish fluctuations
in intracellular calcium. The buffer solution is also used to create a good seal with the
membrane which is essential for accurate measurement, to maintain continuity of medium
and to retain turgidity of the cell as the membrane is ruptured. EGTA, a calcium chelator,
is commonly used in the buffer solution which may cause inaccurate recordings of many
currents due to the interdependence of currents on intracellular calcium levels. In fact,
the abnormal restitution curve of the rat model used in Chapter 4 may be attributed to
the model being formulated from data which are adversely affected by the use of EGTA
in the buffer solution. This is further discussed in Chapters 4 and 7.
In vivo ion channel and ionic current data are used to develop mathematical models of
cardiac AP. As described in the previous paragraphs, the techniques used to acquire the
data may result in recorded data not accurately reflecting in vivo electrophysiology. As a
result, mathematical models formulated from such data also have the potential to display
characteristics which deviate from true in vivo function. However, it is important to note
that widely used mathematical models of cellular electrophysiology have been validated
against numerous data to ensure that parameters which describe the morphology of the
AP and its function fit with other experimental data sets. If the models are validated
against such data and are able to replicate gross in vivo cardiac electrophysiology, the
model may be relied upon to produce physiological results. As such, mathematical models
replicating cellular electrophysiology are used throughout the research conducted for this
Thesis.
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Tissue Level Electrophysiological Data
Optical mapping provides a technique to observe and measure wave propagation across a
tissue. To do this, tissue is perfused with a voltage sensitive dye, the tissue can then be
stimulated and the dye excited by a light source. Emitted fluorescence is then a marker
by which to observe and record membrane potentials travelling across the tissue.
Common voltage sensitive dyes used in this context are from the ANEP family of
dyes and it has been suggested that the dye used in the protocol may have an effect on
the membrane potential and the channels affecting repolarization and restitution, thus
affecting CV and wavelength. In addition, mechanical uncoupling agents are used in
order to stem contraction of the cardiac tissue for the purposes of reducing noise in data
acquisition. It has been reported that mechanical uncoupling agents may also alter ionic
currents which in turn alter AP properties (Liu et al., 1993; Banville and Gray, 2002;
Baker et al., 2004; Fedorov et al., 2007).
Again, such tissue level data are important for investigating wave propagation and
validating single cell research. However, it must be noted that the methodology of data
acquisition does not produce infallible data. Therefore, when drawing conclusions from




Clinical recording of electrophysiological data is necessary primarily for diagnostic pur-
poses to observe the functioning of the heart but is also widely utilised in research. 12-lead
surface electrocardiograms, commonly referred to as ECGs, are obtained by placing elec-
trodes on the surface of the body. Due to the large changes in potential over the cardiac
cycle, average potentials can be measured from surface ECG leads. Characteristic ECG
traces indicate the depolarisation of the ventricles by the presence of the QRS complex,
the major upward deflection of the trace. The smaller deflection occurring after the QRS
complex, known as the T wave indicates the repolarisation of the ventricles. The ventric-
ular APD can be estimated as the difference in time between the T wave and the peak of
the QRS complex.
Abnormalities in cardiac function can be diagnosed by comparing patient traces with
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that of characteristic traces and observing any deviations in rate, magnitude and intervals
between complexes. They provide an invaluable diagnostic tool but lack the ability to be
able to provide investigative techniques to uncover the details of a pathology. For example,
if VT is observed on an ECG trace, the cause of the VT remains unknown from the ECG
data available.
Intracardiac Recording
Intracardiac studies may also be conducted if an ECG indicates an abnormality or if
ischemia and structural heart disease is suspected. Such studies are conducted to provide
additional details about the pathology. For example, if VT is suggested by an ECG trace,
intracardiac recordings could be used to observe abnormalities in electrical activity across
the tissue such as those which may occur as a result of ischemic damage. Importantly,
intracardiac recordings are used during ablation procedures as discussed in Sections 2.6
and 3.7 and the data are used to indicate where the clinician should ablate the tissue
based on observing signs of reentrant circuits in the patterns of electrical activity. In
addition, the research presented in Chapter 6 aims to investigate the clinical application
of a technique to guide the ablation procedure and highlights some of the major limitations
of intracardiac electrogram data. An overview is given here.
Most commonly, catheter electrodes are inserted into the heart through a blood vessel
to gain access to the endocardium although in some cases, access to the epicardium via
a percutaneous approach is performed. Considering an endocardial intracardiac study,
unipolar electrograms are obtained by taking the difference between the membrane poten-
tial at a reference electrode and the membrane potential at a recording electrode (Taggart
et al., 2014). An electrogram records average voltage changes in the extracellular space,
produced by the flux of ions into and out of the myocytes during an AP. The recording
electrode catheter can be moved around the endocardium to record signals from differ-
ent areas of the heart. Thus, it is possible to both localise regions of tissue with altered
electrical properties and record abnormal excitation wave propagation across the tissue.
It is also possible to approximate the time at which the tissue is activated (activation
time (AT)), the time at which the tissue repolarises (repolarisation time (RT)) and the
APD using the activation-recovery interval (ARI) (difference between the repolarisation
time and the activation time) obtained from the electrogram (Coronel et al., 2006). These
measures would be used in the clinical application of the technique studied in Chapter 6.
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Intracardiac electrophysiology studies provide detailed insight in to the excitability of
the tissue which can be of great use in treating an arrhythmia. Although this recording
technique bypasses the methodological problems which have been discussed in relation to
animal research, there are limitations to this method of data acquisition. Firstly, unlike
patch clamp recordings performed in animal models, information about the single cell
biophysics and ionic currents which underlie electrical activation of cardiac tissue is not
routinely available. There are methods which describe recording cellular action potentials
by taking myocardial biopsies (Taggart et al., 2014), however this is not routinely practised
in the clinic. Most commonly, data are recorded from the endocardial surface, neglecting
the fact that wave propagation occurs transmurally. Again, there are techniques available
to study transmural propagation using so-called plunge electrodes (Taggart et al., 2001)
but they are not commonplace. The resolution of acquired data is also a limiting factor
and has been discussed in Chapter 1. Data recorded from clinical intracardiac studies are
generally of low resolution due to the manual manipulation of the catheters and the limited
time period in which data can be obtained. In silico models allow investigation of 3D,
transmural propagation and sampling of in silico data at exceptionally high resolutions.
The work presented in Chapter 6 which concludes the research in this Thesis utilises
high resolution, transmural data from mathematical models of single cell electrophysiol-
ogy which have been formulated from animal data, to investigate the application of a
methodology to the clinic, considering the limitations of clinical data. In fact, taking
into consideration the benefits and limitations of both in silico and clinical data, signif-
icantly contributes to the value of this investigation into the clinical application of the
methodology.
2.5 Computational Modelling of Cardiac Electrical Activity
The benefits of utilising computational models have been discussed in Chapter 1 and in
Section 2.4. The research presented in this Thesis utilises computational models through-
out and so a discussion of modelling methodologies is required here in order to understand
the techniques implemented throughout the following research. In this section we discuss
the methods which are commonly utilised to model both single cell APs and tissue level
wave propagation.
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2.5.1 Modelling the Action Potential in a Single Cell
Deriving the Membrane Potential
Mathematical models of AP model the cell as an electrical circuit, with the sarcolemma
represented as a capacitor, separating the charge between the extracellular and intracel-
lular spaces. Resistors in parallel to the capacitor are analagous to ion channels in the
sarcolemma. The currents through these ion channels (Iion) drive the membrane potential.






where the capacitance of the membrane is Cm.
Mathematical Representations of Ionic Currents
The ionic current, Iion, utilised in the calculation of the membrane potential (Equation
2.5) can be calculated in various ways depending on the nature of the ion channel or pump
and its gating mechanisms. Different methods for calculating Iion are presented here.
It has previously been discussed in Section 2.3 that the Nernst equation provides the
equilibrium potential of the cell membrane when it is permeable to only one ion and
the Goldman equation calculates the equilibrium potential of the cell membrane when
it is permeable to more than one ion. Both the Nernst and Goldman equations can be
rewritten to calculate ionic current via a current-voltage relationship. The ionic current
for one particular ionic species derived from the Nernst equation is given as
Iion = gion(Vm − Eion) (2.6)
where gion is the conductance of the membrane to the ionic species and Eion is the Nernst
potential for the ionic species. The current-voltage relationship derived from the Gold-
man equation, gives the Goldman current equation, which models the ionic current of a
particular ionic species considering varying intracellular ([Ion]i) and extracellular ([Ion]o)
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where Pion is the permeability of the membrane to that ion, F is the Faraday constant, R
is the ideal gas constant and T is temperature.
Ion channels are rarely permeable to an ionic species consistently, but instead are
controlled by sometimes complex gating mechanisms which may be voltage- or time-
dependent. Therefore, the calculation of Iion must represent this stochastic mechanism.
Other formulations of Iion vary in their complexity and ability to model the complexity of
the ionic gating mechanisms. Perhaps the best known is the Hodgkin-Huxley formulation
which presents a method for calculating Iion through gated ion channels (Hodgkin and
Huxley, 1952). In fact, the models of membrane electrophysiology utilised throughout this
Thesis, as well as many others, are based upon the Hodgkin-Huxley formulation. In the
following paragraphs, the Hodgkin-Huxley formulation to determine Iion is presented.
From empirical evidence, Hodgkin and Huxley proposed that the membrane potential
was primarily determined by the currents INa, IK and Ileak. Each ionic current can be
calculated by the equation
Iion = gion(Vm − Eion) (2.8)
The ionic currents involved in driving Vm are determined by the conductance (g) of
the membrane to each ionic species. gleak is a linear term. However, gNa is dependent on
the activation, m and inactivation, h gating variables of the sodium channel. Likewise, gK
is dependent on the potassium activation gating variable n. Each of the gating variables





Ion channels can either occupy an open or a closed state and the gating variable
determines which state the ion channel is in. Each gating variable (x) is time and voltage
dependent which is represented by the equation
dx
dt
= α(Vm)(1− x)− β(Vm)x (2.11)
where x is a gating variable, α is the voltage-dependent rate constant of the channel closing
and β is the voltage-dependent rate constant of the channel opening. For each x, an α
and β value is obtained experimentally.
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Incorporating the complexity of the gating mechanisms of each channel within the g




+ gK(Vm − EK) + gNa(Vm − ENa) + gleak(Vm − Eleak) (2.12)
Thus, each ionic current can be calculated by four ODEs: three ODEs for the time and
voltage-dependent gating mechanisms for each of the gating variablesm, h and n (Equation
2.11), and the ODE calculating the total current across the membrane (Equation 2.12).




Istim − (INa + IK + Ileak)
Cm
(2.13)
2.5.2 Modelling Propagation of an Electrical Activation Wave
Cable Theory
Conduction of electrical propagation is modelled as continuous propagation along a cable
via the cable equation. At a particular point (x) and time (t) in the cable, the Vm is
defined as Vm(x, t). The resistance of the cable is Ra over a specific area and the current
which propagates along the cable is Ia. Another current, analagous to the transmembrane
current of the myocyte is denoted Im.
The transmembrane current Im is the sum of Iion and the current across the capacitor,
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where Vm is
Vm = φi − φe (2.18)
(φi = intracellular potential and φe = extracellular potential).





Considering Kirchhoff’s Law of the conservation of charge, charge can only leave the cable





Substituting the Im term from Equation 2.17 and differentiating 2.19 with respect to x,
the 1D monodomain cable equation is
d2Vm
dx2




Monodomain Representation of the Bidomain Model
It is first necessary to mention the bidomain model which models the propagation of elec-
trical activation thoughout the myocardium. The bidomain model considers both the
intracellular space and the extracellular space which are coupled together by transmem-
brane currents, so that any current leaving the intracellular domain is a transmembrane
current which must pass into the extracellular domain. This gives rise to two bidomain
equations involving intracellular and extracellular conductivities.
Note that the Vm is represented by Equation 2.18, which takes into consideration
the intra- and extracellular potentials. Electrical current density (J) is the product of the
conductivity (σ) and the electric field which can be defined as the negative spatial gradient
of potential (φ). Hence, intracellular and extracellular current densities can be defined as
Ji = −σi▽ φi (2.22)
and
Je = −σe ▽ φe (2.23)
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Considering that current densities in a region of tissue β must equal Im, using Equa-
tions 2.22, 2.23 and the conservation of current in Equation 2.20, the two bidomain equa-
tions can be written as
▽ · σi▽ φi = βIm (2.24)
and
▽ · σe ▽ φe = −βIm (2.25)
A monodomain representation of the bidomain model serves to model the conduc-
tivity through the myocardium with a reduced form of the bidomain model, reducing
computational demand in simulations which don’t require separation of the intracellular
and extracellular conductivities, such as in simulations where no extracellular stimulus
is applied. The monodomain formulation is derived from the bidomain equations above
(Equations 2.24 and 2.25).
However, in the monodomain model, conductivity is assumed to be anisotropic between
the extracellular and intracellular domains. As such, the conductivity of the system is
represented by the intracellular conductivity σ, resulting in the monodomain equation
▽ · (σ▽ Vm) = βm(Iion + Cm
dVm
dt
) + Istim (2.26)
where Istim is the applied stimulus current.
The Finite Element Method
In the context of cardiac computational modelling, the finite element method (FEM)
simplifies the complex geometry of the heart into discrete elements. As such, differential
equations which require solving to calculate membrane potential across the domain can
be reduced to linear matrix problems where linear algebra can solve the Vm equations at
each element. In other words, between the boundaries of each element, linear equations
are used to approximate the more complex differential functions over the same domain.
Linear basis functions describe the straight line connecting two nodes at the boundaries
of an element whose elemental coordinates vary between 0 and 1. Global nodes can be
mapped to local element nodes by a connectivity matrix so that interpolation between
nodes is possible, given the linear basis functions between nodes. The value of the function
at connected nodes is implicitly continuous.
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The basis functions can also be thought of as weighting functions on the nodes so that,
at a point between nodes, there is a linearly varying dependence on the nodal parameters.
For example, between two nodes 1 and 2, the value of the function at node 1 has no
dependence on node 2 whereas the value of the function half way between nodes is equally
dependent on both nodes 1 and 2. This concept of linear independence on the basis
functions also holds for elements with more than two nodes. Crucially, the weighting
functions can be thought of as global functions, so that the weighting functions of a global
nodal parameter decays linearly within each connected element. Although the equations
are solved at the nodal points in the domain, the value of Vm can be determined at any
point in the domain by interpolation of the solution across a distance between nodes, thus
Vm can be linked to a particular physical coordinate.
Tissue simulations are performed on finite element (FE) geometrical meshes and so
implementing the FEM, equations calculating Vm and the conduction of the activation
wave across the myocardium are solved at each discrete element in the mesh. Fibre
direction, a parameter crucial to the propagation of the wavefront, is defined at the centroid
of each element enabling complex, anatomically accurate fibre directions to be incorporated
into the geometrical model. The spatial discretization of the mesh into elements also
allows heterogeneous parameterisation of the model. For example, ionic parameters may
be altered in specific areas of the model by altering those parameters during equation
solves at prespecified element centroids.
2.5.3 The Cardiac Arrhythmias Research Package Software
The Cardiac Arrhythmias Research Package (CARP) (carp.meduni-graz.at) utilises the
FEM to simulate the electrophysiology of the myocardium and is used in Chapters 4, 5
and 6. As more complex models of AP are created and more equations need to be solved
for each ionic current governing the AP, computational demand increases. CARP permits
the use of complex ionic models in whole heart simulations by reducing computational
load.
A parabolic and an elliptical solver component of the software, solve the bidomain
equations and an ionic current component from a library of electrophysiological models
determines the cellular membrane potential. The monodomain equation can also be solved
by CARP, by solving only the parabolic equation. However, if the monodomain equation
is being solved, the bulk conductivity tensor replaces σi and is calculated as the geometric
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mean of the conductivities:
σ = σiσe(σi + σe)
−1 (2.27)
A FE geometrical mesh is required as an input to simulate membrane potential across
the domain with files containing node and element information. Within CARP, element
files can be tagged in order to alter ionic or conductivity parameters at tagged elements.
An ionic membrane model is specified for the simulation and stimulus parameters such as
frequency, location, strength and duration are required. Intracellular and extracellular,
transverse and longitudinal conductivities are inputted for simulation.
Equations are solved at each node in the model outputting Vm for each time step
to simulate an electrical wave propagating in space and time. Simulations of cardiac
electrophysiology can be run on desktop computers within acceptable time frames, and
parameters of the ionic models as well as stimulation, solver and output parameters,
are easily altered for thorough investigation of both cellular and tissue electrophysiology.
Single cell simulations are performed by the CARP subpackage BENCH.
2.6 Myocardial Infarction
Myocardial infarction is a common pathology causing a large proportion of deaths world-
wide due to the altered electrophysiological properties of the heart stemming from the
myopathy, causing arrhythmias. Arrhythmias resulting from an MI are characterised by
the reentrant circuits which propagate around non-excitable tissue caused by ischemic
damage during the MI, resulting in VT. The work presented in Chapters 4, 5 and 6 inves-
tigates the susceptibility of the tissue to post-MI reentrant arrhythmias. In this section,
we discuss how ischemia-induced alterations of the tissue may contribute to the initiation
and maintenance of VT, properties which are essential to the understanding of the work
of this Thesis. Termination of VT by the ablation procedure is also discussed here as the
work in Chapter 6 is focussed on improving this treatment strategy.
2.6.1 Aetiology
The heart itself requires an oxygen supply and so is suffused with blood from coronary
vessels surrounding the heart. Coronary arteries stem from the base of the aorta and
encompass the heart. MI is characterised by the cessation of flow due to occlusion of
these coronary vessels by plaque deposition and stenosis of the vessel resulting in hypoxia
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in regions of the myocardium. The resulting ischemia causes cell death by necrosis and
formation of a myocardial infarct scar.
2.6.2 Myocardial Infarct Scar
In response to necrosis of a portion of the myocardium, the process of fibrosis produces
excess connective tissue in the region of the necrotic tissue. The process of fibrosis exists to
form a rigid structure, protecting the damaged myocardium from further injury which may
be sustained due to the high pressures developed in the cardiac cycle. Fibrotic tissue is not
excitable and so does not display the characteristics of healthy myocardium and cannot
conduct electrical activation waves. However, the resulting scar tissue is not completely
fibrotic, rather regions of non-conducting fibrotic tissue are interspersed with tracts of
surviving myocardium. Figure 2.7, (middle) represents tracts of surviving myocardium
(white) dispersed throughout regions of fibrosis (black). Cardiac activation waves can
Figure 2.7: Myocardial infarction and diverted wave propagation. Left - MRI displays
infarct in white. Middle - Path of activation wave (red) through surviving tracts of
myocardium around fibrotic tissue (black). Right - Proposed circuit of propagation
(yellow to red) around infarct scar (black).
propagate along the myocardial tracts but not through fibrotic tissue and so the activation
wave propagates across the scar region along tortuous routes of viable myocardium (red).
A magnetic resonance imaging (MRI) image of cardiac tissue is displayed in Figure 2.7
(left) with a diffuse region of infarct scar tissue shown in white which may be comprised
of dense fibrotic scar or fibrosis interspersed with surviving myocardium. The image on
the right of Figure 2.7 displays a proposed route of conduction (yellow to red) around two
regions of non-excitable fibrotic scar tissue (black). The excitation wave may initially be
diverted due to alterations in electrophysiological properties of the tissue surrounding the
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scar. Diversion causes the wave to circumvent the scar and conduct retrogradely through
the isthmus between the two scar regions. Under the right circumstances, the wave may
propagate out of the isthmus and continue in self-sustaining reentrant circuits around the
scars and back through the isthmus.
The extent of myocardial scarring is proportional to the severity and duration of is-
chemia, resulting in large variations of infarct scar patterns presenting in the clinic. The
area of fibrotic tissue varies with time post-infarction. Fibrosis continues to occur as a heal-
ing mechanism months after the cessation of ischemia. In addition, there is large variation
in the location of infarct scars in the patient population. Scars can be located anywhere
around the myocardium and can be predominantly epicardial, predominantly endocardial
or span the myocardium transmurally. The extent of variation in the size, shape and
location of infarct scars gives rise to endless variations in resulting wave propagation.
2.6.3 Electrophysiological Remodelling in the Infarct BZ
A region of tissue surrounding the fibrotic infarct scar, known as the border-zone (BZ)
also displays ischemic damage (Kazbanov et al., 2014). Tissue within the BZ remains
excitable, however structural remodelling of the tissue resulting in dispersed fibrosis, the
alteration of the location of gap junctions, in addition to the changes in gap junction
conductance all play a role in altering CV through the BZ. Ionic remodelling occurring
in the BZ alters the AP which in turn, affects the excitability of the tissue and success of
propagation through the BZ. Remodelling affecting APD and CV in the BZ also affects
the wavelength and therefore, can facilitate reentry, as is discussed below.
Ionic Remodelling
Ionic currents which contribute to the shape of the AP are altered by the electrophysi-
ological remodelling of the BZ. In response to hypoxia, protein subunits of ion channels
can become altered, rendering the channel defunct. The conformational change in ion
channel proteins causes a decrease in density of functional channels and hence a decrease
in ionic current through the channels. BZ displays a decrease in density of INa which
causes a slowing of the upstroke phase of the AP. In turn, the slow upstroke causes a delay
in the activation of ICaL which prolongs the plateau phase and prolongs the APD. Also
contributing to the prolongation of the AP is the decrease in outward potassium currents
which cause the membrane to remain depolarised. Many ion channels are altered in the
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BZ and it is the contribution of the remodelling of each channel which acts to produce
the altered electrophysiological properties of the BZ. Crucially, remodelled BZ tissue dis-
plays lengthened APD, delaying repolarisation and causing increased refractoriness of the
tissue. Due to these changes occuring in the BZ, cardiac tissue becomes heterogeneous,
displaying different properties in normal and BZ tissue, which is thought to contribute to
the initiation of reentrant propagation.
Conduction Velocity in the BZ
Conductivity of the BZ tissue is also altered by a number of mechanisms. One such mecha-
nism is the alteration of the gap junctional current. The Cx43 protein which makes up the
subunits of the gap junctions has been shown to be reduced in BZ tissue, which suggests
that the number of functional gap junctions may be reduced. The reduction in functional
gap junctions results in a decreased density of gap junctional current. In addition, the
voltage dependent gating mechanism of the gap junctions is altered, affecting the ionic
current through the channels. The remodelling of gap junctions in the BZ results in an
overall decrease in CV. Additionally, CV is slowed by the structural presence of fibrotic
tissue. Firstly, due to the presence of fibrosis leaving largely longitudinal fibres intact, the
activation wave can only propagate in one direction, decreasing the sink and so increasing
the source-to-sink ratio and hence increasing CV in the longitudinal direction. However,
as activation waves propagate through narrow conduits of surviving myocardium, the path
length of the wave increases, resulting in an overall decrease in CV of the activation wave
through the scar. As a result of fibrotic tissue bordering surviving myocardium along
longitudinal fibres, little to no electrotonic current can flow in the transverse direction,
greatly slowing transverse CV and increasing the anisotropy of the tissue. In addition elec-
trotonic effects of propagation through isthmuses can impact CV. On exiting an isthmus
and propagating into a larger tissue space, the wavefront is highly curved due to the large
sink that the small source current must excite. The curvature of the wavefront serves to
decrease the CV and can cause termination of the wave, or wave block (Romero et al.,
2013). Finally, the decrease in density of INa contributes to the slow CV of the wave
through the BZ due to the slowed upstroke of APs activating the myocyte. In conclusion,
complex mechanisms are involved in the alteration of BZ CV, but combine to produce the




Changes in wave propagation due to the structural and electrophysiological properties
of the myocardium as a result of an MI can cause reentrant arrhythmias, such as VT,
which can destabilise to VF (Clayton, 2008), potentially resulting in SCD. Propagation
of activation waves cannot occur through regions of dense non-conducting fibrotic tissue
and so waves are often diverted around the region of structural wave block, initiating
a potential reentrant circuit around an infarct scar. Waves may then traverse through
tracts of surviving BZ tissue facilitating reentrant propagation due to the altered BZ
electrophysiology. Reentry is a term used to describe circuitous propagation which can
be self-perpetuating. Reentrant propagation can cause an increase in heart rate, or VT,
because the reentrant frequency overrides that of the pacemaker cells in the sinoatrial
node. The fast propagation of waves around a reentrant circuit can destabilise and lead
to wave-break, causing VF and resulting in unsynchronised contraction of the heart. The
implication of desynchronisation of ventricular contractions is that the heart is not able to
pump blood efficiently out of the heart around the body to vital organs, which can result
in SCD. Ionic, structural and conductivity remodelling in the BZ and scar complex all
contribute to the initiation and maintenance of reentrant arrhythmias.
Conduction Wave Block
APD is prolonged in areas of the BZ causing a dispersion of repolarisation throughout
the tissue. In addition, restitution effects and the presence of discordant alternans also
creates spatial heterogeneity in the refractoriness of the tissue. The isolated regions of
lengthened APD are responsible for causing the initial wave block which is a prerequisite
for the initiation of reentrant arrhythmias. Depending on the frequency of the stimulation,
the propagation of a wave across the tissue will be stopped if the wave approaches a region
of refractory tissue which remains depolarised for a lengthened period of time. The wave
then diverts around the region of functional block until it can propagate into tissue which
is no longer refractory.
Conduction Around a Reentrant Circuit
Non-conducting fibrotic regions of the scar may increase the distance that the propagating
wave must travel before propagation into repolarised tissue, increasing the pathlength of
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the circuit. Figure 2.7 (right) displays a proposed reentrant circuit around fibrotic scar
after initial wave block. Here, initial wave block must have occurred at the entrance of
the isthmus to initiate diversion of the activation wave around the scar (black). The scar
regions facilitate the diversion of the wave around the region of block, increasing the path
length.
Slowed CV of propagation through BZ tissue allows sufficient time for the BZ region,
which caused initial block due to a lengthened APD, to repolarise ready for reactivation.
Hence, by the time the slow conducting wave reaches the region of prolonged APD again,
the wave can propagate into the region forming a reentrant circuit.
Success of Reentrant Propagation
The critical factor indicating the possibility of success of a reentrant circuit is whether or
not an excitable gap occurs. Considering a circular path of propagation, an activation wave
propagating in a circle displays a wave head and a wave tail with a gap in between the two,
so that the wave can propagate around the circle ad infinitum. If the wave is so large that
there is no gap between the wave head and the wave tail, the wave will cease to propagate
due to the wavefront-waveback collision. Figure 2.8 illustrates how the pathlength affects
Figure 2.8: An illustration of an excitable gap determining the success of reentrant wave
propagation. A wave (green) propagates around a circle with an excitable gap between the
wavefront and the wave back. An increased pathlength (middle) increases the excitable
gap, whereas an increased wavelength (right) decreases the excitable gap.
the excitable gap. The green area around the circle represents the activation wave which
is propagating around the circle. In the left panel, a large excitable gap exists between
the wave head and the wave tail. Assuming that the wavelength remains constant, a larger
circle, which is analagous to the increased pathlength created by the fibrotic tissue, will
give rise to a larger excitable gap and hence facilitate the maintenance of the reentrant
circuit (middle). A decrease in CV caused by remodelling in the BZ produces a decrease
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in wavelength. A smaller wavelength propagating around the circle will also give rise to
a large excitable gap facilitating reentry. The image on the right, indicates that a larger
wavelength, which can be produced by an increase in either APD or CV results in a smaller
excitable gap which may result in termination of the propagation wave if the wave head
collides with the wave tail.
In summary, the initial wave block and subsequent diversion of a wavefront due to a
region of prolonged APD, initiates the abnormal propagation of a wave across the my-
ocardium. The increased path length and a decrease in wavelength contributes to the
maintenance of reentry by extending the excitable gap between the wave head and the
wave tail.
2.6.5 The Ablation Treatment
VT can be treated with implantable cardioverter defibrillators (ICDs) and antiarrhythmic
drugs such as sotalol and amiodarone. However, both treatment strategies can affect
quality of life and fail to prevent recurrent episodes. Radiofrequency catheter ablation
therapy is a treatment strategy that is often employed to treat recurrences or to initially
treat VT which cannot be treated another way.
Radiofrequency catheter ablation aims to terminate reentrant arrhythmias by creating
a structural barrier to disrupt propagation of the reentrant electrical wave. The structural
barrier is created by burning the tissue with radiofrequency energy resulting in necrosis
of the tissue and a non-conducting ablation scar. The lesion is ideally introduced at the
exit point of the scar, the point where initial block occurs, and after diversion of the
propagation wave, where a reentrant circuit is completed. Figure 2.9 illustrates the ideal
scenario in an ablation procedure. The activation wave encounters a region of refractory
tissue resulting in wave block and is diverted around the scars. The wave propagates
through the isthmus and in a reentrant circuit (left), would exit from the isthmus to
continue propagation. However, an ablation lesion (grey) at the exit point of the scar
interrupts the propagation and terminates the reentrant circuit (right).
In order to locate the exit point of the scar, the location of the scar must be iden-
tified. Recording catheters are inserted into the heart and contact is made between the
electrodes and the endocardium. Low voltage electrograms may indicate the presence of
the scar during pacing at sinus rhythm. If the VT is haemodynamically stable and can be
induced, programmed stimulation is applied to the heart to induce VT in order to better
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Figure 2.9: The ablation procedure. Left - Mechanism of reentry. Right - An ablation
lesion (grey) is introduced at the exit point of the scar, interrupting the circuit and
terminating reentry.
map the substrate and locate the exit site. Electrogram traces are again recorded and
analysed. Ablation targets may be located by analysing the electrograms using a variety
of techniques. By moving the recording catheters around the region indicated as scar, it is
possible to trace the low voltage activation through the isthmus which is isolated from the
activation of the healthy tissue. Fractionated electrograms which occur due to the slow
conduction through the isthmus are also identified by pacing from regions around the scar.
The occurrence of fractionated electrograms recorded at the site of the pacing electrode
are compared to the time of activation of the healthy myocardium in order to predict the
location of the pacing electrode within the reentrant circuit. If the induced VT is haemo-
dynamically unstable, the more accurate mapping techniques can not be performed and
the procedure continues without having located precise ablation targets. A more detailed
account of the ablation procedure is given in Chapter 3.
Ablation therapy is widely used to terminate reentrant arrhythmias. The fact that
more accomplished mapping techniques require VT to be induced increases the danger
and decreases the safety of the procedure. Crucially, the mapping procedure is not in-
fallible, sometimes missing the critical exit point of the scar which could result in failure
to terminate the VT and ablation must be performed at another site. It is possible that
many potential target sites are ablated until one site is ablated which terminates VT. This
hit-and-miss approach results in increased areas of ablation lesions which could contribute
to mechanical dysfunction of the tissue. Due to these limitations of the technique, the
work in Chapters 5 and 6 investigates a method to improve the ablation procedure by




The previous chapter provided fundamental background information about cardiac electro-
physiology, post-MI reentrant arrhythmias and the radiofrequency catheter ablation treat-
ment. This literature review proceeds by discussing the experimental studies which have
provided explanations of the physical mechanisms of reentry and the effects of restitution, in
terms of electrophysiological remodelling of the BZ. In addition, theories of reentry which
have been proposed in the literature are considered in terms of explaining the patterns
of post-MI reentrant arrhythmias. An overview is provided of animal and computational
models used to investigate post-MI arrhythmias, including a review of the more complex
models utilised to represent single cell electrophysiology throughout this Thesis. A review
of the landmark studies which have outlined, and facilitated the progression of the ablation
treatment strategy is presented along with an indication of how the ablation treatment may
be improved. Finally, this chapter is concluded with a discussion of the questions which
remain unanswered by the existing body of literature, indicating the motivation for the
work presented in Chapters 4, 5 and 6.
3.1 Ischemia Induced Remodelling of Cardiac Tissue
In Chapter 2, we outlined how ischemic damage altered cardiac tissue and facilitated
reentry. Here we present the studies which have observed such electrophysiological and
structural remodelling. This literature is not only vital for understanding how we model
BZ electrophysiology in Chapters 4, 5 and 6, but also provides a deeper understanding of
the mechanisms which facilitate reentry, the primary pathology researched in this Thesis.
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3.1.1 Alterations Affecting Ionic Currents
Several studies have indicated that conduction block is often caused by the heterogeneity
of APD across the tissue (Han and Moe, 1964; Allessie et al., 1976; Kuo et al., 1983; Gough
et al., 1985), causing the activation wave to be diverted. The dispersion of repolarisation is
exacerbated between healthy and BZ tissue due to ionic remodelling occurring as a result
of ischemia (Carmeliet, 1999).
Janse and Wit (1989) proposed that the reduced excitability of the tissue can cause
conduction block and lead to reentrant arrhythmias. Such reduced excitability has been
reported in BZ tissue where the AP amplitude and upstroke velocity are reduced (Lue
and Boyden, 1992). In fact, Spear et al. (1979) documented a reduction in INa in BZ
tissue which could explain the reduced excitability of the tissue leading to CV slowing
in the BZ (De Bakker et al., 1988). A reduction in ICaL, also observed in experimental
studies (Aggarwal and Boyden, 1995; Dun et al., 2004) could affect the peak amplitude
of the AP. In addition to the theory that prolonging APD facilitates conduction block
due to refractoriness of the tissue, work by Gough et al. (1988) studying the effect of the
drug Clofilium which lengthened APD, showed that the effect of prolonging APD also
facilitated arrhythmias by inducing early-afterdepolarisations and triggered activity. The
APD has been reported to be prolonged in the BZ due to the reduction in the rectifying
potassium currents, IK1 (Pinto and Boyden, 1998), Ito (Lue and Boyden, 1992), IKr and
IKs (Jiang et al., 2000). In addition, the slow recovery of calcium transients due to the
decreased expression of SR Ca2+ ATPase (SERCA), which is a channel protein responsible
for the reuptake of cytosolic Ca2+ into the SR (Kim et al., 2002), also contributes to the
prolongation of the APD.
In light of experimental data documenting ionic remodelling in BZ tissue, a number of
studies from the Trayanova group at the Johns Hopkins University have simulated electro-
physiological remodelling of BZ tissue in computational models of both rabbit (McDowell
et al., 2011; Rantner et al., 2012) and human (Ashikaga et al., 2013) membrane potential,
by altering the conductance terms of several ionic currents. Namely, the conductance of
ICaL was reduced by 69% based on experimental data from Dun et al. (2004). The con-
ductance term of INa was reduced by 62% (Pu and Boyden, 1997). Observations by Jiang
et al. (2000) from experiments which determined the BZ remodelling of potassium cur-
rents motivated the reduction of the conductance terms of IKr by 70% and IKs by 80% in
the computational modelling studies. These studies provided a basis for the methodology
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used in Chapters 4, 5 and 6 to simulate BZ remodelling.
3.1.2 Structural Remodelling
Significant histological studies of the infarcted human heart were conducted by Fenoglio
et al. (1983) and De Bakker et al. (1988). On observation of the tissue, they concluded that
inexcitable, fibrotic collagen tissue formed as a result of ischemic injury but did not occur
homogeneously through the affected tissue. They revealed that fibrosis could be dense,
forming large areas of inexcitable tissue, or could be dispersed with tracts of surviving
myocardium interspersed with fibrotic tissue. Indeed, Fenoglio et al. (1983) displayed that
isthmuses of surviving myocardium may range from one cell thick to a number of cells thick
and likewise, either thick or thin fibrotic regions may separate tracts of myocardium. It
was observed that the surviving bundles of myocytes thus formed a branching structure
with tracts joining and diverging throughout the scar region and ultimately connected one
side of the substrate to another. The point at which the activation wave emerged from the
myocyte bundles within the scar into the healthy myocardium was termed the exit site or
the site of origin. The vastly heterogeneous nature of the substrate has since been well
studied and documented and the presence of diffuse fibrosis has been proposed to be the
cause of slow conduction through the scar, resulting in reentry (De Bakker et al., 1990,
1993). The slow conduction velocity through isthmuses in the scar tissue is effectively
caused by the tortuous route of the activation wave through the substrate, increasing the
physical path length (De Bakker et al., 1993; Rutherford et al., 2012).
Electrotonic current flowing through gap junctions in the sarcolemmas underlies the
propagation of the activation wave. Fibrotic tissue bordering surviving myocytes decreases
the number of cells which are electrically coupled to each other, thus reducing the elec-
trotonic current, leading to a decrease in CV (Luke and Saffitz, 1991). De Bakker et al.
(1993) suggested that, due to the arrangement of myocyte bundles, regions of fibrosis
border the myocyte fibres primarily along the transverse edge, stemming the transverse
propagation of the wave which decreases transverse CV. As a result of ischemia, gap junc-
tions are also altered in a number of ways, affecting the electrotonic current. It has been
found that fewer gap junctions are present in intercalated disk structures in BZ myocytes
(Luke and Saffitz, 1991). Specifically, it has been shown that Cx43 distribution is altered
during ischemia (Peters et al., 1997), which may explain the reduction in gap junctions
along the elongated edges of the myocytes (Luke and Saffitz, 1991). Yao et al. (2003)
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showed experimentally that cell-cell coupling was reduced in the transverse direction by
90% and that longitudinal cell coupling remained similar. Based on this result, several
subsequent computational modelling studies have simulated tissue anisotropy in the BZ
by reducing transverse conductivity by 90% (McDowell et al., 2011; Rantner et al., 2012;
Ashikaga et al., 2013). This observation motivated the methodology used to simulate BZ
electrophysiology in the computational models utilised in Chapters 4, 5 and 6.
3.2 Post-MI Reentrant Arrhythmias
The work presented in Chapters 4, 5 and 6 is based upon quantifying the likelihood of
reentry occurring. In order to investigate methodologies to study arrhythmia dynamics, it
is essential to understand how reentry occurs and which properties facilitate reentrant cir-
cuits. Here, we present the literature which describes the figure-of-eight pattern of reentry
which occurs around infarct scars. In addition, we employ the previously proposed lead-
ing circle and spiral wave theories of reentry to illustrate how BZ remodelling contributes
to the susceptibility of the tissue to reentry. Crucially, this section clarifies the impor-
tance of the concept of an excitable gap which was introduced in Section 2.6; a concept
which is utilised in Chapter 4 to observe species differences in arrhythmia dynamics and
in Chapters 5 and 6 to locate reentrant circuits.
3.2.1 Figure-of-Eight Reentry Around Infarct Scars
Reentry resulting from MI is widely accepted as the cause of post-MI VT (De Bakker et al.,
1988). De Bakker et al. (1988) proposed that the highly complex nature of the substrate
permits a variety of macro reentrant circuits around the scar and micro reentrant circuits
through the BZ. At approximately the same time, the work of Stevenson et al. (1987,
1993) suggested the now widely observed, investigated and well documented figure-of-
eight pattern of reentry. When modelling reentry around infarct scars in Chapters 5 and
6, we aimed to simulate this reentrant pattern. Figure-of-eight reentry occurs when a wave
encounters conduction block, causing the wave to divert in two arcs around functional and
structural barriers and subsequently both waves propagate retrogradely through an area
of slow conduction, back towards the site of initial block.
In the case of post-MI reentry, initial activation wave block may occur if the wave
travelling from healthy tissue is blocked by refractory BZ tissue as a result of the prolonged
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APD in the BZ, causing the wavefronts to divert around the region of functional block into
recovered tissue. The presence of fibrotic scar results in the wave circumventing the scar
and often, the wave will propagate into an isthmus of surviving tissue, returning towards
the site of initial block. When the wavefront reaches the site of initial block, if the tissue
there is recovered, it will propagate into that tissue setting up a reentrant circuit. The
initial conduction block and subsequent diversion of the wave, in addition to the slow CV
in the BZ, allows time for the tissue in that region to recover before the diverted wavefront
propagates back to the region of initial block, facilitating reentry (Callans et al., 1996).
Much debate has occurred as to whether initial wave block or slow conduction through
BZ tissue is necessary to elicit reentry. Segal et al. (2010) showed that reentry could
be initiated by either initial conduction block or slow conduction through the BZ. In
addition, they showed that a combination of both wave block and slow conduction can
result in reentry. A previous claim reenforces this finding, stating that in many cases
both initial activation block and slow conduction through the BZ are required to initiate
and maintain reentrant circuits (Stevenson et al., 1987). In the modelling studies in
the following chapters of this Thesis, we simulate both initial block and slow BZ CV by
modelling prolongation of the APD in the BZ as well as a reduction in BZ CV.
3.2.2 Leading Circle and Spiral Wave Theories of Reentry
Although figure-of-eight reentry describes reentry around a structural substrate such as
an MI scar, two other descriptions of reentry can be useful in terms of understanding key
concepts of propagation. Comtois et al. (2005) discussed the differences between leading
circle and spiral wave reentry, patterns which occur due to functional substrates. The
leading circle theory was named by Allessie et al. (1973) and can be depicted by a circular
wave propagating around an inexcitable core. It is based on several earlier studies which
observed wave propagation around an obstacle (Mayer, 1906; Mines, 1913). Allessie et al.
(1973) suggested that the wave can propagate around the circle if the tissue in front of it is
recovered. If the tissue in front of the wavefront is occupied by the wave back, conduction
block and termination of reentry will occur. Thus, the gap between the wavefront and the
wave tail, often termed the excitable gap is a measure of the success of the propagation
with a larger excitable gap inferring safe propagation.
A more theoretical view of reentry, spiral wave reentry, was observed by Van Capelle
and Durrer (1980) and can be depicted as a wave spiralling outwards in expanding diameter
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from a central focal origin. Here, the wave tip is curved and it has been suggested that
due to source/sink effects, an increase in curvature in the wave tip decreases the source-
to-sink ratio, which could lead to a decrease in CV or wave block (Pertsov et al., 1993).
Considering figure-of-eight reentry around an MI scar, the spiral wave concept can describe
the safety of conduction of the curved wavefront after it has blocked and is diverting around
the scar. In addition, the wavefront curvature concept described in spiral wave theory can
predict conduction of the wave out of an isthmus into healthy myocardium and explain
how wavebreak due to the mismatched source-to-sink ratio may destabilise the arrhythmia
(Qu et al., 2000), leading to induction of VF. Whereas the leading circle theory can predict
whether reentry will occur or whether the wavefront will collide with the wave back and
terminate reentry. Therefore, post-MI reentry can be thought of as a complex mechanism
and propagation around the circuit can be evaluated with concepts from different theories
of reentry.
3.2.3 Effects of Remodelling on the Success of Reentrant Propagation
The interaction between the APD and CV and their effect on reentry can be illustrated by
the leading circle theory of reentry. It is first necessary to consider the excitable gap which
determines if propagation can occur. It is the wavelength which ultimately determines the
extent of the excitable gap as in a closed circle of a given path length, the excitable gap
is the wavelength subtracted from the pathlength. Thus, if the pathlength is greater
than the wavelength, reentry can occur (Mines, 1913; De Bakker et al., 1993). Stevenson,
Weiss, Wiener and Nademanee (1989) proposed that it is not only the wavelength which
determines the excitable gap but also the size of the inexcitable core, or in the case of
post-MI reentry, the size of the structural obstacle. A large wavelength may produce a
very small excitable gap, terminating reentry unless the obstacle is very large, in which
case the wavelength will be able to propagate around the obstacle because the excitable
gap is enlarged but a large wavelength propagating around a small obstacle will reduce
the excitable gap leading to conduction block (Xie et al., 1998). In addition, two reseach
groups in the nineties observed that if the obstacle is large with respect to the wavelength,
the wave anchors to the non excitable core and reentry is stabilised (Pertsov et al., 1993;
Xie et al., 1998).
As the wavelength is the product of the refractory period and the CV (De Bakker
et al., 1988; Stevenson, Weiss, Wiener and Nademanee, 1989), both APD and CV play
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a vital role in determining the success of propagation around a reentrant circuit. The
APD governs the wave back and if the APD is prolonged, the wavelength increases. Thus,
the wavefront travelling around the circle may collide with the wave back and terminate
reentry (Comtois et al., 2005). However, if the APD is decreased, the wavefront will be
able to travel into the recovered region and maintain the reentrant circuit.
Importantly, reducing CV in the leading circle analogy decreases the wavelength and
facilitates reentry, an effect which was observed by De Bakker et al. (1993). A reduction
in CV allows time for the tissue at the wave back to recover before the wavefront arrives.
The observed reduction in INa in BZ tissue is responsible for reducing CV and is thus
proarrhythmic. It has also been demonstrated that slow VTs are stable and sustain
reentry, whereas fast VTs become unstable and can lead to conduction block and wave
break resulting in VF (Stevenson, Weiss, Wiener and Nademanee, 1989; Xie et al., 1998).
However, according to the spiral wave theory, a reduction in INa decreases the source-to-
sink ratio and increases the curvature of the wave. The resulting source/sink mismatch can
cause conduction block and have an antiarrhythmic effect (Pertsov et al., 1993; Comtois
et al., 2005).
3.3 Restitution and its Effect on Arrhythmia Dynamics
It is well known that repolarisation heterogeneity initiates reentry by causing conduction
block at a region of depolarised tissue (Janse et al., 1985). Indeed, a larger repolarisation
gradient between two areas is arrhythmogenic (Opthof et al., 2007). Moreover, it has been
shown by Nash et al. (2006) and Sheridan et al. (2010) that dynamic changes occurring as
a result of cardiac restitution can contribute to repolarisation heterogeneity and facilitate
reentry.
Pacing according to an S1S2 protocol can illustrate how an increase in pacing fre-
quency facilitates reentry. Considering the scenario on the right of Figure 2.7 displaying
a reentrant circuit around an infarct scar, a repolarisation gradient would exist between
the healthy tissue and the tissue where initial block (also termed the exit site) occurs, as
a prolonged APD is likely to occur in BZ tissue. An initial paced beat (S1) will depolarise
all of the tissue including the BZ isthmus. However, the prolonged APD at the exit site
causes the wavefront of a second paced stimulus (S2) to block as it approaches the BZ
region. Importantly, if the APD is shortened in the healthy tissue, as may occur with
51
3.3. RESTITUTION AND ITS EFFECT ON ARRHYTHMIA DYNAMICS
an increase in pacing rate due to restitution effects, the S2 wave propagating through the
isthmus back to the exit site, is less likely to encounter conduction block on exiting the
isthmus, because the healthy tissue will have recovered sooner, and reentry can occur. This
experimental evidence clearly illustrates that an increase in pacing frequency alters the
wavelength to facilitate reentry and that the prematurity of the stimulus combined with
the dispersion of repolarisation is critical in initiating arrhythmias (Boyett and Jewell,
1978; Rosenbaum et al., 1991).
The work of Janse et al. (1985), Garfinkel et al. (2000) and Clayton and Taggart
(2005) illustrated that APD alternans occurring as a result of increasing stimulation rate
is arrhythmogenic, due to inducing steep repolarisation gradients. As the frequency speeds
up, alternans ensue. A beat with an increased APD will be followed by a premature beat
with a short APD. As a result, the activation wavefront of the premature beat will be
blocked by the lengthened APD of the previous beat. Unstable propagation occurs as a
result of APD alternans as waves block and break up, eventually destabilising the reentrant
circuit and resulting in the potentially fatal VF arrhythmia, a scenario which has been
widely documented in the literature (Koller et al., 1998; Qu et al., 1999). Interestingly, in
a paper by Cherry and Fenton (2004), it was explained that decreasing frequency flattens
the APD restitution curve, decreasing the risk of alternans and so stabilises propagation.
Increased stability of the wave propagation decreases the arrhythmogenic dispersion of
repolarisation and in addition, decreases the likelihood of VF occuring.
CV is rate dependent in a similar manner to APD where CV decreases as pacing
frequency increases. Qu et al. (1999) investigated the effects of ion channel function on
restitution and found that the recovery from inactivation of INa is a major determinant
of steep CV restitution. As the pacing frequency increases and DIs decrease, INa does
not have sufficient time to recover, resulting in a decreased CV. As frequency continues
to increase, CV alternans also occur, leading to wave break and possible initiation of
VF (Wu et al., 2002). As described in the leading circle theory of reentry, decreasing
CV decreases the wavelength and facilitates reentry indicating that increasing pacing
frequency is arrhythmogenic in a similar manner to APD. It has also been reported that
decreasing CV decreases the rate of the arrhythmia, stabilising reentry (Banville and Gray,
2002). However, Qu et al. (1999) suggested that in fact, increasing CV and flattening the
restitution curve promotes wave break, due to the wavefront-wavetail interactions that
occur as a result of a smaller excitable gap, suggesting that also increasing the CV could
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be arrhythmogenic by a different mechanism.
Having discussed the effects of APD and CV restitution on reentry and considering
that the wavelength is the product of APD and CV, it follows that wavelength decreases
as pacing frequency increases, facilitating reentry. Indeed, under normal physiological
conditions and normal pacing frequencies, the wavelength is long and normally exceeds
any substrate induced path length so reentry is unable to occur (Girouard et al., 1996).
However, premature beats, or an increase in pacing frequency, increases the susceptibility
to initiating and maintaining reentry.
3.4 In Vivo Studies of Post-MI Arrhythmias
In Chapter 1 we explained the need to research post-MI reentrant arrhythmias due to the
vast health and economic burdens of the disease. We also outlined the importance of in
vivo research to the field. The following section looks at some of the important studies of
post-MI arrhythmias which have been performed in vivo, which have contributed to our
increased knowledge of the pathology, paving the way for improving therapeutic strategies.
A rigorous ethical review process is required to gain approval for clinical research. As
such, in vivo research in patients is limited to the least invasive approaches and often
is required to be performed during an existing scheduled treatment or investigation of
a condition. For example, research into the mechanism of post-MI reentry in humans is
often based on non-invasive 12-lead ECGs in combination with midly invasive intracardiac
electrophysiological studies measuring extracellular potentials. Many studies have taken
this approach, of particular note are the many fundamental studies by Stevenson and his
group which have provided insights into the mechanisms of conduction block and slow
conduction in figure-of-eight reentry (Stevenson, Weiss, Wiener and Nademanee, 1989;
Stevenson et al., 1993) and have enabled the investigation of substrate mapping techniques
to guide the ablation procedure (Stevenson et al., 1987; Stevenson, Weiss, Wiener and
Nademanee, 1989).
The reentrant circuit can be further investigated by in vivo intracellular recordings
and histological examination as was performed in a study by De Bakker et al. (1988)
in which they excised human hearts and perfused the isolated hearts in a Langendorff
preparation. In addition, endocardial resection, a technique which was used prior to
radiofrequency ablation to remove the reentrant substrate, provided tissue samples of in-
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farcted myocardium. Intracellular membrane potential recordings empirically showed that
conduction block occured at regions of functional heterogeneity. Histological examination
of the tissue provided crucial evidence about the structure of MI scar tissue and showed
that excitable bundles of myocytes were dispersed throughout and separated by fibrotic
tissue. Another histological study (Fenoglio et al., 1983) also reported tracts of surviving
tissue throughout the fibrotic scar region and in addition, presented evidence that the
ultrastructure of myocytes such as the location of gap junctions, differs between states of
health and disease. It is clear that such invasive studies can provide essential information
about the underlying mechanisms of post-MI reentry. However, such in vivo examina-
tion is rarely accessible or approved by ethical committees. Hence, invasive and thorough
observation of post-MI reentry is usually performed in animal models.
Reentry around an obstacle in cultured rat myocytes has shed light on some funda-
mental properties of spiral-wave reentry around an infarct scar and has been proposed as
a potential model to investigate post-MI reentry and defibrillation. For example, it was
found that CV around the obstacle is reduced due to a reduction in membrane excitability
because of altered ionic properties (Entcheva et al., 2000). BZ remodelling responsible
for alterations in ionic currents has been further studied in rat myocytes in order to
validate and propose novel drug therapies which target ionic remodelling (Chang et al.,
2009). The study systematically blocked ion channels to simulate remodelling and ob-
served the effect of reentry dynamics. As a result, they concluded that the ICaL channel
blocker nitrendipine was antiarrhythmic. Rat myocytes have also been used to examine
the source/sink effects at play during reentry. Entcheva et al. (2000) showed that CV is
decreased when the wavefront is highly curved due to an increased sink-to-source ratio. It
was also shown that source/sink mismatches at the exit point of an isthmus can slow CV,
cause conduction block and as a result of AP prolongation at the exit site, reactivation of
the isthmus can occur, reversing the direction of the wavefront (Auerbach et al., 2011).
MI can be induced in rats by ligation of the LAD and reperfusion of the tissue, which has
been shown to faithfully reproduce the progression and characteristics of clinical anterior
wall MI, resulting in a non-excitable scar surrounded by BZ tissue (Goldman and Raya,
1995). The model has been used to observe how changing the severity of ischemia results
in varying degrees of infarct size and shape, myocardial dysfunction and the effect it has
on reentry (Wu et al., 2011). The mechanism and efficacy of angiotensin-II receptor and
β-adrenergic receptor blockade has also been studied using this model in order to inform
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drug development (Goldman and Raya, 1995).
Guinea pigs have also been used as animal models to study post-MI reentry. Laurita
and Rosenbaum (2000) used optical mapping techniques to observe how changes in BCL
affect the repolarisation heterogeneity across the myocardium and also observe source/sink
effects at the exit site. These properties of the myocardium are both essential to the success
of reentry and studies investigating their effects on reentry are crucial to understanding the
pathology. A mechanism by which fibrosis causes arrhythmias was also studied in guinea
pigs using optical mapping (Pastore and Rosenbaum, 2000). It was found that due to cell
uncoupling as a result of fibrosis, APD alternans increased resulting in increased APD
heterogeneity and arrhythmia induction. Drug action studies have also been performed
in guinea pig models to investigate the INa channel blockers flecainide and quinidine,
which were found to be proarrhythmic due to the action of the drugs decreasing CV by
decreasing the rate of recovery from inactivation of the INa channels (Osadchii, 2014).
Sotalol was found to have an antiarrhythmic action only at low frequencies by increasing
APD (Girouard and Rosenbaum, 2001) in guinea pig whole-heart models.
Langendorff perfused rabbit hearts have been used in drug studies investigating the
APD restitution curve flattening mechanism by which β-blockers stabilise VF to a stable
VT rhythm (Pak et al., 2003). It has been shown that increasing gap junctional cell cou-
pling with rotigaptide terminates reentry, whereas decreasing gap junction coupling with
carbenoxolene promotes spiral wave reentry and anchoring of the wave to the substrate,
by decreasing CV and decreasing wavelength (Takemoto et al., 2012). Dual effect mech-
anisms of the IK channel blocker HMR1098 have been shown to increase APD causing
the antiarrhythmic effect but increase the slope of APD and CV restitution causing a
proarrhythmic effect. Ablation therapy has also been studied in rabbit hearts. Mercader
et al. (2012) proposed a methodology to visualise the size of the ablation lesion using
fluorescence imaging of the increase in NADH in damaged cells. They claim to be able
to visualise lesions with a 0.5mm resolution which could increase the ablation procedure
success rates whilst reducing procedure time, although it is questionable whether such a
technique could be applied in the clinic due to limited access to the heart.
In summary, studies in animal models can be used to investigate structural substrates
and mechanisms of reentry as well as to elucidate drug action and effect. Such in vivo
studies are limited in humans due to ethical restrictions, sample sizes and applicability of
techniques. Animal models are widely used to investigate vital aspects of post-MI reentry
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which may otherwise remain elusive.
3.5 Computational Modelling of Post-MI Arrhythmias
Computational models are used as a vital tool to supplement investigation in the clinic
and in animal models (Clayton et al., 2011). Whilst animal models overcome many ethi-
cal restrictions imposed on clinical research, highly regulated ethical review processes are
required for animal studies. Computational models overcome these restrictions as well
as providing a low cost alternative to animal models (Goldman and Raya, 1995). More-
over, in silico modelling provides a framework to model heart function at multiple levels
(Smith et al., 2011), allowing the investigation of arrhythmias from the level of the single
cell biophysics to the whole organ level. Crucially, simplified models permit investigators
to dissect out the component parts contributing to arrhythmias. Biological systems are
inherently exceptionally complex and being able to study one component in a myriad of
contributing factors can provide in depth insight into arrhythmia mechanisms (Clayton
and Taggart, 2005). We have previously covered the importance of in silico models in
investigating post-MI arrhythmias (Chapter 1). Here we cite some important studies in-
troducing computational methodologies to model single cell cardiac electrophysiology as
well as wave propagation across the heart. In addition, studies which have contributed
novel findings to the field of post-MI arrhythmias using a computational modelling ap-
proach are reviewed.
3.5.1 Electrophysiological Models of Ventricular Action Potential
The Hodgkin-Huxley Formulation to Determine Ionic Current
In Section 2.5, an outline of the approach to single cell electrophysiology modelling was
given. In particular, the mathematical methods of deriving ionic current in order to solve
the equation of the membrane potential (Equation 2.5) were discussed. The seminal work
by Hodgkin and Huxley (1952) provided the formulation, presented in Section 2.5, to
derive the ionic current and hence the membrane potential from a series of ODEs. This
formulation provided a methodological foundation for subsequent models of cardiac AP.
Hodgkin and Huxley (1952) formulated a mathematical model to model the propaga-
tion of an AP down a squid giant axon. From empirical observation using, at the time,
novel techniques such as voltage clamp recordings, they proposed that Vm was largely
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determined by three currents; INa, IK and Ileak and that both INa and IK were controlled
by voltage-gated ion channels. In the resulting mathematical model, activation variables
(m and h for the sodium channels and n for the potassium channels) were associated with
the voltage-gating mechanisms, which determined the probability that the channel is open
or closed. In turn, for each activation variable, rate constants which were also voltage-
dependent, determined how many times an ion channel opened and closed per second.
Thus, a series of ODEs incorporating the activation variables and their rate constants,
were formulated to solve the ionic current across the membrane which could in turn, be
utilised to solve the membrane potential. The fundamental concepts of their mathemati-
cal model have been implemented for the purposes of modelling the excitability of cardiac
myocytes.
More complex models of cellular AP, examples of which are discussed below, incorpo-
rate other ionic currents such as a calcium current and current through active transport
pumps. The formulation of Iion may also become more complex, representing the variety
and complexity of the gating mechanisms controlling various ionic currents. Invariably
models incorporating more ionic currents controlled by more complex gating mechanisms
are based upon the Hodgkin-Huxley formulation. Here we describe four mathematical
models of ventricular AP for the human, rabbit, guinea pig and rat, which have been
presented in the literature and are utilised in Chapters 4, 5 and 6.
Human
The Ten Tusscher model of human ventricular AP (Ten Tusscher et al., 2004) was originally
devised to assist in the study of clinical arrhythmias. It was formulated to represent
experimentally derived values of AP and its rate-dependence, as well as CV restitution
(Morgan et al., 1992; Cao et al., 1999; Nash et al., 2006) in human tissue whilst remaining
viable in terms of computational demand. The Ten Tusscher 2 model (TT2) (Ten Tusscher
and Panfilov, 2006) used in this study is based on the previous model and incorporates the
main ionic currents involved in the AP, such as INa, ICaL, Ito, IKr, IKs and IK1, as well
as their gating mechanisms regulating conductance and a calcium handling system (Stern
et al., 1999; Shannon et al., 2004), resulting in a model with 53 parameters. Experimental
data used to create the model were obtained primarily from human (Benitah et al., 1992;
Nabauer et al., 1996; Nagatomo et al., 1998) but where human data were unobtainable,
some data from animal studies were used (Luo and Rudy, 1994). Characteristics which
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render the model useful for studying arrhythmias, are that the model produces spiral
waves with an ECG trace similar to that of clinical VT recordings and alternans occur as
a result of short DIs at fast pacing frequencies as predicted by the restitution hypothesis.
Alternative human models (Priebe and Beuckelmann, 1998; Bernus et al., 2002) are
largely based on the Luo-Rudy (LR) guinea pig model (Luo and Rudy, 1994) and so
TT2 was favoured for use here, for the purposes of relating modelling studies to clinical
applications. The Grandi model (Grandi et al., 2010) incorporates a calcium handling
system from a previously published rabbit model (Shannon et al., 2004) and as such,
replicates rabbit APD restitution properties (Holzem et al., 2014). Due to the importance
of restitution in this Thesis, we chose to use the TT2 model which best replicates human
APD restitution curves. Possibly the most up-to-date model of human ventricular AP
is the O’Hara model (O’Hara et al., 2011) which was formulated mainly from human
electrophysiological data. However, due to the complications of implementing the cell
models at the tissue level, it has been observed that the O’Hara model is unable to replicate
the slope of the human APD restitution curve at the tissue level, is unable to produce
similar maximum CVs to those observed experimentally, and as a result, VT dynamics
produced by the model show discrepancies with clinical VT data with lower frequencies
being produced (Elshrif and Cherry, 2014). Due to the fact that the TT2 model is able
to replicate clinical VT, a characteristic which is vital to the research presented in this
Thesis, we chose to use the TT2 to conduct this research.
Rabbit
We chose to use a model of ventricular AP in the rabbit because it has been suggested that
the rabbit displays a similar effective electrical size of the heart to the human (Panfilov,
2006) and we wanted to further investigate that claim at varying pacing frequencies.
The model that we used, the Mahajan et al. (2008) model is based on a previous model
of rabbit ventricular AP (Shannon et al., 2004) but incorporates an improved calcium
handling system. A seven-state Markovian model for the control of ICaL was implemented
in order for the model to be able to replicate intracellular calcium cycling (Shiferaw et al.,
2003), a feature which causes flux in the intracellular ionic concentration of Ca2+, which
in turn affects the dynamics of APD alternans. There are 52 parameters which govern
the shape of the AP via the currents INa, Ito, IKr, IKs, IK1 and INaK and the more
complex calcium handling system. Experimental data used to construct the model are
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from a variety of mammalian species due to the Shannon model being based on a previous
generalised mammalian model of ventricular AP (Luo and Rudy, 1994). However some
currents such as IKr were reformulated based on rabbit-derived data (Puglisi and Bers,
2001). The model is useful for studying arrhythmias as it was constructed to model the
AP at fast heart rates such as might occur during VT. In addition, the incorporated
intracellular calcium cycling enables the model to predict the arrhythmogenic wave-break
due to APD alternans. In fact, the model was used to elucidate the effect of ICaL and its
gating mechanism on the repolarisation of the AP and its effect on APD (Mahajan et al.,
2008).
Guinea Pig
The guinea pig model used in this study, the Luo-Rudy phase-2 model (LRdII) (Luo and
Rudy, 1994) is an extension of a previous model (LR) from the same group (Luo and Rudy,
1991) and was created to provide a generalised model of mammalian ventricular AP. The
original LR model was based on the simple formulations of membrane potential presented
by Hodgkin and Huxley (1952) and Beeler and Reuter (1977), incorporating minimal ionic
currents and their gating mechanisms. The LRdII model expands on the LR model by
adding ionic exchange pump currents and a simple calcium handling system in order to
model fluctuations in intracellular ionic concentrations during an AP, a feature which was
lacking in previous models. Where available, data from experimental studies on guinea
pigs were used to formulate the model (Sakmann and Trube, 1984; Nilius, 1988). However,
because the model was created to represent a generalised mammalian cell model, data from
other animals, mainly mammals, were also used (Brown et al., 1981; Forbes et al., 1985;
Rasmusson et al., 1990).
Rat
The rat is an animal model which is frequently used to study cardiac electrophysiology in
healthy hearts (Clark et al., 1993; Shimoni et al., 1995) and hearts post-MI (Qin et al.,
1996; Yao et al., 1999) and is also a target for genetic and drug development studies
for cardiomyopathies (Cheung et al., 1993; Franz et al., 1997; Lijnen and Petrov, 1999).
As such, we chose to study the rat model here, for comparison with other species. The
Pandit mathematical model (Pandit) (Pandit et al., 2001) of rat ventricular AP used in
this study models the membrane potential as generated by INa, ICaL Ito, various outward
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potassium currents, a background leak current, and the ionic exchange currents INaK and
INaCa in addition to a simple calcium handling system. The majority of data used to
create the model were from rat experimental studies (Weis et al., 1993; Stengl et al., 1998;
Lee et al., 1999; Volk et al., 2001) but the calcium handling system was adpated from a
model of canine electrophysiology (Winslow et al., 1999). The model was created with
two variations, an epicardial and an endocardial model. The epicardial model proved a
better representation of the AP as observed experimentally (Shimoni et al., 1995) and so
was chosen for use in this study.
3.5.2 Anatomical Models
The ability to research transmural activation in real-time in in vivo studies remains elusive.
A particularly valuable aspect of computational modelling of cardiac function is that
three-dimensional, transmural characteristics of activation waves can be studied in real-
time (Clayton et al., 2006; Holden et al., 2006). Anatomical models of rabbit ventricles
have been reconstructed for the purposes of being able to investigate and observe three-
dimensional wave propagation throughout the myocardial wall, a result otherwise difficult
to obtain in animal models. Here we describe this anatomical model of rabbit ventricles,
which is utilised in Chapter 6 of this Thesis.
Simulations modelling propagation throughout the myocardial wall in Chapter 6, are
conducted on an anatomically accurate three-dimensional model of the rabbit ventricles,
described previously (Deo et al., 2009) and shown in Figure 3.1 with incorporated fibre
Figure 3.1: 3D model of rabbit ventricles with incorporated fibre orientation information.
Left - posterior lateral view and right - anterior view (from Vetter and McCulloch (1998)).
direction information. The model displays an average wall thickness of 4.98mm at the
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LV free wall, where reported fibre angles are −71.0◦ at the epicardium and 59.6◦ at the
endocardium with respect to the apex-base axis. The finite element mesh contains 3074982
tetrahedral elements and 547680 node points with, on average, 250µm between nodes.
This model is based upon a preceding model (Vetter and McCulloch, 1998) for which,
the geometrical information of the myocardial surfaces, as well as fibre orientations, was
acquired manually from histological slices and so whilst being accurate, the model lacks
fine-scale structural details such as endocardial trabeculations, papillary muscles and blood
vessels. It is essential that the geometrical model used in this study is able to produce
arrhythmia dynamics similar to those observed in vivo, in order for the results of this
research to correlate with those seen in the clinic. The model should be sufficiently accurate
to produce these reentry dynamics, but not so detailed that it becomes too computationally
demanding to run simulations. Fine-scale anatomical structures, such as those that are
absent in the model, have been implicated in playing a role in sustaining arrhythmias
in large animal models (Pertsov et al., 1993; Kim et al., 1999; Nielsen et al., 2009), due
to structures acting as anchors around which spiral waves rotate. This is contrary to
conclusions from rabbit models which do not observe such anchoring effects of micro
structures (Chen et al., 2000; Wu et al., 2002). A subsequent study confirmed, with
computational modelling, that the gross ventricular geometry, rather than the fine-scale
anatomy of the rabbit ventricles largely governs arrhythmia dynamics (Bishop and Plank,
2012). The study also made an important observation that the activation wavelength
is relatively short in comparison to heart size in large animal models and wavelength
is relatively long in comparison to heart size in humans and rabbits. Therefore, the
anchoring effect of small structures observed in large animal models can be attributed to
the short activation wavelength, relative to the size of the anatomical structure; the wave
is able to sustain propagation around structures without collision and wavefront-wavetail
interactions due to the small size of the wavelength. In summary, fine-scale anatomical
features may not play a role in governing arrhythmia dynamics in rabbit or human hearts
and so the gross anatomical geometrical model used in this study is of sufficient detail to
produce propagation as may be seen in the human heart.
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3.5.3 Utilisation of In Silico Models to Investigate Post-MI Arrhyth-
mias
In the previous paragraphs, we described existing methodologies used to study arrhythmias
using computational models. We now consider some of the work which has utilised a
computational modelling approach to investigate post-MI arrhythmias.
Computational electrophysiological models of APs permit parameter sensitivity anal-
yses to uncover the effects of solitary parameters or a select combination of parameters on
wave propagation and the underlying mechanisms of reentry (Cherry and Fenton, 2004).
Isolating such parameters or recording the effects of the investigation is often not possible
in animal models. However, a computational model of rabbit AP was utilised to study the
effects of reducing INa on conduction of the wave and results indicated that source/sink
mismatches at the wave tip affecting conduction are exacerbated in BZ remodelled tissue
(Boyle et al., 2014). Several studies have investigated the effects of pacing and restitution
in simplified two-dimensional models on reentry dynamics, verifying that steep resitution
slopes result in alternans (Qu et al., 2000) and increase the likelihood of wavebreak (Xie
et al., 2002; Groenendaal et al., 2014) and importantly, uncover the mechanisms causing
the effect. Of note, several studies have altered ion channel parameters to simulate BZ
remodelling based on experimental data and observed the effects on APD and conduction.
Decker and Rudy (2010) verified that ICaL and INa remodelling increased the dispersion of
repolarisation causing conduction block. Several studies from the Trayanova group which
simulate BZ remodelling (details in Section 3.1) in ventricular models, illustrate that such
models can be of tangible use in investigating the effects of BZ tissue anisotropy on ar-
rhythmia dynamics (McDowell et al., 2011), and in investigating and optimising both
the defibrillation (Rantner et al., 2012) and ablation (Ashikaga et al., 2013) treatment
strategies.
Computational models of post-MI reentry are utilised in order to overcome the limita-
tions of both animal model and clinical research. Importantly, computational models can
provide visual, detailed insight into three-dimensional wave propagation dynamics in a way
which is unachievable in both animal model and clinical research. A model of infarcted
rat ventricles was constructed incorporating the dense fibrotic scar as well as BZ tissue in
order to observe three-dimensional propagation post-MI (Rutherford et al., 2012). Elec-
trophysiological membrane potential properties were simulated on the anatomical model
and changes in wave propagation due to gap junction remodelling and tissue anisotropy
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were observed. The widely used and validated anatomical model of rabbit ventricles which
was described above (Deo et al., 2009) has been used to observe the complex propagation
in shock-induced reentry. It is important to stress that at present, only computational
models could provide such insight into the transmural propagation of a wave based on
physiological data.
It has been established that computational models of anatomy and electrophysiology
can be of use in simulating both structural MI scar heterogeneity and ionic properties of
healthy and BZ tissue in order to thoroughly investigate mechanisms of wave propagation
post-MI and potential therapies. Crucially, with the advancements in computational mod-
elling techniques and high-performance computing, in silico models are increasingly being
studied with the intention of complimenting clinical studies with patient specific computa-
tional models. Sermesant et al. (2005) have showed that it is possible to construct models
of heart function utilising patient specific data. The resulting models are then used to
simulate the patient’s pathology and guide the personalised treatment.
3.6 Can Animal Models Replicate Clinical Arrhythmias?
Animal models are used extensively to investigate arrhythmia dynamics which have clinical
signficance and potential treatment strategies for clinical use. However, in order to draw
conclusions about the relevance of the study to clinical scenarios, it is vital to understand
the differences between animals and humans. In particular, when studying arrhythmia
dynamics, it is necessary to know how similar wave propagation is around the myocardium
of different species.
Panfilov (2006) addressed this question directly. It was originally thought that animals
with larger hearts similar to the size of the human heart, such as pigs and sheep were the
best animal models for studying reentry, in order to draw conclusions which informed
clinical scenarios. However, as previously discussed (Section 2.6), it is not only the size of
the heart that is a crucial parameter in determining the success of wave propagation, but
also the wavelength plays a vital role in determining the size of the excitable gap. The
study compared rabbit, pig and dog hearts to the human heart in order to answer the
question about which animal model is most suitable for use in modelling arrhythmias.
Panfilov proposed a metric called the effective electrical size of the heart to determine
how similar spatial patterns of VF wave propagation are in different hearts. In order to
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calculate the effective size, the size of the tissue was divided by the wavelength. Due to the
complex anatomy of the ventricles, the relative size of hearts were used in the calculation.
It was assumed that the hearts were of similar shapes and so the cubic root of the mass
of the heart ( 3
√
M) was used. The mass of the heart was estimated to be 0.6% of body
mass. Wavelengths were estimated using the period of the spiral wave rotation obtained
from ECGs to approximate the dominant frequency of the VF.
Species with similar effective sizes displayed similar propagation dynamics, as the
calculation determines how propagating waves fit into the physical tissue. Figure 3.2
displays the results of the effective size calculation. Surprisingly, the study concluded that
Figure 3.2: Results of the effective size of the heart calculation (from Panfilov (2006)).
the effective size of the rabbit heart was most similar to the human despite having the least
similar physical size of the hearts. In fact, both the rabbit and the human displayed small
effective sizes suggesting that, in these species, wavelength is relatively large in comparison
to the size of the tissue, which may indicate that VT and VF are less likely to occur in
these species, than in the pig and the dog.
Importantly, the study suggested that it is the effective size of the heart which can
predict how similar the hearts of different species are and provided a method to investigate
which species is most likely to replicate arrhythmia dynamics of the human in order to
provide clinically useful results. However, considering the importance of rate adaptation
of APD and CV resulting in changes in wavelength, and potential species differences in the
restitution profiles, it would be expected that restitution dynamics may affect the effective
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size and species differences in wave propagation.
3.7 Ablation Treatment
Radiofrequency catheter ablation is a common procedure used to treat post-MI VT. In
Section 2.6, we provide an overview of the ablation procedure. Here, we present the studies
which have contributed to the development of the ablation procedure methodology. In
particular, a critical review of the literature describing techniques to map the infarct scar
and determine the ablation lesion location is given.
Since the 1960s intracardiac electrodes have been used to record electrical activity
in the heart (Durrer et al., 1967). In the following years, the technique commonly used
to terminate VT was endocardial resection, which resulted in significant tissue damage
because large amounts of scar and BZ tissue were removed, but success rates of the proce-
dure were high (Stevenson, Weiss, Wiener and Nademanee, 1989; Stevenson et al., 1995).
The first closed chest catheter ablation treatment of atrial arrhythmias was performed by
Scheinman et al. (1982), which proved a much less invasive procedure. However, lower
success rates of ablation therapy suggests that finding the optimal target site for ablation
to terminate the VT is inadequate and requires improvement. Since the first ablation
treatment in 1981, considerable research has been conducted to improve mapping the scar
region in order to determine the optimal location of the ablation lesion.
The endpoint of an ablation procedure is ill defined (Aliot et al., 2009), but can be
considered as the termination of a clinical VT. The clinical VT is a spontaneous rhythm
that has been recorded by surface ECG. Mapping techniques to identify ablation lesion
targets are based on observation of local electrograms and surface ECGs. Scar may be
detected by low amplitude voltages on local electrograms and slow conduction indicative
of isthmuses through the BZ (Fenoglio et al., 1983; Stevenson et al., 1993) can be detected
by fractionated electrograms or isolated diastolic potentials (IDPs) (Stevenson et al., 1995;
Lambiase et al., 2004).
3.7.1 Optimal Location of Ablation Lesions
For a sucessful ablation treatment, it is necessary to understand where the theoretical
optimal site of the lesion is. The complex nature of the structural substrate results in
the possibility of a circuit having multiple exit sites or multiple paths through the scar,
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or a variety of completely distinct circuits (Fenoglio et al., 1983; De Bakker et al., 1988;
Stevenson et al., 1995). The question then is where should the ablation lesion be located
in order to terminate the clinical VT? Fitzgerald et al. (1988) tested possible optimal sites
of location lesions by ablating both sites within the slow conducting isthmus and sites
located at the exit site of the scar. They found that creating ablation lesions at the exit
sites of the scars was only successful 50% of the time and ablating regions within the
isthmus itself was more successful. However, later Stevenson et al. (1995) suggested that
only the exit point of the circuit needs to be ablated to terminate reentry. Segal et al.
(2010) suggested that due to initial block facilitating reentry, the site of initial block should
be the target for the ablation lesion. Nonetheless, the removal of one exit site or site of
initial block does not ensure termination of other VTs that may occur at a later stage
(Fenoglio et al., 1983). Others have suggested that in order to prevent future occurrences
of all VTs, all regions of slow conduction should be ablated, although this technique may
produce significant damage to the heart and result in later dysfunction (Stevenson, Weiss,
Wiener and Nademanee, 1989; Stevenson et al., 1993; Jais et al., 2012).
3.7.2 Mapping the Scar During Ventricular Tachycardia
Activation Mapping
Initially proposed mapping techniques were conducted whilst VT was induced in the pa-
tient by programmed stimulation. One such technique is termed activation mapping which
compares local electrograms recorded during VT, measured at different locations through-
out the scar region to trace the sequence of presystolic IDPs, produced by slow conduction
through the isthmus (Stevenson, Weiss, Wiener and Nademanee, 1989; Bogun et al., 1997;
Strohmer and Hwang, 2003). De Bakker et al. (1988) showed that from a sequence of
electrograms (a− g) activation occurred from a− c where conduction was blocked so the
wave travelled around the refractory tissue to g and travelled back to the site of initial
activation (a) through a slow conducting isthmus (Figure 3.3). Large deflections occured
sequentially in time on the electrograms representing the spread of activation across the
myocardium from a. IDPs occurring from e− a depict the propagation through the isth-
mus back across the initial region of block to synchronise with the second activation of
the healthy myocardium at a. They verified this mechanism by recording intracellular
membrane potential traces from sites within the isthmus and showed that IDPs on local
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Figure 3.3: Activation mapping reveals propagation of reentrant wave through slow con-
ducting isthmus as IDPs on electrograms (from De Bakker et al. (1988)).
electrograms correspond to depolarisation of the membrane within the isthmus. Stevenson
et al. (1993) suggested that the QRS on a surface ECG occurs when the activation wave
exits the isthmus and activates the healthy tissue. Therefore, ablation is targeted at sites
where electrograms have been recorded which display activation just prior to the QRS,
namely the exit point of the scar (Stevenson et al., 1993). However, it is possible that
IDPs which may be involved in the circuit are not detected unless the electrode is within
200− 300µm of the site (Fenoglio et al., 1983).
Entrainment Mapping
Initiation of VT is required in another mapping technique; entrainment mapping. Steven-
son et al. (1987) described the method in which pacing is performed from sites of identified
IDPs, at rates slightly faster than the VT rate. VT is initiated and fractionated ECGs
are sought. If the pacing site is located within a reentrant circuit, the paced VT will
display a similar QRS to that of the clinical VT. This is called entrainment with con-
cealed fusion (Stevenson et al., 1993). If during pacing at a certain location entrainment
occurs, ablation is carried out at the pacing location. However, it was observed that when
the pacing location was changed, the exit point of the scar could also change, invoking
possibly a different VT but with identical QRSs, resulting in inaccurate definition of the
ablation target. Indeed, half of patients had to undergo the procedure twice because of
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its inaccuracy in locating a sufficient ablation lesion target site. Another problem with
defining ablation targets based upon ECG and local electrogram QRS patterns is that,
during VT, the QRS may become less well defined and is also affected by anti-arrhythmic
drugs (Stevenson et al., 1987).
3.7.3 Mapping the Scar During Sinus Rhythm
Crucially, the induction of VT greatly increases the risk of the procedure as the rhythm
is able to deteriorate to VF, which needs to be rapidly defibrillated to avoid cardiac
arrest. Mapping of the VT therefore requires that the clinical VT be inducible in the
clinic at the time of the procedure. Indeed, the clinical VT is often non-inducible during
the clinical procedure. Moreover, It is well documented that multiple VTs supported by
different reentrant circuits can occur within the same patient (Fenoglio et al., 1983). On
average 3-4 different VTs have been reported in any one patient (Stevenson et al., 1995).
The induction of the clinical VT is further complicated by the fact that different pacing
protocols can induce different VTs (Stevenson, Weiss, Wiener and Nademanee, 1989). In
order to ablate the clinical VT, mapping of the scar region needs to be performed when,
specifically, the clinical VT is induced which is not always attainable. In addition, VT
must be haemodynamically tolerated, that is, not cause haemodynamic compromise to
the patient. Whether the VT is haemodynamically stable depends on the severity of
the damage caused by the MI and also on the rate of the clinical VT (Stevenson et al.,
1995), factors which are highly variable. As a result, it is often not the case that VT is
haemodynamically tolerated and so mapping during VT cannot be performed. The VT
must also be stable for a period of time in order for electrograms of the paced VT to be
recorded, a requirement which is also often not fulfilled. The complications of mapping
the substrate during VT have led to the development of techniques to map the substrate
during sinus rhythm.
Mapping the VT during sinus rhythm can be performed based on defining areas of
slow conduction (Stevenson et al., 1995). Slow conduction occurs through isthmuses in the
infarct scar due to the tortuous routes of conduction through surviving myocyte bundles,
separated by non-excitable fibrotic tissue. It is supposed that these isthmuses form part of
a reentrant circuit, as conduction block and propagation through the substrate are required
for figure-of-eight reentry. Stevenson, Weiss, Wiener and Nademanee (1989) suggested
that during sinus rhythm, fractionated electrogram signals occur after the QRS complex
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is observed on the surface ECG. This is due to the QRS being produced by the activation
of the healthy myocardium and slow conduction then occurring through the isthmus, after
the activation of the ventricle has finished. However, it has also been noted that these sites
may be involved in the reentrant circuit, but may also be bystander sites not involved in
the circuit but still displaying the pattern of fractionated electrograms (Stevenson et al.,
1987, 1995). As such, fractionated electrograms which may occur throughout the scar and
BZ regions are a good indicator of the general region causing the reentry, but not of the
specific sites involved in the reentrant circuit.
Pace Mapping
The problem with any technique relying on IDPs or fractionated electrograms such as
activation mapping, is that the low amplitude voltages may just be an artefact of the
electrogram recording (Stevenson, Weiss, Wiener, Rivitz, Nademanee, Klitzner, Yeatman,
Josephson and Wohlgelernter, 1989). A mapping technique which doesn’t rely on low-
amplitude voltage data is pace mapping, which can be performed in sinus rhythm and is
based on determining where the pacing catheter is in relation to the circuit (Stevenson
et al., 1993). In the late eighties and early nineties, Stevenson’s laboratory described and
studied the pace mapping protocol. Pace mapping involves pacing from locations, which
have been suggested as being part of a reentrant circuit by the detection of low ampli-
tude electrograms, in the region detected during sinus rhythm (Stevenson, Weiss, Wiener,
Rivitz, Nademanee, Klitzner, Yeatman, Josephson and Wohlgelernter, 1989; Bogun et al.,
2006). If the QRS resulting from paced rhythm is similar to the clinical VT QRS, it sug-
gests that the pacing location is located near to the exit site of the scar (Stevenson, Weiss,
Wiener and Nademanee, 1989). However, the site is not necessarily located within the
reentrant circuit (Brunckhorst et al., 2003). More specifically, the time at which the tissue
is stimuluted within the reentrant circuit is compared to the surface ECG. This is termed
the S-QRS interval. If the S-QRS interval is large, it indicates that pacing was performed
within the reentrant circuit and the activation wave propagating through the isthmus con-
ducted slowly towards the exit site of the scar where, on the wavefront spreading from
the isthmus to the healthy myocardium, the QRS is initiated. These sites where a large
S-QRS is indicated are deemed to be ablation lesion targets (Brunckhorst et al., 2003).
If the S-QRS is very small, it indicates that no delay occurred due to slow propagation
through the isthmus and the QRS complexes of the paced rhythm and clinical VTs are
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very similar (Stevenson, Weiss, Wiener, Rivitz, Nademanee, Klitzner, Yeatman, Josephson
and Wohlgelernter, 1989). These sites displaying a small S-QRS would normally not be
ablated. However, the exit point of the scar would also display a small S-QRS (Stevenson,
2009) and would not be ablated according to the pace mapping protocol despite being the
optimal site of ablation (Stevenson et al., 1992).
Substrate Mapping
Mapping VT in sinus rhythm greatly increases the applicability of the treatment to more
patients and a variety of techniques have been proposed (Bogun et al., 2002). Marchlin-
ski et al. (2000) proceeded by performing voltage mapping in sinus rhythm, in order to
specify precise voltage limits to distinguish between dense scar, BZ and healthy tissue.
They proposed that dense scar could be located by potentials less than 0.5mV and BZ
tissue was located at regions displaying voltages of between 0.5 and 1.5mV. Having iden-
tified the substrate regions, they performed linear ablation lesions which extended from
an estimated exit point of the dense fibrotic scar, all the way to healthy myocardium
resulting in potentially very large lesions. Other research groups have also employed the
substrate mapping technique in the clinic, ablating sites displaying low voltage ECGs and
in addition, search for sites of low excitability which require larger stimulus current to
excite the tissue (Stevenson, 2009). Verma et al. (2005) suggested that substrate mapping
could fail to identify ablation targets due to diseased myocardium sometimes displaying
voltages within the range of healthy myocardium. In addition, many electrogram traces
are needed for accurate mapping of the substrate. As such, long procedure times result in
the technique being less favourable in the clinic.
3.7.4 Improving the Ablation Treatment
The major problems with current mapping techniques requiring VT induction have already
been discussed, but these techniques remain the most accurate with highest success rates.
Another problem encountered with current mapping techniques is that they rely on map-
ping and identifying regions of slow conduction by the presence of IDPs and fractionated
electrograms. In fact, due to the resolution of mapping, narrow isthmuses may well not
be located (Arenal et al., 2004). It was also found that only 30% of channels identified by
IDPs actually formed part of the VT circuit (Mountantonakis et al., 2013) and so multiple
ablation lesions were required until one location terminated the reentry. It has also been
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found that ablation relying on IDP identification to map the substrate was only 73% effec-
tive in terminating the clinical VT and moreover, anti-arrhythmic drugs were still utilised
after the procedure to reduce the risk of another VT occurrence (Morady et al., 1993).
A study by Verma et al. (2005) suggested that 63% of procedures which ablated within
an identified BZ isthmus resulted in termination of the VT. However, their results also
indicated that ablation lesions created at sites outside of an identified BZ isthmus were
successful in terminating VT. These results suggest that the techniques employed to locate
successful ablation lesions are fallible. In addition, reentrant circuits may involve regions
of endocardium as well as epicardium and whilst it is routine to map endocardial scar
locations, it has been shown that mapping both epicardial and endocardial scar locations
may improve ablation success rates (Kaltenbrunner et al., 1991). However, it is possible
to ablate transmural circuits from the endocardium if the scar tissue is thin enough or if
the lesion is large enough (Stevenson et al., 1995).
Low success rates of the ablation procedure, with some reporting only a 50% success
rate in terminating VT (Tung et al., 2010), indicate that susbtantial improvements are
required if the treatment is to be a reliable therapy. The major limiting factor in the success
of the ablation procedure can be attributed to the mapping technique. Specifically, the
lack of accuracy in locating the critical exit point of the scar and the requirement of the VT
to be inducible and haemodynamically tolerated, both contribute to the poor procedure
success rates. Despite various techniques available to map the substrate during both VT
and sinus rhythm, advancement in the accuracy of locating the critical exit point of the
infarct scar is required (Stevenson et al., 1987; Stevenson, Weiss, Wiener and Nademanee,
1989; Haqqani et al., 2013) if treatment success rates are to be improved.
A novel application of computational modelling to simulate patient-specific patholo-
gies has been studied by Sermesant et al. (2005). Utilising x-ray and magnetic resonance
(XMR) imaging patient data, computational models of anatomy and electrophysiology
were created. The study suggested a possible future application of these models which
could guide the ablation procedure using the patient-specific computational models. How-
ever, as conveyed in the paper, these techniques require long procedure times and expose
the patient to large amounts of x-rays. Therefore, despite the potential of this technique,
further research needs to be performed in order to more efficiently guide the ablation
procedure, so that the methodology may be incorporated into such patient-specific treat-
ments.
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3.8 Predicting the Success of Reentrant Propagation
Considering the need for improved scar mapping techniques to increase the success rates
of the ablation procedure, we turn our attention to a proposed methodology which can de-
termine whether reentry can occur within a potential circuit. If it is possible to determine
whether reentry is able to occur or not, there may be a potential application to guide the
ablation procedure by determining ablation lesion targets.
It is evident that many ionic and electrical properties of healthy and diseased my-
ocardium interplay to determine the success of reentry, making it difficult to accurately
predict whether a particular circuit could maintain reentry. A pioneering study by Coronel
et al. (2009) provided a simple metric based on the leading circle approach and wavelength
metrics, to determine the success of propagation.
The group set up a Langendorff-perfused porcine heart and induced repolarisation
heterogeneity between two regions of the heart. Namely, the APD was shortened by ad-
ministration of pinacidil into the left anterior descending (LAD) artery which shortened
APD in the anterior LV region which was termed the proximal region. Sotalol was ad-
ministered into the aortic cannula which increased the APD in an adjoining region of the
myocardium, and was termed the distal region. Intracardiac electrodes recorded electro-
grams from the two regions and ATs and RTs were calculated from the recordings.
An S1S2 pacing protocol was implemented from the proximal region and the premature
S2 beat resulted in conduction block as it approached the refractory distal region. Figure
3.4 (left hand column) shows that the distal zone repolarises from S1 at 300ms, whereas
the S2 beat activates the proximal tissue at 280ms. As such, the wave was diverted around
the block until it propagated into the distal region as it recovered, and the wavefront
curved in a spiral wave towards the site of intial block. Crucially, they proposed that if
the proximal tissue was recovered when the wavefront reached the distal side of the initial
block, as seen in the right hand column (top & middle), the wave could propagate into the
proximal region forming a reentrant circuit due to uni-directional block (UDB). However, if
the proximal tissue remained refractory, the wave would block again causing bi-directional
block (BDB) and terminate the wave and reentrant circuit. Considering these conditions,
the success of reentry depended on the repolarisation time in the proximal region and the
activation time in the distal region.
Coronel et al. (2009) proposed a simple metric, which they termed the fibrillation factor
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Figure 3.4: AT and RT maps of wave propagation across heterogeneous tissue. The
proximal zone is located above the dotted line, the distal zone is located below the dotted
line. The blue symbol in the proximal region illustrates the stimulus location. Images in
the left hand column illustrate initial conduction block of S2 (bottom) due to refractory
tissue in the distal region resulting from S1 activation (upper). The right hand column
displays the occurrence of reentry. UDB occurs due to the proximal tissue being recovered
from S2 activation (middle) before S2 activation of the distal zone occurs. A reentrant
beat ensues and its activation map is shown bottom right (from Coronel et al. (2009)).
(FF), which could be used to predict whether reentry could occur. The FF is the AT at
the distal region substracted from the RT at the proximal region. Hereby, it is possible
to reveal whether an excitable gap exists and whether reentry can occur. A negative, or
low positive FF value suggests that the wave activates the distal region after the proximal
region has recovered and the wave can reenter. A higher positive value of FF indicates
that no excitable gap is present as the wave activates the distal region before the proximal
zone is recovered and reentry cannot occur.
A subsequent paper further investigated the metric by altering the CV to determine the
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arrhythmogenic effect (Coronel et al., 2010). It was previously suggested that a reduction
in INa is both pro- and anti- arrhythmogenic and so they set about to investigate the
mechanisms involved in reentry resulting from sodium channel blockade.
The same experimental preparation was used and the sodium channel blocker fle-
cainide, was administered into the distal region. Figure 3.5 illustrates the effects of the
Figure 3.5: Illustrating the FF calculation theory. Top row - Membrane potential traces
of the proximal and distal zones before flecainide administration results in BDB. Bottom
row - after flecainide administration in the distal zone, the CV is reduced, delaying the
activation of the distal tissue, enabling UDB (from Coronel et al. (2010)).
drug on the FF. The top row of images display AP traces in both the proximal (red) and
distal (blue) zones prior to flecainide administration. It is possible to see that the RT of
the S2 in the proximal zone occurred after the S2 AT in the distal zone resulting in BDB
and a positive FF value. The bottom row of images display the effect of flecainide reducing
CV in the distal region. The time at which the S2 wavefront arrived at the distal side of
the line of block was increased, effectively increasing the AT used in the FF calculation
(whilst RT remained the same). As such, the proximal tissue had time to recover before
the wave propagated from the distal region and the wave could reenter. The resulting
FF values were negative, both substantiating the FF calculation and indicating that a
reduction in CV in the distal zone was proarrhythmic. When flecainide was administered
to the proximal zone, the CV in the proximal region was decreased which delayed the time
in which the activation wavefront reached the line of block. As a result, the repolarisation
of the proximal zone was delayed and the effect of reducing CV in the proximal zone was
antiarrhythmic. In addition, the delay of the activation wave reaching the distal region
from the stimulus site decreased the dispersion of repolarisation resulting in a smaller line
of block, which in turn decreased the path length, an effect which was also antiarrhythmic.
Despite the complexity of pro- and anti- arrhythmic mechanisms which govern reentrant
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circuits, the FF metric appears to be able to predict the success of reentry with minimal
calculation and data requirements.
3.9 Summary and Motivation
We have presented a review of the literature in which small animal models are utilised
to study post-MI VT. Studies investigating post-MI VT ultimately seek conclusions to
inform clinical treatment strategies. As such, animal models used in these investigations
should resemble, as closely as possible, clinical VT. We outlined the study by Panfilov
(2006) which proposed a method to determine the effective electrical size of the heart.
The effective size determines the critical ratio between the heart size and the activation
wavelength which in turn indicates the dynamics of wave propagation. Panfilov utilised the
methodology to determine the similarities between the human and larger animal model
hearts in terms of VF dynamics. Given that small animal models are used widely in
research of post-MI VT, as seen in this chapter, it remains to be seen which small animal
model most closely replicates the arrhythmia dynamics of the human. In addition, it
is necessary to determine which animal model is most suitable to model VT dynamics
which occur at slower frequencies than VF. Given the influence of pacing frequency on
wavelength via the restitution effect, it could be assumed that restitution may affect the
similarities or differences between hearts of different species.
In this chapter we have also demonstrated the importance and benefits of computa-
tional modelling and as a result, we utilise the techniques described above to model cardiac
function, for the purposes of investigating post-MI VT. In Chapter 4 we employ the ef-
fective size calculation to determine which small animal model displays the most similar
effective size to the human at pacing frequencies indicative of VT. In addition, we observe
the effects that restitution plays on the effective size in each species model. In order to
determine which species model is most suitable for investigating scar-related reentry, we
simulate BZ remodelling based on protocols described in this chapter and observe how
the effective size is affected. We then use the information gained about the most suitable
model, to investigate post-MI reentry and utilise those models for further investigation in
the following chapters.
In spite of the substantial efforts to improve the accuracy of the mapping techniques
utilised in the ablation procedure, there remains to be developed, a technique which can
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be performed during sinus rhythm and which does not rely upon location of low voltage
or mid-diastolic potentials which require very precise catheter manipulation. The pivotal
experimental work by Coronel et al. (2009) describing the FF metric to determine whether
reentry could occur based on the temporal excitable gap between the wavefront and the
wave back, may lend use to a novel technique to improve mapping of the substrate. If
the FF metric can predict reentry based on AT and RT data alone, it suggests that a
mapping technique based on the FF metric could improve the accuracy of locating an
ablation lesion target. In addition, the fact that the FF can identify BDB indicates that
potential reentrant circuits could be identified without the need to induce VT. In Chapter
5 we apply the concepts described by Coronel et al. (2009) to investigate a novel technique
which can predict the susceptibility to reentry over a region of tissue rather than between
two points. In Chapter 6 we extend the study to investigate the technique in 3D tissue.
However, considering the limitations of clinical data as discussed above, we test whether,
despite those limitations, the technique remains viable in the clinic and can be used to
guide the ablation procedure.
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Chapter 4
Assessing the Effects of Species
Differences in Activation
Wavelength and Heart Size on
Reentry Dynamics
Chapter 3 outlined the mechanism of reentry around MI scars and how the relationship
between the size of the activation wavelength and the size of the tissue may affect the
pattern of propagation around the scar. In addition, it was explained that the cardio-
protective property of restitution affects the APD and CV, in turn causing the wavelength
to vary depending on pacing frequency. In this chapter, we investigate the relationship
between the wavelength and size of the heart by calculating the effective electrical size of
the heart. Wavelength restitution and its impact on the effective size is also observed. Also,
incorporated in Chapter 3 was a discussion about the importance and the use of animal
models in researching post-MI reentrant arrhythmias. Here, we utilise the effective size
to infer how reentrant propagation around infarct scars differs between species due to the
differences in heart size, activation wavelength and restitution properties, with the aim of
concluding which species model most effectively replicates reentry dynamics of the human




Arrhythmias caused by reentrant wave propagation around infarct scars can be lethal,
necessitating research to understand the mechanisms of induction, propagation and ter-
mination, in order to be able to formulate treatment strategies. We saw in Chapter 3
that animal model studies and computational models based on animal data, are an im-
portant supplement to clinical studies of arrhythmias, providing the ability to overcome
restrictions faced in clinical research such as the inability to conduct the research in vivo,
insufficient sample sizes, ethical restriction or economic infeasibility. Animal or computa-
tional models utilised in such studies are required to faithfully replicate aspects of human
in vivo cardiac structure or function, which may affect arrhythmia mechanisms. However,
inherent species differences in cardiac anatomy and electrophysiology exist (Ten Tuss-
cher et al., 2007, 2009). Indeed, it is plausible to suggest that using clinical data and
computational models of human electrophysiology is the best way to investigate clinical
pathologies (Kazbanov et al., 2014; Taggart et al., 2014). However, due to the extensive
use and important benefits of animal models, it is necessary to determine which species
model most closely replicates the essential characteristics influencing the mechanisms of
reentry in the human, in order to suggest an optimal animal model for use in studying
clinical arrhythmias.
Reentry caused by an MI occurs due to the structural heterogeneity of the tissue
formed by the fibrotic scar and the surrounding BZ region displaying altered ionic and
conductivity properties (Sections 2.6 and 3.1). As a result, activation waves may propagate
around a structural obstacle such as an infarct scar. The ability of a reentrant wave to be
sustained around such a circuit, strongly depends upon the relative size of the wavelength
to the size of the obstacle, as previously discussed in Sections 2.6 and 3.2. Both of these
crucial measures, wavelength and the size of the tissue or heart size, vary between species
and may result in species differences in arrhythmia dynamics.
APD, CV and wavelength are dependent on changes in pacing frequency, which in turn
can affect wave propagation. The changes in APD and CV as a result of increasing pacing
frequency occur, due to the reduced recovery from inactivation of the ionic channels which
has been discussed in detail in Sections 2.3 and 3.3. These changes in APD and CV with
changing BCL contribute to the phenomenon of wavelength restitution as wavelength can
be calculated as the product of APD and CV (See Equation 2.4 in Section 2.3). The
78
4.1. INTRODUCTION
resulting relationship between wavelength and BCL, indicates that wave propagation and
arrhythmia dynamics change as pacing frequency varies due to the changing size of the
wavelength, relative to the constant size of the tissue.
In order to be able to draw conclusions about arrhythmias from animal experimental
models or computational models based on animal data which are relevant to the clinic,
species differences in ventricular size and wavelength need to be considered. As explained
in Section 3.6, a recent theoretical study sought to determine the similarity of animal
models of VF relative to VF in the human (Panfilov, 2006) by calculating the relative
effective size of the heart (I), taking into consideration the size of the heart in relation to
the wavelength, in order to characterise similarities in wave propagation between species.





By considering the effective size of the hearts of different species such as the dog, pig,
rabbit and human, it was suggested that the rabbit provided the closest clinical analogue
for studying VF, indicating that wave propagation dynamics in the rabbit are likely to be
most similar to that of the human. Hence, important conclusions may be drawn about
the use of specific animal models to inform clinical research.
The Panfilov (2006) study compares the effective size between rabbit, dog, pig and hu-
man computational models of electrophysiology. However, small animal model studies are
increasingly being utilised to study reentrant mechanisms (Section 3.4) with the additional
benefits of reduced ethical constraints and economic cost. Inter-species comparisons be-
tween small animal models and human models in terms of the similarities in effective size,
have not previously been investigated. Here, we perform the analysis, calculating I from
in silico ventricular AP data, in order to compare wave propagation dynamics between
the human and small animal models, for the purpose of drawing conclusions about the
most suitable small animal model to use in studies of post-MI VT arrhythmias. Contrary
to the Panfilov (2006) study in which I was calculated at fast pacing frequencies, similar
to those produced by VF, we compare the effective size between species at slower pacing
frequencies, to observe the important inter-species differences that may occur during scar-
related reentry, which typically occurs at slower frequencies than VF. In addition, APD,
CV and wavelength restitution and the effect of varying pacing frequency on the effective
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size is observed. The characteristics of these restitution effects may vary between species
and may cause augmented species differences in wave propagation. Observing the effect of
restitution on the effective size will determine the suitability of the different small animal
models in replicating post-MI VT arryhthmia dynamics of the human. BZ remodelling
is known to affect both APD and CV around the perimeter of infarct scars (Sections 2.6
and 3.1). A crucial step in this study is to simulate BZ remodelling and study the effect
of remodelling on the effective size. Such information can provide insight into reentrant
propagation in the critical BZ region where activation waves propagate around the scar
(Lim et al., 2006). This work therefore presents a first step towards suggesting the best
species to model post-MI VT.
We study APD restitution in both single cell and tissue models in addition to CV
and wavelength restitution at the tissue level, by observing how these metrics change
with varying pacing frequency. I was calculated by taking into consideration wavelength
and heart size and the effects of restitution on the effective size were investigated. The
method was implemented in four different species models to be able to draw conclusions
about which species model most closely replicates that of the human model in terms of
effective size and hence, wave propagation dynamics. The protocol consisted of replicating
electrophysiological BZ remodelling in the models for the purposes of indicating species
differences in wave propagation, in relation to the human model, around infarct scar
substrates.
4.2 Investigating APD Restitution in Healthy Single Cells
4.2.1 Computational Model Set-Up
Simulations in this chapter and throughout the Thesis were carried out on a Dell Op-
tiplex 990 PC with eight 3.40GHz processing cores and 1TB of disk space, running the
Linux Ubuntu 12.04 operating system. All data analysis was performed in the Matlab
environment on the same PC.
For the purpose of elucidating species differences, four widely used computational mod-
els of ventricular ionic membrane potential were utilised in the following simulations. The
models used were the Ten Tusscher and Panfilov (2006) human model, the Mahajan et al.
(2008) rabbit model, the Luo and Rudy (1994) guinea pig model and the Pandit et al.
(2001) rat model. These electrophysiological models are described in detail in Section 3.5
80
4.2. INVESTIGATING APD RESTITUTION IN HEALTHY SINGLE CELLS
along with an account of why these models were chosen. The Ten Tusscher and Panfilov
(2006) model provides a model of human ventricular AP which has largely been formu-
lated from human data and is an extensively validated model. We utilise the model here
to compare the effective size of the human to that of other small animals. The Mahajan
et al. (2008) rabbit model, the Luo and Rudy (1994) guinea pig model and the Pandit
et al. (2001) rat models are used here to make comparisons between the electrophysio-
logical characteristics of the human model and these small animal models. Each of these
models incorporates the main ionic currents and calcium handling system which drive the
membrane potential and in addition, are widely used in the literature. The sub-package
BENCH, of the CARP software (Section 2.5) was employed to solve the membrane po-
tential in the following single cell simulations. Cell models run in CARP are implemented
from the cell model library, LIMPET. Models published in this library are validated against
the variable outputs from the source code and other published characteristic traces.
4.2.2 Steady State Pacing Protocols
Electrophysiological models must undergo a prolonged period of pacing at slow pacing
frequencies before simulation protocols are performed, in order for the models to reach
a steady state. After an initial stimulus current is applied, gating variables of the ionic
currents and ionic concentrations are in flux, resulting in a membrane potential with an
increased amplitude. The model requires time and steady pacing to recover from the
effects of the initial stimulus, in order for the gating variables, ionic concentrations and
hence, the membrane potential to reach a steady state and provide accurate membrane
potential data for use in subsequent studies.
A parameter sensitivity analysis was conducted using the four electrophysiological
models to ascertain the steady state pacing protocols required for each species model.
The number of stimulus beats were varied in the analysis. Graphs of intracellular ionic
concentrations and APD were outputted to observe how many stimulus beats were required
for the model to reach a steady state. The BCLs at which the models were paced to
conduct the parameter sensitivity analysis were chosen to be longer than the frequency of
sinus rhythm. The BCL of the steady state protocol performed for the human model was
1000ms, for the rabbit model was 400ms, for the guinea pig model was 500ms and for the
rat model was 500ms.
Graphs revealing the results of the steady state parameter sensitivity analysis in the
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human model are presented in Figure 4.1. The graphs display how intracellular ionic
Figure 4.1: Parameter sensitivity analysis determining a steady state pacing protocol in
the human model.
concentrations and APD vary as the model is paced for an increasing number of beats,
whilst the model was paced at a BCL of 1000ms. On observation of the results of the
parameter sensitivity analyses in each cell model, the steady state pacing protocols were
formulated using the BCLs given above. The human model was paced for 500 beats, the
rabbit model was paced for 1000 beats, the guinea pig model for 100 beats and the Pandit
model was paced for 50 beats. These steady state protocols were used prior to all single
cell simulations.
4.2.3 Restitution Pacing Protocols
Models were paced to a steady state according to the protocol described above prior to
commencing the restitution protocols. Dynamic and S1S2 protocols described in Section
2.3, were implemented in order to replicate both a gradual change in pacing frequency to
represent changes in heart rate observed, for example, during exercise (dynamic protocol),
and to replicate ectopic beats known to be involved in the initiation of reentry (S1S2).
Implementing the dynamic pacing protocol, we began with pacing the model at the
longest BCL stated for each model in Table 4.1. After the completion of 20 beats at that
frequency, the BCL was decreased by 20ms without halting the simulation and a further
20 beats were paced at the new frequency. This pattern of stimulating the model for 20
beats at each test frequency and decreasing the BCL by 20ms each time was continued
82
4.2. INVESTIGATING APD RESTITUTION IN HEALTHY SINGLE CELLS
Table 4.1: BCLs (ms) used in each restitution protocol for each species model.
Human Rabbit Guinea P ig Rat
Single Cell Dynamic 1000-200 400-160 500-280 500-200
S1S2 1000-340 400-200 500-260 500-80
until the BCL being utilised resulted in loss of capture. 20 beats were conducted at each
pacing frequency in order for the model to stabilise and reach a steady state at each new
pacing frequency before data was recorded.
The S1 section of the S1S2 protocol consisted of the model being paced for 20 beats at
the longest BCL utilised for each model (Table 4.1) in order to simulate a steady state. On
completion of the S1, a single premature stimulus (S2) was initiated at a test frequency.
In order to vary the frequency of the S2 beat, the complete S1S2 protocol was repeated
but the BCL of each subsequent S2 beat was decreased by 20ms until a BCL was utilised
which resulted in the loss of capture. The range of BCLs used for the S2 beat is displayed
in Table 4.1.
4.2.4 Restitution Analysis
The restitution analysis of the single cell modelling, utilised APD values calculated by
the BENCH software (Section 2.5). APDs produced by the dynamic pacing protocol
were determined for both the 18th and 19th beat at each frequency for the purposes of
observing the presence of alternans. For analysis of the S1S2 restitution protocol, APDs
were calculated for the S2 beat at each frequency. Graphs of APD were plotted against
BCL and the maximum gradients of the restitution plots were calculated.
4.2.5 The Restitution Effect of Single Cell Models
Restitution Response to Dynamic Pacing
Figure 4.2 displays APD restitution curves produced by dynamic stimulation of the human,
rabbit, guinea pig and rat single cell models for both the 18th (blue) and 19th (red) beats of
the stimulation protocol and the calculated maximum gradients of each line. The human,
rabbit and guinea pig graphs all display a positive restitution curve; as BCL increases,
APD increases also. This result reflects the physiological occurrence of APDs decreasing
as pacing frequency increases, in order to maintain functional contractility of the heart.
Whilst the major patterns of the restitution graphs of the rabbit and guinea pig models are
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Figure 4.2: APD restitution graphs for human, rabbit, guinea pig and rat single cell
models produced by the dynamic pacing protocol. APDs for beats 18 (blue) and 19 (red)
are displayed and maximum gradients of each beat are displayed alongside the graphs.
similar to those of the human model, values of the maximum gradients of the restitution
curves show that the human model produces a much steeper restitution curve, which could
potentially predict the occurrence of species differences in wave propagation with varying
pacing frequencies. Of note, the rabbit displays the most similar maximum gradient (0.74)
of the restitution graph to the human (0.93).
A negative restitution curve is produced by the rat model with APD increasing as the
BCL decreases. This is confirmed by the negative value of the maximum gradient of the
graph. In fact, the negative slope of the graph is very steep with a maximum gradient of
−0.90. A negative restitution curve is physiologically unlikely as if APD increased with
decreasing BCL, APs would cease to be intiated due to sustained depolarisation of the
membrane and the heart would be unable to function. The negative slope of the restitution
curve of the rat model therefore indicates that the model does not replicate physiological
restitution properties (Kondratyev et al., 2007; Fenton and Cherry, 2008; Salle´ et al., 2008)
and the results should be interpreted with caution.
The graphs of the human, rabbit and guinea pig models display pronouced bifurcations
at faster BCLs indicating the presence of alternans, with the APD of beat 19 decreasing
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as the BCL decreases, whilst beat 18 produces a much longer APD. Alternans occur as
a protective mechanism to ensure that at faster pacing frequencies, a regular heart rate
is maintained. Beat 19 consistently displays the highest maximum gradient compared
to beat 18 as the APD of beat 19 gets progressively shorter with an increase in pacing
frequency and the opposite occurs at beat 18. The similarity between beats 18 and 19 in
the graph of the rat model suggests no alternans occurred at faster BCLs.
Restitution Response to S1S2 pacing
The restitution graphs displayed in Figure 4.3 display similar trends to those produced by
Figure 4.3: APD restitution graphs for the human, rabbit, guinea pig and rat single cell
models paced according to the S1S2 protocol with maximum gradient values displayed
beside the graphs.
the dynamic pacing protocol with the human, rabbit and guinea pig models all displaying
positive restitution curves and the rat model displaying a negative slope. Maximum gra-
dient values displayed beside the graphs suggest that the human and guinea pig models
produced a similar restitution curve with a similar maximum gradient during dynamic and
S1S2 pacing. Although the shape of the restitution curve of the rabbit displays a decrease
in APD as BCL decreases during S1S2 pacing, the maximum gradient value reveals that
the slope of the rabbit restitution curve produced by S1S2 stimulation is significantly less
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steep than the graph produced by the dynamic pacing protocol, with a decrease in max-
imum gradient of 0.27. The rat model again produced a negative restitution curve but
with a significantly decreased maximum gradient which was reduced by -0.84 during S1S2
pacing compared to the dynamic protocol. These slight variations in restitution curves
between pacing protocols suggests that variations in wave propagation due to varying pac-
ing frequency may occur depending on whether the increase is gradual (such as during
exercise) or abrupt (such as an ectopic beat).
Interestingly, despite the variation in maximum gradient values produced by the dy-
namic and S1S2 pacing protocols between the human and rabbit models, the restitution
curve of the rabbit model remains most similar to that of the human in terms of the
significant decrease in APD as the BCL increases. This result again suggests that whilst
species differences occur between the two models, the rabbit model displays a restitution
curve most similar to the human and therefore, may better replicate variations in wave
propagation due to increasing pacing frequency in the human.
4.3 Observing APD, CV and Wavelength Restitution in
Healthy Tissue Models
4.3.1 Geometrical Model
A simplified geometrical model was utilised in the following simulations for the purpose of
calculating the CV and wavelength produced by the four species models at varying pac-
ing frequencies. Later in this chapter, the wavelengths measured across this geometrical
model are utilised to calculate the effective size of the heart. It could be assumed that
if a study aims to investigate wave propagation in the heart, that performing simulations
on an anatomically accurate model of the heart may be the optimal approach. Whilst
it is important to consider the many aspects of cardiac anatomy and electrophysiology
which affect wave propagation, it is also important to be able to study the individual
components which affect wave propagation to produce a deeper understanding of a par-
ticular mechanism (Clayton and Taggart, 2005). Utilising the simple geometrical model
described below, we can observe restitution dynamics of the electrophysiological models
without the results being affected by other parameters which may affect wave propaga-
tion, such as complex anatomical structures and electrotonic effects. In this simplified
model, performing the dynamic restitution protocol, utilising 6 cores of the PC described
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in Section 4.2, took approximately 1hr to perform the 20 beats for each pacing frequency
(depending on pacing frequency and model used). As such, it was feasible to run large
numbers of simulations to perform a comprehensive parameter sensitivity analysis. Per-
forming a sensitivity analysis on a much more complex geometrical model would be very
much more computationally demanding. The geometrical model utilised in these tissue
level simulations provided sufficient results with an acceptable computational demand, an
important consideration in any modelling study (Clayton and Panfilov, 2008).
Electrophysiology at the level of the tissue was modelled on a simple 2D rectangular
geometry measuring 5mm-by-1mm-by-0.005mm (Figure 4.4). A rectangular model was
Figure 4.4: Model utilised in tissue level simulations. The stimulus site and the node from
which data were sampled are indicated in red.
chosen in order to observe the propagation of the wavefront across the tissue and observe
CV and wavelength properties. In addition, the shape of the model allowed the node from
which data were sampled, to be located away from the stimulus location to ensure that
no unusual electrotonic effects associated with the stimulus affect the results.
The mesh generator software, Mesher (carp.meduni-graz.at), was utilised to generate
the tetrahedral finite element mesh which had a resolution of 50µm between nodes. The
resulting model consisted of 10000 elements and 4242 nodes. The low computational de-
mands required to perform simulations on the simple model allowed the use of a relatively
high resolution finite element mesh, providing very accurate wave propagation data.
By default, simulations were conducted with the fibres arranged in the longitudinal di-
rection. For the purposes of comparison, in some simulations, fibre direction was switched
to the transverse direction.
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4.3.2 Simulation Protocol
The CARP software (Section 2.5) was utilised to solve the monodomain equation to simu-
late propagation in tissue. A detailed explanation of the mathematical methods required
to model wave propagation in tissue and an outline of how CARP solves the membrane
potential across a finite element model was given in Section 2.5. As in the previous single
cell analysis, electrophysiological models of human (Ten Tusscher and Panfilov, 2006), rab-
bit (Mahajan et al., 2008), guinea pig (Luo and Rudy, 1994) and rat (Pandit et al., 2001)
ventricular AP were utilised. Electrical propagation across the geometrical mesh used
throughout this study was visualised in the software Meshalyzer (written by Dr Edward
Vigmond).
The model utilised in simulating wave propagation in tissue was stimulated along the
shorter side of the model as displayed in Figure 4.4. This resulted in a plane electrical
activation wave travelling down the longer dimension of the model.
Conductivity Parameters
Conductivity parameters are a required input of CARP in order to simulate the elec-
trotonic current which conducts the electrical activation signals between cells and across
the tissue. Intracellular and extracellular, longitudinal and transverse conductivity are
required input parameters for CARP but as the monodomain equation is solved through-
out the simulations in this Thesis, the bulk conductivity tensor replaces the bidomain
conductivities in the monodomain equation.
Due to the large intraspecies variation in reported CV values, previously reported
conductivity values (Clerc, 1976) were utilised for each electrophysiological model as shown
in Table 4.2.
Table 4.2: Conductivity values utilised in simulations (Clerc, 1976).
Parameter Description V alue
gli longitudinal intracellular conductivity 0.17S/m
gti transverse intracellular conductivity 0.019S/m
gle longitudinal extracellular conductivity 0.62S/m
gte transverse extracellular conductivity 0.24S/m
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Steady State Protocol
In order for the tissue models to reach a steady state, first the cell models were paced to a
steady state according to the protocols described in Section 4.2. The resulting parameters
were saved and used as initial starting parameters in further tissue simulations. A further
10 beats at the pacing frequency used in the cell model steady state protocols, were paced
in the tissue simulation to ensure that the parameters in the tissue model reached a steady
state. This method describes the steady state pacing protocols required to stabilise the
membrane potential after initial stimulation, before any further simulations are performed.
Restitution Protocols
A description of the restitution protocols used in this chapter is given in Section 4.2. The
same protocols were utilised in this tissue level study and the range of BCLs utilised are
presented in Table 4.3.
Table 4.3: BCLs (ms) used in each restitution protocol for each model.
Human Rabbit GuineaP ig Rat
T issue Dynamic 1000-280 400-180 500-200 500-220
S1S2 1000-360 400-220 500-200 500-80
4.3.3 Restitution Analysis
Restitution data in the tissue model were analysed using Matlab. Data were analysed
from a node located away from the stimulus (Figure 4.4) in order to avoid sampling
electrophysiological data where stimulus artifacts may affect the sampled data. In order
to observe APD restitution effects, ATs and RTs were calculated for beats 18 and 19 using
a linear interpolation algorithm to find the time points at which Vm crossed -40mV on the
upstroke and -70mV during the repolarisation phase respectively. APDs were calculated
by subtracting the AT from the RT and were plotted against BCL to produce an APD
restitution graph. Graphs of CV restitution were created by plotting CV against BCL. CV
was calculated by determining the speed that the activation wave took to travel between
the stimulus site and the node from which the data were sampled. Equation 2.4 was
utilised to calculate wavelength. Wavelength was plotted against BCL in order to create
the graph of wavelength restitution.
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4.3.4 APD, CV and Wavelength Restitution in Healthy Tissue Models
Restitution Response to Dynamic Pacing
Figure 4.5 displays APD, CV and wavelength restitution curves and their maximum gra-
Figure 4.5: APD, CV and wavelength restitution graphs for each species model. Tissue
models were paced according to the dynamic protocol. Maximum gradients are displayed
alongside each line graph. Units of maximum gradient of the CV restitution curve are
cm/s/ms and units of the maximum gradient of the wavelength restitution curve are
mm/ms.
dient values for each species tissue model paced according to the dynamic protocol. The
APD curves of the human, rabbit and guinea pig are all positive however, the rat model
displays a negative restitution curve, as observed in the single cell restitution analysis.
Importantly, the maximum gradient of the human APD restitution curve decreased in
comparison to the restitution graph in the single cell analysis and the slope of the rabbit
APD restitution graph remained similar between single cell and tissue analysis. This re-
sults in the maximum slope of the human and rabbit APD restitution curves being more
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similar at the tissue level than at the single cell level. Decreased maximum gradients of
the APD restitution graphs observed in the tissue analysis compared to the single cell
analysis, suggest that the electrotonic effects occurring at the tissue level decrease the oc-
currance of very short APDs, when the model is paced at short BCLs. Such electrotonic
effects occur in tissue due to the positive charge of the depolarised cells surrounding the
cell in question, slowing down the repolarisation phase of the cell, causing a prolongation
of the APD at the tissue level. Bifurcations of the human, rabbit and guinea pig graphs
are also present in the tissue analysis suggesting the occurrence of alternans.
CV restitution graphs displayed in Figure 4.5 show that positive CV restitution curves
are produced by human, rabbit and rat models and a biphasic curve is produced by the
guinea pig model. In general, as BCL decreases, CV decreases. The shape and maximum
gradient of the CV restitution curve of the rabbit model is again most similar to the human
(difference of 0.04cm/s/ms) with both the rat and guinea pig models producing a curve
with a much more shallow maximum gradient (difference of approximately 0.16cm/s/ms
compared to human).
The wavelength restitution curve displayed in Figure 4.5 is the product of the APD
and CV restitution curves. As such, the human, rabbit and guinea pig models display a
positive wavelength restitution graph and the rat model produces a negative wavelength
restitution curve. In the human, rabbit and guinea pig models, wavelength decreases as
BCL decreases. The human model restitution curve displays the steepest maximum gradi-
ent (approximately 0.5mm/ms) compared to the rabbit and guinea pig models producing
a maximum gradient of approximately 0.4mm/ms for beat 18.
Simulations conducted with fibres arranged in the transverse direction produce APD
restitution graphs of a similar morphology to those produced by simulations in which fibres
are orientated longitudinally. However, changing the fibres to be arranged in the transverse
direction reduced CV by approximately half and the range of CV values decreased also, due
to the preferential conduction of the activation wave longitudinally. As a result, maximum
gradients of wavelength restitution graphs are also reduced.
Restitution Response to S1S2 Pacing
Figure 4.6 displays the results of the APD, CV and wavelength restitution analysis pro-
duced by S1S2 pacing in tissue models. The human, rabbit and guinea pig models displayed
positive APD, CV and wavelength restitution curves similar to the results produced by
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Figure 4.6: APD, CV and wavelength restitution graphs for each species tissue model
paced according to the S1S2 protocol. Maximum gradients are displayed alongside each
line graph. Units of maximum gradient of the CV restitution curve are cm/s/ms and units
of the maximum gradient of the wavelength restitution curve are mm/ms.
models paced according to the dynamic protocol. However, the maximum gradient of
the human APD restitution graph increased by approximately 0.2 compared to the result
when the model was paced according to the dynamic protocol.
The maximum gradient of the human and guinea pig CV restitution graphs increased
very slightly during S1S2 pacing whereas the maximum gradient of the rabbit and rat
graphs decreased. The maximum gradient of the wavelength restitution curve increased
in the human, rabbit and guinea pig graphs compared to those produced by the dynamic
pacing protocol. Importantly, the difference between the maximum gradients of wave-
length restitution of the dynamic and S1S2 analysis appear small in the tissue analysis as
well as at the single cell level.
Changing fibre direction so that fibres are arranged in the transverse direction results
in the loss of capture occurring at longer BCLs. This is due to the slower conduction in the
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transverse direction causing an increase in wavelength and therefore subsequent propaga-
tion waves paced at very short BCLs will be blocked by the preceding waveback. Hence,
slight reductions in the maximum gradient of APD restitution graphs occur, compared to
those produced by simulations conducted with longitudinal fibre direction. CV is reduced
due to the transverse fibre direction in all species models, contributing to a decrease in
wavelength. However, the relative effects of changing fibre direction remain similar in all
species models.
4.4 Investigating Species Differences in Effective Size
4.4.1 Calculating the Effective Size
Utilising the results of the tissue simulations, the relationship between the activation
wavelength in relation to the size of the heart was calculated. We utilised Equation 4.1
proposed by Panfilov (2006) to determine the effective electrical size of the heart.
The measure of heart size utilised in the study by Panfilov (2006) was the cubic root
of the mass ( 3
√
M), estimated as 0.6% of body weight. This metric was used for the
purposes of comparing heart sizes between species, despite the highly complex shapes
involved. Hence, the cube root of volumes were compared by calculating 3
√
M , assuming
that shapes and densities were consistent.
Primarily, 3
√
M was used as the size metric in the effective size calculation. In addition
two further size metrics were utilised in the calculation, in order to determine whether the
size metric greatly affects the relationships of the effective size restitution curves between
different species. Due to the propagation patterns of reentrant waves travelling around
the heart and throughout the walls, two metrics were utilised which are tangibly related
to the wave propagation dynamics around the myocardium. These two metrics were the
diameter of the heart across both ventricles measured in the coronal plane in the centre
of the heart (diameter) and thickness of the LV wall (LV wall). Measures were either
obtained from MRI data analysed using Seg3D or from the literature. The value of each
metric for each species model is displayed in Table 4.4.
The effective size was calculated using wavelength values from simulations paced ac-
cording to the dynamic and S1S2 pacing protocols, with fibres arranged in the longitudinal
direction. Confidence limits were calculated by scaling each heart size metric by +/−20%
in order to account for error in the heart size measurements and considering the species
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Table 4.4: Measurements of heart size used in the effective size calculation.
Human Rabbit GuineaP ig Rat
3
√
M (g) 7.1791 2.9240 1.7100 1
Diameter(mm) 85 24 19 (Girouard et al., 1996) 12
LV wall(mm) 9 (Troy et al., 1972) 5 4 (Dhalla and Singal, 1994) 3
variation in conductivity values, which were kept constant in the modelling simulations.
4.4.2 Species Differences in Effective Size
Figure 4.7 displays the results of the effective size calculation, when 3
√
M was utilised as the
Figure 4.7: Graphs of I calculated using 3
√
M as the measure of heart size, for both the
dynamic (left) and S1S2 (right) pacing protocols. Confidence limits are shown by the
dotted lines.
measure of heart size, produced by both dynamic and S1S2 pacing protocol simulations.
Graphs for the human (black), rabbit (red), guinea pig (blue) and rat (green) models are
displayed, with the confidence limits (dotted lines) on each graph for comparison.
Analysis of I calculated, utilising 3
√
M as a measure of heart size, shows that the
shape of the rabbit and guinea pig graphs are similar to that of the human. That is,
as BCL decreases, I increases. This is contrary to the graph produced by the rat model.
Importantly, the rat model does not display similar restitution properties of I to the human
and therefore, it could be concluded that as pacing frequency varies, wave propagation
dynamics in the rat model do not replicate those of the human.
Values of I of the rabbit graph are lower than the human graph and values of the
guinea pig graph are still lower than the rabbit, suggesting that the rabbit model may best
replicate the restitution effect of wave propagation dynamics in the human. Additionally,
as the BCL decreases, I increases rapidly in the human model. This effect is most closely
replicated by the rabbit model with the guinea pig model displaying a flatter curve of I
with varying pacing frequency.
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Graphs of I restitution produced by models paced according to the S1S2 protocol
(right) differ, compared to those produced by the dynamic protocol (left). It is evident
that I restitution is affected by pacing protocol, due to the differences in wavelength resti-
tution between the two pacing protocols. What seemed like small differences in maximum
gradient of wavelength restitution between the two protocols, are clearly large enough to
affect I. The graph of I restitution of the human, maintains its steep negative gradient
as BCL decreases. The similar pattern of the rabbit model seen in the dynamic protocol
graph is not replicated in the S1S2 graph. In fact the gradient of the rabbit graph becomes
less steep with decreasing BCL and the gradient of the guinea pig graph more closely repli-
cates that of the human at fast pacing rates. The differences between the rat and human
model observed in results of the dynamic protocol are lessened with the positive slope of
the rat graph decreasing in the S1S2 graph.
Figure 4.8 displays the results of I analysis using diameter and LV wall size metrics
Figure 4.8: Graphs of I calculated using both diameter (top) and LV wall (bottom)
measures of heart size. Data were obtained from simulations paced according to both the
dynamic (left) and the S1S2 (right) protocols.
in the calculation for both dynamic and S1S2 pacing protocols. Comparing the analysis of
I utilising different measures of heart size in the calculation, it is possible to see that the
measure of heart size used in the calculation can change the relationship of I between dif-
ferent species. Altering the size metric used in the calculation only changes the numerator
of the equation (Equation 4.1) hence, only shifts the graphs up and down with relation to
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each other and doesn’t alter the shape of the I restitution graphs. Indeed, it is possible to
see that although the values of I vary slightly using diameter and LV wall metrics, the
shape of the graphs and relationships of I with varying BCL remain the same.
Utilising the diameter measure of heart size produced I relationships very similar
to those seen in the graphs of I using 3
√
M as the heart metric. Interestingly, utilising
LV wall as the size parameter, served to decrease the magnitude of I of the human heart,
resulting in the human heart displaying an I much more similar to that of the rabbit and
guinea pig. This can be seen by the overlapping graphs of the human, rabbit and guinea
pig, particularly at slower pacing frequencies.
Considering the restitution of I calculated using wavelength produced by dynamically
paced simulations with fibres arranged in the transverse direction, the graphs, and im-
portantly, the relationship between species, remain similar to the results produced by the
longitudindal fibre direction simulations. Altering fibre direction alters the magnitude of
the wavelength and not the gross morphology of the wavelength restitution graph. Hence,
the graphs of I only differ in their magnitude, not in their shape or relation to each other.
4.5 Investigating the Effect of BZ Remodelling on the Ef-
fective Size
4.5.1 Simulating BZ Remodelling
This section aims to observe the effects of BZ remodelling on the effective size. Based
on the conclusion of the Panfilov (2006) study and the results observed in Section 4.4,
suggesting that the rabbit model displays the most similar effective size to the human
heart, we performed the following simulations using only the human and rabbit models.
Single Cell Models
Single cell simulations were conducted as described in Section 4.2. Simulations were per-
formed in BENCH and models were paced to a steady state before the dynamic restitution
protocol was initiated. APD data were calculated in the BENCH software.
Sections 2.6 and 3.1 describe the alterations to both the ionic currents and conduction
velocity which occur in the BZ as a result of ischemic damage. Here we compare the
electrophysiological properties of healthy cells to those of BZ remodelled cells. Healthy
cellular electrophysiology was simulated by using the human (Ten Tusscher and Panfilov,
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2006) and rabbit (Mahajan et al., 2008) models of ventricular AP. BZ alterations to the
ionic currents were modelled by varying parameters of the electrophysiological models,
based on previous protocols which have been implemented in both human and rabbit
models to replicate BZ ionic current remodelling (Ashikaga et al., 2013; McDowell et al.,
2011; Rantner et al., 2012). All changes to ion channel conductances were motivated
by data produced from patch-clamped BZ cells, which displayed a decrease in the ionic
currents (Litwin and Bridge, 1997; Pu and Boyden, 1997; Jiang et al., 2000). The maximal
conductance value of INa was reduced to 38% of normal, the strength of the ICaL flux was
decreased to 69% of normal, IKr was reduced to 30% of normal, IKs was decreased to 20%
of normal and the maximal INaCa was increased to 132% of normal. This BZ remodelling
protocol was implemented in both the human and rabbit models.
Graphs of Vm were plotted to compare APs in healthy cells to APs in BZ remodelled
cells. We compare APD restitution between healthy cells and BZ remodelled cells by
plotting APD against BCL for both models.
Tissue Level Models
In models of tissue electrophysiology, it is possible to simulate not only BZ remodelling of
ionic currents but it is also possible to model alterations to conduction velocity which occur
in the BZ. In order to observe the effect of the altered ionic currents and conduction velocity
on the effective size, four different models were utilised. A model simulating healthy tissue
with no remodelling affecting the ionic currents or conduction velocity (IonnormCondnorm)
was used for comparison. The other models incorporated ionic current BZ remodelling and
normal conduction velocity (IonBZCondnorm), normal ionic current parameters and BZ
conduction velocity (IonnormCondBZ) and BZ remodelled ionic currents and conduction
velocity (IonBZCondBZ). Ionic current remodelling was incorporated into the models
according to the protocol described previously in this section. To simulate conduction
velocity in healthy tissue, conductivity values were assigned as previously described (Table
4.2). Conductivity remodelling was modelled by decreasing the transverse conductivity
values to 10% of normal values as previously described in studies which have replicated BZ
remodelling in human and rabbit computational models (Ashikaga et al., 2013; McDowell
et al., 2011; Rantner et al., 2012).
Simulations were performed using each model as described in Section 4.3 using both
the human and the rabbit cell models. Due to the transverse conductivity remodelling,
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simulations were run on the geometrical model (Figure 4.4) with fibres arranged in the
transverse direction. The models were paced to a steady state before the tissue level
steady state protocol was implemented and the dynamic restitution pacing protocol was
performed.
Data obtained from the simulations were analysed as described in Section 4.3. Graphs
of APD, CV and wavelength restitution were produced.
The effective size of the heart was calculated according to Equation 4.1, using 3
√
M as
the measure of heart size and the wavelength produced by the tissue simulations described
in this section. The effective size was calculated for each BZ remodelling condition for
both the human and rabbit models.
4.5.2 APD Restitution in BZ Single Cell Models
Figure 4.9 displays APs produced by human (left) and rabbit (right) models. The blue
Figure 4.9: Graphs of APs of the human (left) and rabbit (right) models produced by
both a normal model (blue) and a model incorporating BZ remodelling (red).
lines show normal healthy APs with the red lines depicting BZ remodelled APs. BZ
remodelling significantly alters the shape of the AP. In both models, BZ remodelling
increases the APD by approximately 150ms. In addition, remodelling in both the human
and rabbit models causes a decrease in the peak and a prolonged notch phase of the AP.
It appears that BZ remodelling has a similar effect on the APD in both the human and
the rabbit model.
The results of BZ remodelling on APD restitution is displayed in Figure 4.10. Considering
the graph of human (left) APD restitution and comparing the graphs of the BZ remod-
elled simulations (solid line) to the normal (dotted line) cell simulations, it is evident that
BZ remodelling causes a prolongation of APD by approximately 150ms. Graph bifurca-
tions occur in both healthy and BZ remodelled cases at low BCLs, indicating the presence
of alternans. Due to the increase in APD, the model with incorporated BZ remodelling
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Figure 4.10: Graphs of human (left) and rabbit (right) APD restitution, comparing
differences in BZ (solid line) and healthy (dotted line) APDs. Maximum gradients are
displayed beside each graph.
was unable to be paced at the fastest BCLs. Importantly, although the graphs display
disparity in the values of APD between the normal and BZ remodelled models, the shape
of the restitution curve remains similar, reflected in the similarity of the maximum gra-
dient values displayed on the graphs. This finding could suggest the restitution effect on
wave propagation is similar between healthy and BZ remodelled tissue.
The APD restitution curves of the rabbit model (right) also show that BZ remodelling
causes an increase in APD of approximately 150ms, which can be seen in Figure 4.9.
These results can be expected, considering that the same BZ remodelling protocol was
implemented in both the human and rabbit models. The increase in APD caused the loss
of capture at lower BCLs in the BZ model which in turn provided a short restitution graph
for comparison. The maximum gradients of the restitution graphs of the BZ remodelled
case remain in the range of the maximum gradients of the normal tissue graphs. Again,
this result could suggest that the effective size restitution of healthy tissue will display
similar dynamics to the effective size restitution of the BZ remodelled rabbit model.
4.5.3 APD, CV and Wavelength Restitution in BZ Tissue Models
Figure 4.11 displays graphs of APD (top), CV (middle) and wavelength (bottom) restitu-
tion for human (left) and rabbit (right) models. Graphs of IonnormCondnorm (green),
IonnormCondBZ (blue), IonBZCondnorm (red) and IonBZCondBZ (black) models were
plotted on the same graph for comparison. Observing the APD restitution graphs of both
the human and rabbit models, it is evident that ionic remodelling in IonBZCondnorm
(red) and IonBZCondBZ (black) models increases the APD by approximately 150ms in
each model. In general, the human displays steeper APD restitution graphs than the rab-
bit model indicating that as pacing frequency increases, APDs decrease to a greater extent
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Figure 4.11: Graphs of APD (top), CV (middle) and wavelength (bottom) restitution for
human (left) and rabbit (right) models which either have normal or BZ remodelled ionic
current and conduction velocity parameters.
in the human model than in the rabbit model. Interestingly, in only the human model,
CondBZ remodelling (black and blue curves) causes further prolongation of APDs at lower
BCLs resulting in a more shallow APD restitution curve. During a very slow conducting
wave, more of the tissue is activated at a particular time and so the electrontonic current
from activated tissue contributes to the slower repolarisation of the tissue from which the
data are sampled in this case.
The graphs of CV (middle) display a general decrease in CV compared to those shown
in Figure 4.5, due to the fibres arranged in the transverse direction in the model used to
run these simulations. Conductivity remodelling decreases CV as can be seen from the
CV restitution graphs produced by both models (blue and black curves). In addition,
IonBZ remodelling also causes a decrease in CV (compare red to green graphs) due to
the reduction of the maximal conductance of INa. Whilst the CV restitution curves of the
human model display a slight reduction in CV as the BCL decreases, the CV restitution
curves produced by the rabbit model are very flat, a trait which can also be seen in Figure
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4.5.
Evident from the wavelength restitution curves, CondBZ remodelling causes a decrease
in wavelength in both models (compare black and blue graphs to green and red graphs).
The graphs produced by CondBZ remodelled simulations (black and blue) are more shallow
in both models than the Condnorm graphs. This result suggests that when CV is slowed
in BZ tissue, a decrease in BCL does not cause an even greater reduction in CV, resulting
in flatter wavelength restitution graphs. The magnitude of the wavelengths produced
by the rabbit model are approximately half of those produced by the human model and
in addition, the gradients of the wavelength restitution graphs of the human model are
generally steeper than those produced by the rabbit model, due to the steeper APD and
CV restitution curves in the human model.
4.5.4 Species Differences in Effective Size in BZ Models
Figure 4.12 compares the graphs of I of the human (black) and rabbit (red) models for
Figure 4.12: Graphs of I produced by models of normal or BZ remodelled ionic current
or conduction velocity properties. Black - human, red - rabbit.
the four cases: IonnormCondnorm, IonnormCondBZ , IonBZCondnorm and IonBZCondBZ .
There remains disparity between the I of the human and the rabbit models in all four
cases as a result of differences in wavelength.
The magnitude of I varies between the human and rabbit model as a result of the
difference in the magnitude of the wavelengths between the human and rabbit models.
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The human produces a longer wavelength and hence, a larger I, suggesting that the
wavelength in the human model is smaller compared to the size of the tissue than the
rabbit, and so reentry is more likely to occur in the human than the rabbit model.
In general, the human model displays a steeper gradient of I restitution than the rabbit
model. The flatter wavelength restitution graphs of the rabbit models displayed in Figure
4.11 contribute to the shallow gradients of I restitution. Particularly in the human model,
the steepness of I restitution occurring at smaller BCLs indicates that reentry is more
likely to occur at shorter BCLs, due to the decrease in wavelength increasing the excitable
gap.
Comparing the results of I restitution between the models with Ionnorm (top) and
IonBZ (bottom), the magnitude of I decreases as a result of IonBZ remodelling. This result
can be explained by the lengthened APD as a result of IonBZ remodelling contributing
to a longer wavelength which in turn, would decrease I and the likelihood of reentry.
The gradient of I restitution appears to be reduced by CondBZ remodelling (right) when
compared to graphs of Condnorm (left). This is possibly due to the fact that with reduced
CV in the BZ, CV can not decrease further with decreasing BCL. This effect can be seen
in the CV restitution curves in Figure 4.11.
From the results presented in this section it is evident that species differences occur,
such as the magnitude and restitution of I. The differences in I between species suggest
that susceptibilty to reentry is increased in the human model but perhaps most impor-
tantly, decreasing the BCL increases the susceptibilty to reentry in the human model more
than in the rabbit model. Interestingly however, the effects of BZ remodelling on I resti-
tution appear to have similar effects in both the human and rabbit models which could
suggest that alterations in wave propagation around infarct BZs could be similar in both
the human and the rabbit.
4.6 Discussion
4.6.1 Limitations
Despite the previous idea that the rabbit model is most similar to the human in terms
of effective size compared to the dog and pig at pacing frequencies akin to those during
VF (Panfilov, 2006), it would be beneficial to compare the effective size of larger animal
models to the human at slower pacing frequencies, similar to those observed during scar-
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related VT. The results could validate the claim made here, that in fact the rabbit model
does display the most similar effective size to the human over a complete range of species
models and pacing frequencies.
Due to limited experimental data available on the remodelling of ionic currents in
human BZ, the same remodelling protocol was utilised for both the human and rabbit
models. The protocol utilised was formulated based upon data from rabbit and canine
animal studies and so there could be discrepancies between the BZ remodelling which
occurs in animals and that which occurs in humans, post-MI. Potentially, differences in
ionic current remodelling could alter the restitution dynamics of the effective size, altering
the relationship of effective size between species.
4.6.2 Summary
Results from the APD restitution analysis of the single cell models and the results of
APD, CV and wavelength restitution analysis from tissue models, suggest that APD, CV
and wavelength all display positive restitution graphs for the human, rabbit and guinea
pig models. Therefore, as BCL decreases, APD, CV and wavelength all decrease in a
rate-dependent manner which replicates a well documented restitution effect.
Another important restitution effect which is replicated by the human, rabbit and
guinea pig in both single cell and tissue models is observed by the presence of alternans.
As the pacing frequency increases, alternans may occur in order to maintain CO. Here
we verify that these mathematical models of electrophysiology replicate the important
restitution properties observed in animal studies and can therefore be utilised in studying
aspects of heart function which are dependent upon restitution, such as wave propagation.
The rat model is the only model which produces a negative restitution graph. That is,
as BCL decreases, APD increases. As a result, in the tissue models, wavelength restitution
also follows the same rate-dependent trend. This effect is not physiologically possible. As
pacing frequency increases, the APD must decrease in order for the heart to maintain
CO and sustain life. In addition, the results of the effective size of the rat model reflect
the negative wavelength restitution curve, contrary to the restitution curves of the other
models. Therefore, the results of the the rat model should be treated with caution and it
can be suggested that the Pandit rat model is not a suitable model to replicate restitution
dynamics of the human.
A crucial result is that APD, CV and wavelength restitution curves illustrate that the
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rabbit model displays restitution effects most similar to the human model. In addition
these two models are most similar in terms of the magnitude of the wavelength. Due to
these similarities, it was found that the rabbit model produced an effective size most similar
to the human model in terms of both magnitude and rate-dependency. This important
result supports the conclusion of a previous study (Panfilov, 2006), suggesting that the
rabbit displayed the most similar effective size to the human, at pacing rates indicative
of VF. We can suggest here, that the rabbit and human models display the most similar
effective size at pacing rates indicative of VT. Hence, we can propose that, compared
to the other models tested, the rabbit model is the most useful model to replicate wave
propagation dynamics of the human and could be of potential use in informing clinical
studies.
It should be noted that whilst the effective size of the human and rabbit models are
most similar, species differences in the magnitude of the effective size still exist. The human
model produces a larger effective size, indicating that the model is more susceptible to
reentry than the rabbit model. In addition, the rate-dependency of the effective size of
the human model is greater than that of the rabbit model, as can be seen by the steeper
gradient of the human graph at faster pacing frequencies. Hence, we conclude that despite
similarities, species differences occur between the effective size of the human and rabbit
which may suggest the presence of important species differences in wave propagation
dynamics between the models. Thus, we can suggest that for the most robust conclusions
to be drawn about wave propagation dynamics in humans, the human model of AP should
be utilised. However, the rabbit model provides a respectable alternative if necessary which
can approximate the wave propagation dynamics of the human and its rate-dependency.
Observing the effect of changing the size parameter in the calculation of the effective
size, it is evident that changing the numerator of the calculation only alters the magni-
tude of the graphs between the species and does not affect the restitution dynamics of
the effective size. Indeed, changing the size parameter from 3
√
M to diameter or LV wall
increases the similarity between the human, the rabbit and the guinea pig models. How-
ever, changing the measure of the heart size in the calculation does not alter the main
conclusion discussed above; that the rabbit provides the most similar model to the human
in terms of the magnitude and the restitution dynamics of the effective size.
Results of restitution dynamics produced by the two pacing protocols, the S1S2 and
dynamic protocols remain similar in both the single cell and tissue level models suggesting
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that the rate-dependency of APD, CV and wavelength remain similar, whether a gradual
or an abrupt change in pacing frequency occurs. Although slight differences occur in
effective size depending on the pacing protocol, namely that the restitution effect of the
effective size in the rabbit model was decreased using the S1S2 pacing protocol, the main
result remains that the human and rabbit models have the most similar effective size
irrespective of pacing protocol.
In light of the similarities in the effective size between the human and rabbit models,
only these models were utilised to study the effect of BZ remodelling on the effective size.
Although species differences between the human and rabbit occur in terms of the magni-
tude and the extent of the rate-dependent properties of the effective size, BZ remodelling
produces similar effects in both the human and rabbit models. Specifically, ionic current
BZ remodelling decreases the magnitude of the effective size and conductivity remodelling
decreases the gradient of restitution in both models. Therefore, it could be suggested that
the rabbit model produces similar changes in wave propagation dynamics which occur in





Investigation of a Method to
Determine the Success of
Reentrant Propagation
In Chapter 4 we investigated the effective electrical size of the heart in terms of species
differences and demonstrated that whilst the rabbit displays the most similar effective size
to that of the human, clear species differences remain. We utilise our findings from the
previous chapter by progressing our studies using a human electrophysiological model. Ad-
ditionally, it is essential to consider the work of the previous chapter regarding the effective
size of the heart, as the topic of this chapter focuses on quantifying reentry, a mechanism
which is governed by wavelength and its relation to the size of the tissue, the definition of
effective size. Here we investigate a proposed metric to identify regions of tissue which are
susceptible to reentry based on wavefront-waveback interactions.
5.1 Introduction
Reentrant arrhythmias are characterised by activation waves propagating in a circuitous
fashion. Often, reentry occurs as a result of UDB caused by APD heterogeneity in the
tissue. Propagation of an electrical impulse wave is blocked as it travels from healthy tissue
towards tissue which remains refractory due to a lengthened APD, causing diversion of the
wave around the region of block. Crucially, once a reentrant circuit has been established,
the continuation of reentry depends on the excitable gap, as described in Sections 2.6 and
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3.1. If there is an excitable gap, the wave can propagate into repolarised tissue within the
circuit, facilitating the maintenance of the reentrant propagation. Reentrant arrhythmias
cause a significant number of deaths, hence research into the mechanisms of reentry and
possible clinical therapies is of great interest.
A metric was proposed by Coronel et al. (2009) (Section 3.8) to highlight regions of
tissue susceptible to reentry by taking into consideration potential interactions between
the wavefront and the wave back around a possible reentrant circuit. Experiments were
conducted on a Langendorff perfused porcine heart. Dispersion of repolarisation was
induced, resulting in half of the tissue (the proximal half) displaying a shorter APD than
the other half of the tissue (the distal half). This is represented in Figure 5.1 where AP
Figure 5.1: Experimental model set-up to investigate the RVI described by Coronel et al.
(2009). Green X indicates the stimulus site in the proximal region. APs in left hand
corners show the lengthened APD in the lower region. Labelled arrows depict wave prop-
agation from the stimulus site and subsequent block (1), diverted propagation (2) and
propagation back towards the site of initial block (3). Points p and d show sites from
which electrophysiological data were sampled.
traces in the left-hand corners of the tissue illustrate that a longer APD was initiated in the
distal (d) half of the tissue. The longer APD in the distal region is responsible for causing
initial wave block, as depicted by arrow 1, because the distal half remains depolarised due
to the lengthened APD. The wave is then forced to divert around the region of block, until
the distal region has repolarised (arrow 2). The wave then propagates through the distal
region towards the site of initial wave block (arrow 3). Crucially now, whether or not the
wave can propagate back into the proximal region forming a reentrant circuit, depends
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on the membrane potential in the proximal side of the tissue. If the proximal tissue has
repolarised, the wave from the distal region will be able to reenter. If the proximal tissue
remains depolarised, the wave from the distal region will block again and not reenter.
Hence, a metric was devised to compare the time of repolarisation at p with the time of
activation at d. An electrode grid over the tissue recorded electrophysiological data from
which AT and RT values were deduced. The metric takes into consideration the RT at
point p in the upper region (ie. prior to the activation wave block) and the AT at point
d after the diversion of the wave around the region of refractory tissue. The concept of
the metric is simply; if d is activated by the time that p is recovered, propagation can
occur from d to p resulting in UDB, initiating a reentrant circuit. Conversely, a situation
in which BDB occurs, and hence no reentry, would be indicated by the activation at d
occurring before p is repolarised, because the wave would not be able to propagate from
d into depolarised p. The FF calculation they proposed was
FF = RTp −ATd (5.1)
Implementing the equation, a negative FF result would be produced by a scenario where
RTp is smaller than ATd indicating reentry. Low, positive values of FF indicate BDB.
The results from the study showed that utilising this calculation can determine the sus-
ceptibility to reentry between two points, not only when UDB occurs but also when BDB
occurs.
A subsequent study (Child et al., 2015) proposed a clinical application of the metric,
utilising the same concepts to produce a spatial map of the susceptibility to reentry across
the heart. Sections 2.6 and 3.1 describe how MI scars create both structural and functional
heterogeneity in the tissue, due to fibrosis and ionic remodelling of the BZ. These substrates
provide the prerequisites for reentry: lengthened APD in the BZ regions and structural
barriers around which propagation waves are diverted. Figure 5.2 depicts a representation
of an infarct scar and the typical pattern of reentry around it. The wave is blocked at
the region of lengthened APD which occurs in the BZ (blue) and is diverted around dense
non-conducting fibrotic tissue (black), entering the BZ isthmus distally and propagating
back towards the site of initial block. It is this figure-of-eight reentry around infarct scars
which causes life threatening arrhythmias and so methodologies to terminate episodes
of reentry are vitally important. In Chapter 3, the limitations of the current ablation
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Figure 5.2: The typical pattern of figure-of-eight reentry around an infarct scar. The
wave is blocked (dotted yellow line) by the refractory tissue in the BZ (blue) facilitating
reentrant propagation around the infarct scar (black).
procedure technique were discussed in detail. Specifically, it was shown that the method
of mapping the scar to locate the optimal site for the ablation lesion is inaccurate and
requires improvement. Therefore, a method to highlight regions susceptible to reentry,
such as the method proposed by Child et al. (2015), could prove an important tool to
improve the clinical ablation procedure by providing a technique to locate the optimal
ablation lesion site. The clinical study utilises the concept described previously (Coronel
et al., 2009) to locate regions of tissue susceptible to reentry. However, instead of producing
a result between only two points, the metric is calculated between points over the entire
surface of the endocardium, to produce a spatial map of regions susceptible to reentry, in
order for clinicians to use the map to guide where an ablation lesion is to be created.
Rigorous analysis of the methodology proposed by Child et al. (2015) is needed in order
to draw firm conclusions. The calculation has been tested using experimental porcine
data and has been implemented in the clinic on an individual patient. Therefore, the
utility of the method needs to be further investigated. Moreover, the preclinical study
utilising the calculation only implemented the analysis in situations of functional reentry.
Considering the clinical application of the algorithm in guiding the ablation procedure,
the methodology requires investigation in models of post-MI reentry. In addition, further
analysis is needed for optimisation of the methodology and to ensure that the technique
is robust under varying physiological conditions.
From the results presented in Chapter 4, we observed that species differences in the ef-
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fective size and hence, wave propagation dynamics, do occur and that if possible, utilising
a human model of electrophysiology would be the optimal approach in order to simulate
human wave propagation dynamics. Therefore, in this chapter, we investigate the pro-
posed calculation (Child et al., 2015) using human in silico data. The benefits of utilising
computational models to study post-MI arrhythmias have been discussed in Section 3.5.
Considering investigating a proposed calculation for use in the clinic, computational mod-
elling allows the thorough study of the methodolgy using human electropyhsiological data
whilst not being restricted by sample sizes, ethics or clinical practice. Hence, we simulate
propagation using a model of human ventricular AP (Ten Tusscher and Panfilov, 2006) on
a simple 2D geometrical model, emulating the experimental set-up described by Coronel
et al. (2009), and implement the proposed RVI algorithm (Child et al., 2015). Computa-
tional modelling also allows us to investigate variations of the methodology to ensure that
the method proposed for clinical use is optimal. Therefore, we investigate other possible
calculation methods based on the algorithm described previously (Coronel et al., 2009)
which may predict susceptibility to reentry over a 2D surface and hence, we may be able
to suggest the most effective calculation for this purpose. In addition, we can examine
thoroughly, the effect of varying calculation parameters on the result, to draw conclusions
about the optimisation of the calculation proposed by Child et al. (2015). Due to not
being restricted by the small quantity of patient data available, we are able to verify that
the calculation maintains its ability to detect a vulnerability to reentry in varying phys-
iological conditions, such as increasing arrhythmogenicity. The arrhythmogenicity is the
ability of the substrate and its properties to facilitate reentrant wave propagation, with in-
creasing arrhythmogenicity describing a substrate which is more likely to facilitate reentry.
Here, we alter simulation parameters to increase the arrhythmogenicity of the simulation
and observe whether the calculation maintains its ability to locate regions susceptible to
reentry. It is possible, utilising computational models, to alter such parameters one at a
time, for the purpose of observing the effect of individual parameters. Importantly, we can
utilise computational models to incorporate 2D idealised scar regions into the geometrical
model in order to investigate the utility of the methodology in post-MI, figure-of-eight
reentry, which has not previously been investigated.
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5.2 Investigating the Method in a 2D Experimental Model
5.2.1 Computational Model Set-Up
Computational Model Geometry
The geometrical model utilised in simulations throughout this chapter was created in order
to replicate the experimental set-up described by Coronel et al. (2009). Therefore, A 2D,
5cm-by-5cm finite element mesh with a resolution of 200µm between nodes was created
using the Mesher software (carp.meduni-graz.at). This resulted in a model consisting of
62500 quadrahedral elements and 63000 nodes. The shape of the geometry was chosen to
replicate the previous experimental geometry and the square shape permitted the model
to be divided into two halves in order to incorporate APD heterogeneity. Moreover, the
square shape and the size of the geometry was chosen to permit the propagation of waves
around a line of block to form and sustain a reentrant circuit. The resolution of the
model was decreased compared to the model utilised in Chapter 4 in order to be able
to conduct parameter sensitivity analysis with acceptable simulation run-times and data
storage requirements. Importantly, decreasing the resolution of the finite element mesh
did not impair the simulation of wave propagation in the model.
Essentially, the experimental model (Coronel et al., 2009) consists of a region of healthy
myocardium and a separate region displaying prolonged APD, representing the APD het-
erogeneity required for the initiation of reentry. We replicated this experimental model by
dividing the geometrical model in half parallel to the x-axis, as displayed in Figure 5.3 by
assigning separate tags to the elements within each region. Those defining tags enabled
each spearate region to be assigned different parameters, forming two regions with dis-
tinct properties. Reference to proximal and distal regions of the model refer to the healthy
tissue (white) and tissue with lengthened APD (red) respectively.
Model Parameterisation
Simulations were run utilising the TT2 model of human ventricular AP (Ten Tusscher
and Panfilov, 2006), described in Section 3.5. This model was chosen due to the results of
Chapter 4 suggesting that due to species differences in the effective size between human
and small animal models, the optimum method for studying VT arrhythmias is to utilise
human in silico data where possible. All of the elements in the mesh were assigned isotropic
fibre directions with conductivity values of 0.1S/m in both longitudinal and transverse
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Figure 5.3: Geometrical model utilised to investigate an algorithm to predict the occur-
rence of reentry. The white region depicts healthy tissue and the red region depicts tissue
displaying a longer APD. The green X indicates the site of stimulation.
directions, in order to retain simplicity of the model for the purposes of understanding the
fundamental mechanisms affecting the results of the calculation.
In order to introduce a sufficient gradient of repolarisation to cause conduction block,
the conductance term (GKs) of IKs was varied from the value stated in the TT2 model;
0.4nS/pF (Ten Tusscher and Panfilov, 2006). An APD of approximately 250ms was pro-
duced in the white region of the model (Figure 5.3) by increasing GKs to 0.75nS/pF. APD
was lengthened in the red region to approximately 300ms by decreasing GKs to 0.2nS/pF.
Stimulation Protocol
Steady state pacing protocols were implemented as described in Section 4.3. The model
was stimulated at the location of the Green X in Figure 5.3, in the region of shorter APD
and located off-centre in order to be able to view the sideways propagation of the wave
due to conduction block. In order for the heterogeneous repolarisation of the tissue to
initiate conduction block, a premature stimulus is required so that the wavefront reaches
the border between the two regions prior to the red region being repolarised. Therefore,
after obtaining a steady state, an S1S2 protocol was initiated, by stimulating the model
prematurely (S2), 300ms after the previous stimulation (S1). The model was stimulated
for 3ms with a current of 300µA. To run an S1S2 simulation, it took approximately one
hour and the resulting data files were approximately 300MB. Resulting simulations were
visualised using the software Meshalyzer.
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5.2.2 Producing a Spatial Map of Susceptibility to Reentry
Child et al. (2015) proposed a calculation termed the reentry vulnerability index (RVI),
which produces a spatial map of the susceptibility to reentry over a surface. The RVI
calculation was implemented to produce the results of this study. The RVI is based on the
concept described by Coronel et al. (2009) however, the calculation is conducted over all
nodes in the model rather than between only two points and an averaged spatial map of
the results is produced. Described here is the protocol used to produce a map of the RVI.
Experimental Data
The in silico data used in the calculation are the AT and RT data obtained from the sim-
ulations described in this section. The output of the simulations are membrane potential
traces and so AT and RT data must be calculated from the simulation output. ATs and
RTs were calculated for both the S1 and the S2 beats at each node in the geometrical
model using a linear interpolation algorithm to find the time points at which Vm crosses
-40mV on the upstroke and -70mV during the repolarisation phase respectively. APDs
were calculated by subtracting the AT from the RT at each node.
The RVI Calculation
Figure 5.4 illustrates the method utilised in calculating the RVI. The following calculation
protocol was performed on every successive node in the model (nodei) (red). A spatial ra-
dius (rs) (black circle) was created around nodei for the purposes of determining potential
pairs of calculation nodes. rs was formulated utilising the equation
(X −Xi)2 + (Y − Yi)2 <= r (5.2)
where X and Y are x and y coordinates of all nodes within the model, Xi is the X
coordinate of nodei, Yi is the Y coordinate of nodei and the radius of the rs circle is r .
Any nodes which satisfied Equation 5.2 and hence their coordinates fell within rs were of
potential use in the RVI algorithm. Nodes within rs were further screened and only those
nodes activated after nodei on the S2 beat (downstream nodes) were utilised in the RVI
calculation. Downstream nodes were determined by comparing the ATs of the S2 beat
between nodei and all other nodes within rs. The image at the top of the figure depicts
the identification of downstream nodes (orange) with the superimposed AT map.
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Figure 5.4: RVI calculation methodology. Top - Search radius (rs, black circle) around red
node (nodei) is used to determine calculation node pairs. Nodes within rs and activated
after nodei (see underlying AT map) are denoted nodej (orange) and used in the RVI
calculation. Bottom - Summarises method of RVI calculation between each node pair
(nodei and each nodej).
Downstream nodes were denoted nodej (orange) and the RVI algorithm was calculated
between nodei and each nodej as depicted by the image at the bottom of the figure, to
produce a number of RVI values. Equation 5.3 was used to calculate the RVI between
each node pair:
RV Ii,j = RTi −ATj (5.3)
The RVI essentially calculates a time between the wave back and the wavefront between a
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pair of nodes to determine whether reentry is able to occur. If the pair of calculation nodes
are a great distance apart from each other, the calculated time gap between the nodes
becomes meaningless due to the distance the wave would have to travel to complete the
hypothetical circuit, hence a spatial radius is required to determine potential calculation
nodes. Only downstream nodes were utilised in the calculation to ensure that nodej was
distal in time, to the stimulus site, compared to nodei. In this case, if wave block occurred
between the two nodes, nodei was always located prior to the block and nodej was always
located after block occurs. This method ensures that the calculation subtracts a value
nearer to the wavefront, from a value which is sampled nearer to the wave tail. This
situation is identical to the experimental set up used to propose the fundamental concept
of the calculation (Coronel et al., 2009).
Plotting a Spatial Map of the RVI
For each calculation node pair, a spatial midpoint was calculated between the two nodes
and the nearest node to the midpoint was identified. The RVI calculated between each
pair was associated with their respective midpoint node. For visualisation, an average of
the RVIs was taken and plotted at each node point. The resulting RVI map was visualised
using the software Meshalyzer.
5.2.3 Examining the Optimum Protocol to Identify Susceptibility to
Reentry
The methodology described in the previous paragraphs is the method which is employed
to produce the results which are presented in this chapter. However, in order to ensure
that the methodology described above is the optimum method to produce a spatial map
which displays the susceptibility to reentry, other methods were tested. In doing so, some
important findings shed light on the mechanism of the RVI calculation and the important
findings are described below.
Identifying Calculation Node Pairs
In order to be of clinical use, it is necessary that a method is devised which can predict
susceptibility to reentry over a relatively large surface, such as that of the heart. The
original FF algorithm was based upon calculating the FF between two nearby points and
so the proximity of the proximal and distal nodes used in the calculation must be taken
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into consideration. Considering that the experimental model used in this study measured
5cm-by-5cm, the algorithm calculating a possible excitable gap between nodes that could
potentially be 5cm apart becomes obsolete, as the wave would have 5cm to complete the
hypothetical circuit, making times calculated between RTi and ATj meaningless. Consider
a scenario in which nodei was 5cm apart from nodej . The RT of nodei may have occurred
after the AT of nodej , indicating that the tissue at nodei would not be repolarised, and
unable to conduct an activation wave returning from nodej . However, by the time the
activation wave returned to nodei after travelling 5cm from nodej , the tissue may have
repolarised and so be able to sustain a reentrant circuit. As such, it was thought perhaps,
to be necessary to account for the distance between calculation node pairs. Several different
techniques were tested to account for the distance between nodei and nodej . Firstly, the




Secondly, a term was added to the algorithm (∆t) which accounted for the time it would
take for the wave travel from nodei to nodej , to complete the hypothetical circuit between
the calculation node pair. ∆t was calculated by finding the difference between the AT of
S1 at nodei and nodej . This technique was implemented utilising the equation
RTi − (ATj +∆t) (5.5)
Both equations produced maps displaying critical low values clustering more strongly
around the site of initial wave block than maps produced by a calculation which didn’t
account for distance between the calculation node pair. Yet a more accurate way of
considering this crucial distance is to only calculate the algorithm between node pairs
within a certain distance of each other, dispelling the need to account for the distance
within the algorithm. This technique was implemented in the RVI calculation used in this
chapter by creating a spatial radius, rs around nodes to determine calculation node pairs.
The algorithm described by (Coronel et al., 2009) sampled the RT from a node proximal
to the stimulus site (nodep) and the AT at a node distal to the stimulus site (noded)
to determine the excitable gap between the two points. This method however fails to
take into account the direction of wave propagation. In our more complex model, with
electrophysiological data being sampled from many different nodes, it was observed that
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a scenario could occur (see Figure 5.5) in which a node could be defined as nodep (as it
Figure 5.5: Illustration of the problem with defining nodep and noded from proximity to
the stimulus site (green X). Nodep is proximal to the stimulus site compared to noded
but is activated after noded.
is in closest proximity to the stimulus site) which is activated after noded, due to the line
of block and subsequent conduction delay of the wavefront reaching nodep. In this case,
the fundamental concept of the algorithm, subtracting an AT at a later point in a circuit
from an RT at a point earlier in a circuit to calculate the time of an excitable gap (or lack
of), is lost.
Several different techniques of determining nodep and noded to ensure that nodep
was activated before noded were tested. However, the only technique robust enough to
ensure that nodep was indeed activated before noded was the technique utilised in the RVI
calculation described above, in which the ATs of each possible node pair were compared.
Plotting the Results on a 2D Surface
It was also necessary to consider how the results of the calculation were to be plotted, in
order to identify regions which are susceptible to reentry. Considering the large number
of calculations between node pairs which are performed over the model, not all of the
calculated values could be displayed on the model concurrently. Considering that low
values of RVI indicate a susceptibility to reentry, the minimum result calculated within
each radius was found and plotted on the model. Interestingly, the results from this
method indicated that the minimum value calculated within a radius was always calculated
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between nodei and a nodej which was activated last. In addition, across the map, the
minimum values were clustered around the stimulus site due to the fact that repolarisation
occurs first at that location. The method produced a large area of low values and the
lowest values were very negative (approximately -200ms), much more negative than values
previously reported (Coronel et al., 2010; Child et al., 2015). In order to overcome the issue
of very negative values clustering around the stimulus site, all values calculated within the
radius were considered in the final protocol utilised in this study by taking an average,
rather than only the minimum value.
In the previously described experimental protocol (Coronel et al., 2009), the value of
the result was associated with the two calculation nodes. After performing the calculation
in the computational model, result values were plotted as lines between the calculation
node pair (nodep and noded) and colour coded according to the value of the result. This
methodology of plotting the result provided a map with very poor clarity due to the
amount of lines produced, with some lines displaying different values superimposed, pos-
sibly masking critical values. The method also produces a very diffuse region exhibiting
the critical low result values, as they are plotted between potentially two distant points.
For improved visualisation and ability to locate a specific region of low values, results
were plotted on individual nodes rather than as lines between a calculation node pair.
The results of the calculation were plotted only on proximal nodes. This method provided
a clear map of results for visualisation and a specific region displaying critically low RVI
values. However, plotting results only on the proximal nodes may skew results and displace
values indicating a susceptibility to reentry in another area.
Plotting values of the RVI either as lines between the node pairs or on one node of
the node pair did not produce clear, reliable results. Hence, a method of plotting the
result on the spatial midpoint between the calculation node pair was utilised in the RVI
methodology in the following study, in order to provide a full and accurate spatial map of
the RVI results.
5.2.4 Can the RVI Predict Susceptibility to Reentry?
Figure 5.6 displays the AT (top), RT (middle) and RVI (bottom) maps for UDB (left)
and BDB (right) simulations. The site of initial wave block is evident (left hand side) in
the AT maps of both UDB and BDB simulations. Notably, the activation wave travelled
further in the UDB simulation before entering the lower half of the model than the acti-
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Figure 5.6: Results of the RVI algorithm in the 2D experimental model. Top - AT maps,
middle - RT maps, bottom - RVI maps for UDB (left) and BDB (right) simulations.
vation wave in the BDB simulation. This resulted in an increased delay of the wavefront
reaching the lower half, producing slightly larger ATs in this region (approximately 900ms)
compared to the same region in the BDB map (approximately 750ms). In turn, the larger
ATs in the lower half of the UDB map produce a more negative RVI at the region of block
(approximately -50ms) than that in the BDB map (approximately -15ms). In addition,
there is a smaller area of the lowest RTs in the BDB RT map than the UDB RT map
due to the electronic effects at the smaller line of wave block. This smaller area of low
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RTs in turn produces a smaller area of low RVI in the BDB map. Crucially, a specific
region of low RVI values is located at the site of initial wave block in both UDB and BDB
simulations with more negative values being produced by the UDB simulation. In simu-
lations where no wave block occurs (not shown), the wave propagates normally over the
tissue with a plane wavefront and the corresponding RVI values are homogeneously high
(> +100ms). The result substantiates the results of previous experiments utilising porcine
data and validates the method using a human model of ventricular AP. The lack of species
specificity of the methodology is expected due to the method assessing the likelihood of
reentry occurring based on the fundamental AT and RT parameters.
5.2.5 Optimisation of the RVI Calculation: Data Resolution Parameter
Sensitivity Analysis
The computational model provided in silico data from 63000 nodes. In the clinic, data
are obtained from recording catheters at much lower resolutions, as described in Section
2.4. Typically, a decapolar catheter is repositioned around the endocardium 20 times to
provide approximately 200 recording locations (Child et al., 2015). In order to determine
the effect of decreased sampling resolution on the result of the RVI, the resolution of the
nodes utilised in the calculation was decreased.
Simulations continued to be conducted on the full resolution model. Analysis was
conducted using data from a UDB simulation. The radius of rs utilised in the analysis
was 25mm in order to be able to calculate RVI values between node pairs on a model with a
resolution of 10mm between nodes. Instead of sampling AT and RT data from every node
in the model (which lay 0.2mm apart), the resolution between nodes from which data was
sampled was decreased in a parameter sensitivity analysis, with distances between nodes
ranging from 0.4mm to 10mm. The calculation proceeded as described above, utilising
data only from the nodes in the low resolution model and results were only plotted on the
nodes of the low resolution model. New meshes of the low resolution models were created
for the purposes of plotting the RVI results on a surface rather than vertices, producing a
smooth result for improved visualisation.
Metrics to describe the results across the entire model were calculated for the purposes
of analysing parameter sensitivity analyses. The metrics used were the minimum RVI in
the model (RV Imin) and the percentage of the model which displayed an RVI less than
50ms (RV Iarea<50).
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5.2.6 The Effect of Altering Data Resolution on RVI
The images at the top of Figure 5.7 display RVI maps produced by the calculation con-
Figure 5.7: Result of varying data resolution. Top - RVI maps calculated from data with
resolutions of 0.4mm (left) and 10mm (right). Middle - effect of varying resolution on
RV Imin. Bottom - effect of varying resolution on RV Iarea<50.
ducted on models with resolutions of 0.4mm (left) and 10mm (right). A region of low RVI
values (approximately 0ms) is located around the site of initial wave block irrespective of
the resolution of the model. Results were less well defined in the 10mm resolution model,
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because plotting the results on the surface of a mesh with 10mm between nodes rather
than on vertices spaced 10mm apart, inherently involved some blurring of the results. As
displayed in the middle panel showing the effect of varying the resolution on the RV Imin,
results of the RVI calculated on smaller resolution models produced more negative values
of RVI. The RV Imin found in the 0.4mm resolution model was approximately -30ms com-
pared to approximately 15ms in the 10mm resolution model. The RV Iarea<50 generally
increased as distance between nodes increased from approximately 4% in the 0.4mm reso-
lution model to approximately 6% in the 8mm resolution model. The results produced in
this parameter sensitivity analysis verify that sampling data at smaller intervals is more
likely to capture the data at immediately either side of the line of block which produces the
most negative values of RVI, most accurately indicating the region susceptible to reentry.
In addition, using an increased number of nodes in the plotting method, produces a spatial
map which more accurately indicates the critical region, as results can be plotted close
to the actual midpoint, rather than being plotted on a node which may be some distance
away from the calculated midpoint.
As can be seen from Figure 5.7, there is very little difference in RV Imin and RV Iarea<50
between 0.4mm and 1mm resolution models. Therefore, further analysis throughout the
study was conducted on a model with a resolution of 1mm between nodes.
5.2.7 Optimisation of the RVI Calculation: Search Radius Parameter
Sensitivity Analysis
Due to the low resolution of data recorded in the clinic, the radius of rs was large (25mm)
(Child et al., 2015) in order to determine an acceptable number of downstream nodes,
hence an acceptable number of RVI values are averaged and plotted to produce an accurate
representation of RVI across a tissue. Here, we investigate the effect that the size of rs
has on the result of the RVI by varying the radius of rs. The effect of varying the size
of rs on the result of the RVI was studied utilising data from a UDB simulation and the
radius was varied between 1mm and 25mm.
5.2.8 The Effect of Altering the Size of the Search Radius on the RVI
The results of varying the size of rs on the RVI are displayed in Figure 5.8. The images
at the top of the figure display RVI maps for calculations using a radius of 5mm (left)
and 25mm (right). Irrespective of rs size, the calculation can locate the area susceptible
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Figure 5.8: Result of varying the size of rs on the RVI. Top - RVI maps calculated utilising
a radius of 5mm (left) and 25mm (right). Middle - effect of varying the size of rs on
RV Imin. Bottom - effect of varying the size of rs on RV Iarea<50.
to reentry with low values of RVI at the site of initial block. It is evident that varying the
size of rs has a significant effect on the RV Imin (middle) with a smaller rs producing more
negative values of RVI. The difference between RV Imin calculated with an rs with a radius
of 5mm and the RV Imin calculated with an rs with a radius of 25mm is approximately
20ms, indicating that using a smaller rs in the RVI algorithm may be more effective
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than using a larger rs. This effect is due to the method of plotting an average RVI on
the midpoint between the calculation node pair. If a smaller rs is utilised to determine
calculation node pairs, a smaller number of values of RVI will be produced and so fewer
values will be averaged on each node, resulting in a more diverse range of values being
plotted on the model. A smaller rs results in a smaller RV Iarea<50 (bottom). Values of RT
and AT which produce the most negative RVI values are sampled at nodes immediately
either side of the line of block. Using both a small and a large rs results in data being
sampled from nodes either side of the line of block. However, using a small rs results in
only a small number of calcuation node pairs which incorporate these data and so a small
number of negative RVIs are produced and are localised within the region of initial block.
These effects indicate that whilst a smaller rs may more accurately locate the region
susceptible to reentry, using a larger rs may produce more reliable results. Hence, an rs
with a radius of 25mm was utilised in subsequent analysis.
5.2.9 Investigating the Effect of Varying Arrhythmogenicity on the RVI
Utilising computational models permits parameters to be changed which cannot be done in
in vivo studies. Varying parameters such as APD and CV alters the arrhythmogenicity of
the model. The arrhythmogenicity of the model was varied in order to determine whether
the algorithm was robust in varying physiological scenarios and if the RVI result could
indicate the severity of the arrhythmogenicity of the model. Qualitative results of the sim-
ulations were observed in Meshalyzer to study whether UDB, BDB or no block occurred,
prior to RVI analysis. In order to illustrate the qualitative results of the simulations, bar
charts were produced to indicate whether UDB (red), BDB (blue) or no block (green)
occurred. Line graphs were produced in the analysis in the calculation optimisation sec-
tions, because only data from one simulation was analysed. In contrast, here different
simulations were run producing different wave propagation patterns, so bar charts were
produced to represent the different wave propagation patterns. The arrhythmogenicity of
the simulations was altered by changing BCL, APD in the lower half of the model and
CV in the lower half of the model.
Increasing stimulation frequency is well known to increase arrhythmogenicity and
hence, the prematurity of the S2 beat was varied between 300ms and 360ms. Pacing
at a faster frequency results in the S2 beat reaching the depolarised lower half of the
model prematurely, causing the wavefront to be diverted further around the site of initial
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block, in order for the lower half of the model to repolarise before conduction of the S2
wave into the region. This allows time for the upper half of the model to repolarise before
the wavefront (propagating from the lower half) reaches the upper region and a reentrant
circuit can be initiated.
APD was only increased in the lower half of the model in order to increase the gradient
of repolarisation between the two halves, an effect which is well documented to increase
arrhythmogenicity. Similar to increasing BCL, increasing the dispersion of repolarisation
between the two halves increases arrhythmogenicity by extending the pathlength of the
wave which has to travel further around the site of initial wave block, delaying conduction
into the lower half of the model, allowing the upper half to repolarise ready for reactivation
by the reentrant wave. Gks was decreased in the lower half of the model to produce
an increase in APD. Gks was altered from 0.8nS/pF to 0.4nS/pF producing APDs of
approximately 294ms and 328ms respectively.
Altering CV was implemented by changing the conductivity values in the lower half of
the model from 0.05S/m to 0.4S/m to produce CVs of 22cm/s and 63cm/s respectively.
Increasing CV in the lower half of the model was predicted to decrease the arrhythmo-
genicity of the simulation as it enables the wavefront entering the lower half of the model
after initial block to travel faster towards the point of reentry, reducing the time that the
upper half of the model has to repolarise.
Effect of Varying Arrhythmogenicity on RVI
Figure 5.9 displays the results of varying BCL and its effect on the RVI. The top two
images show RVI maps of simulations where UDB occurred when the models were paced
at a BCL of 300ms or 320ms. Pacing the simulation at slower BCLs resulted in no wave
block occurring. The RVI maps illustrate the ability of the algorithm to locate regions
susceptible to reentry in both scenarios indicating that the algorithm is robust in varying
physiological situations. The graph displaying the effect of varying BCL on the RV Imin
(middle) shows an important trend: as the arrhythmogenicity of the simulation increases,
the RV Imin decreases, with negative values being produced in UDB simulations (red)
and positive values being produced by simulations in which no block occurred (green).
This important finding indicates that the results of the RVI algorithm can predict not
only whether reentry occurs but also, if reentry does occur, the algorithm can indicate
the severity of the arrhythmia from the values of the RVI. The RV Iarea<50 increases
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Figure 5.9: Effect of varying BCL on RVI. Top - RVI maps calculated with data from
simulations paced at 300ms (left) and 320ms (right). Middle - effect of varying BCL on
RV Imin. Bottom - effect of varying BCL on RV Iarea<50. Red - UDB simulations, green
- no block simulations.
with increasing arrhythmogenicity confirming the use of the algorithm in predicting the
likelihood of reentry occurring.
It is evident in the top two images of Figure 5.10, showing the RVI maps calculated
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Figure 5.10: Effect of varying APD in the lower half of the model on the RVI. Top -
RVI maps calculated with data from simulations exhibiting an APD of 328ms (left) and
301ms (right) in the lower half of the model. Middle - effect of varying APD in the lower
half of the model on RV Imin. Bottom - effect of varying APD in the lower half of the
model on RV Iarea<50. Red - UDB simulations, orange - BDB simulations green - no
block simulations.
using data from simulations with an APD of 328ms (left) and 301ms (right) in the lower
half of the model respectively, that the algorithm locates regions susceptible to reentry in
both cases. Interestingly, UDB occurred in the simulation used to produce the RVI map
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on the left, whereas only BDB occurred in the simulation used to produce the RVI map
on the right. It can be concluded that the RVI algorithm can predict susceptibility to
reentry from data which doesn’t produce reentry. Themiddle graph shows the relationship
between RV Imin and varying APD. The most arrhythmogenic UDB (red) simulation with
an APD of 328ms in the lower half of the model produced an RV Imin of approximately
-180ms, whereas a BDB (orange) simulation with an APD of 301ms produced an RV Imin
of approximately 15ms and a simulation where no block (green) occurred with an APD
of 294ms produced an RV Imin of approximately 75ms. It is evident from these results
that the RVI algorithm is robust in situations of varying physiology and can even imply
the likelihood of reentry occurring. The result is also substantiated in the bottom graph
of RV Iarea<50 with an increasingly large percentage of RV Iarea<50 being produced by
more arrhythmogenic simulations, a small RV Iarea<50 (approximately 2%) being produced
by BDB simulations and no RV Iarea<50 being produced by simulations where no block
occurred.
The effects of increasing the CV in the distal half of the model produces a biphasic
result shown in Figure 5.11. Between conductivities of 0.05S/m and 0.2S/m (producing
CVs of 22cm/s and 45cm/s respectively), arrhythmogenicity of the simulation decreases,
producing less negative RVI results. UDB simulations produce negative RV Imin results
from -170ms to -30ms for conductivities of 0.05S/m to 0.15S/m and a BDB simulation
with a conductivity of 0.2S/m produces low positive values of RV Imin, approximately
30ms. However, simulations run with conductivities greater than 0.3S/m (producing CVs
greater than 55cm/s) in the lower half of the model result in UDB and RV Imin becomes
more negative. A potential explanation of this biphasic pattern is that when CV is slow,
it increases the time that the upper half of the model has to repolarise in order to allow
conduction of a reentrant wave. When CV is fast, the wavelength in the lower half of the
model will increase, increasing the dispersion of repolarisation, causing the wavefront to be
diverted further around the site of initial block, effectively increasing the pathlength which
the wave must traverse in order to propagate into the lower half and back towards the site
of initial block. This effect facilitates reentry due to the increased time that the wave takes
to travel around the larger area of refractory tissue before reaching the site of initial block.
During this lengthened period of time, the tissue in the upper half may have recovered
from inactivation and be able to conduct the reentrant wavefront. This finding validates
the previous results and conclusions drawn from the results of varying arrhythmogenicity
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Figure 5.11: Effect of varying conductivity in the lower half of the model on the RVI. Top
- RVI maps calculated with data from simulations run with conductivity of 0.05S/m (left)
and 0.4S/m (right) in the lower half of the model. Middle - effect of varying conductivity
in the lower half of the model on RV Imin. Bottom - effect of varying conductivity in the
lower half of the model on RV Iarea<50. Red - UDB simulations, orange - BDB simulations.
and its effect on the RVI, and highlights the importance of the algorithm being able to
elucidate the arrhythmogenicity of the simulation from which the data are sampled.
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5.3 Analysis of the RVI in a Model Incorporating Infarct
Scars
The clinical application of the RVI algorithm currently being investigated is to predict
the susceptibililty of tissue to reentry around infarct scars in order to guide the ablation
procedure. Mechanisms of reentry around infarct scars have been discussed in Sections 2.6
and 3.1 but crucially, the non-conducting fibrotic tissue of the scar and the remodelling
of the ionic currents in the BZ cause the conduction block and wave diversion required to
elicit reentry. In order to study the RVI algorithm in a more clinically realistic model, an
idealised scar and BZ region was introduced into the 2D computational model.
5.3.1 Computational Model Set-Up
Computational Model Geometry
The scar and BZ geometry utilised here was motivated by the concept that waves propagate
via conducting isthmuses dispersed throughout fibrotic scar tissue as displayed in Figure
5.2. Crucially, tissue within the isthmus displays slowed CV and a region of lengthened
APD at the exit site-end of the isthmus, as it has been observed that functional block
occurs at only a specific site and not throughout the BZ region (Segal et al., 2010).
Figure 5.12 depicts the 2D geometrical model utilised in this study which is based on
the concept illustrated in Figure 5.2. The same 5cm-by-5cm finite element mesh with a
resolution of 200µm between nodes was created as described in Section 5.2, resulting in a
model consisting of 62500 quadrahedral elements and 63000 nodes.
In order to introduce a scar region in to the tissue, two back-to-back semicircular fi-
brotic scar regions (black) were created in Matlab by finding coordinates of nodes within
regions which satisfied equations for right and left semicircles. The two semicircles, spaced
approximately 5mm apart, each measured approximately 1cm wide by 2cm tall and the
scar complex was positioned in the centre of the model. Nodes whose centroids fell
within these regions were tagged with an identifier so that they could be modelled as
non-conducting tissue.
A BZ region displaying slow CV (BZcond) was introduced into the model. The BZcond
(blue) was created in Matlab by finding nodes which fall within an ellipse, located in the
same region and the same size as the scar complex (approximately 2.5cm-by-2cm). Nodes
whose centroids fell within this region and not within the scar regions were tagged with
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Figure 5.12: 2D model geometry with incorporated scar and BZ regions. White - healthy
tissue, black - scar, red - BZAPD, blue - BZcond.
an identifier which enabled assignment of BZcond parameters to the region.
A circle with a diameter of approximately 5mm was created at one end of the BZcond,
between the two scar regions, to represent BZ with a lengthened APD (BZAPD) at the
exit point of the scar. The circle was again created in Matlab to determine the centroids of
elements which fell within the bounds of the circle in order to tag the elements as BZAPD
for parameter assignment.
Model Parameterisation
All elements in the model were assigned isotropic fibre directions with conductivity values
in the BZcond being 0.05S/m in both longitudinal and transverse directions, compared to
0.1S/m in healthy tissue.
The electrophysiology of healthy tissue was modelled utilising the human model of
ventricular AP (Ten Tusscher and Panfilov, 2006). In the BZAPD region, the APD was
lengthened by altering the parameters of the human model based on previously described
protocols (Rantner et al., 2012; Ashikaga et al., 2013). The maximal conductance value
of INa was reduced to 38% of normal, ICaL to 69%, IKr to 30% and IKs to 20% and the
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maximal value of INaCa was increased to 132% of normal. These changes produced an
increase in APD of approximately 150ms in the BZAPD.
5.3.2 Stimulation Protocol
Simulations were run according to the protocol described in Section 5.2, with the model
being paced to a steady state and the S1S2 pacing protocol initiated. The model was
stimulated in the centre of the model in the x-direction, approximately 5mm above the
BZAPD, with a stimulus current of 300µA applied for 3ms.
5.3.3 RVI maps in a 2D Model with Incorporated Infarct Scar
The algorithm described in Section 5.2 was conducted utilising data from simulations run
on the 2D scar model. Nodes within the scar region were not utilised as nodei or nodej
in the RVI calculation due to the lack of data at the non-conducting nodes of the model.
However, the result of the RVI could be plotted on scar nodes to produce a spatial map
of RVI over the entire surface of the model.
Figure 5.13 displays the AT (top), RT (middle) and RVI (bottom) maps for both UDB
(left) and BDB (right) simulations. It is evident from the AT maps that the propaga-
tion wave is blocked at the BZAPD and circumvents the scar regions before entering the
isthmus from below. RTs prior to the line of block are approximately 1100ms in both simu-
lations. The ATs within the isthmus below the line of block differ between UDB and BDB
simulations with the AT occurring later in the UDB simulation than the BDB simulation
due to the wave taking longer to propagate around the scar region and back up through
the isthmus. This results in the tissue above the isthmus, at the exit point of the scar,
having sufficient time to repolarise and so is able to conduct the wave propagating from
the isthmus to form a reentrant circuit. The AT in the BDB simulation at the same region
occurs before the tissue above the isthmus is repolarised and so the wavefront collides with
the wave back and terminates propagation. In both the UDB and BDB simulations, low
values of RVI are situated around the point of initial wave block and at regions of non-
conducting, scar-like tissue, with lower RVI values being produced by the UDB simulation.
However, unlike the results produced by the experimental model in Section 5.2, the lowest
values of RVI in the UDB RVI map are positive at approximately 50ms. An explanation
for the less negative result observed is that the region of initial block and therefore, the
regions displaying the most extreme values of AT and RT which will give the most negative
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Figure 5.13: Results of the RVI algorithm in the 2D model with incorporated scar and
BZ. Top - AT maps, middle - RT maps, bottom - RVI maps for UDB (left) and BDB
(right) simulations.
RVI result, is very small in comparison to the area in the experimental model. Although
negative values of RVI are produced by the UDB simulation, only a small number are
produced which get averaged in the plotting method, contributing to the positive values
of RVI displayed here. This result verifies that the RVI algorithm maintains its ability to
identify a susceptibility to reentry in a more physiologically realistic scar geometry.
134
5.3. ANALYSIS OF THE RVI IN A MODEL INCORPORATING INFARCT SCARS
5.3.4 Optimisation of the RVI: Resolution and Radius Parameter Sen-
sitivity Analyses
The resolution of the calculation model and the size of rs utilised in the RVI calculation
were varied as previously discussed in Section 5.2. The analysis was repeated here to ensure
that the effects of varying these parameters remained consistent, despite vast changes in
the geometry of the model. Analysis was conducted utilising data from a UDB simulation.
The graphs in Figure 5.14 show RVI maps calculated on 0.4mm (left) and 8mm (right)
resolution meshes and how varying the resolution affects RV Imin (middle) and RV Iarea<50
(bottom). The RVI maps indicate that both the value of RVI and the area of low RVI
are similar between both resolution parameters. The middle panel depicts how RV Imin
varies with varying resolution between nodes in the model. Interestingly, varying resolu-
tion between 0.4mm and 8mm does not have a significant effect on RV Imin which remains
relatively constant at approximately 30ms. This result does not replicate the positive cor-
relational trend observed in the simple experimental model, possibly due to the significant
averaging effect of the plotting technique which produces a more positive RV Imin due to
the smaller area of conduction block. The RV Imin significantly increases to approximately
115ms in a model with a resolution of 10mm between nodes. It is possible that data from
either side of the line of block producing the most negative RVI values are not sampled in
the 10mm resolution model so no negative values of RVI contribute to the averaged RVI
map. In addition, the RV Iarea<50 graph shows a general decrease in RV Iarea<50 as the
resolution decreases suggesting that sampling data at finer resolutions will more accurately
locate regions susceptible to reentry. Further analysis was conducted on a model with a
resolution of 1mm between nodes.
Varying the size of rs in the scar geometry replicated the results observed in the
experimental model. Figure 5.15 displays the results of varying the size of rs in the model
with incorporated scar region. The black regions in the RVI map on the left have no RVI
values associated with them due to the smaller rs not spanning the scar regions (which have
no data associated with them). An RVI value calculated between a node pair is plotted on
a spatial midpoint between the pair, which does not lie in the scar regions if rs does not
span the scar. This artefact does not alter the efficacy of the RVI algorithm. It can be seen
from the RVI map using a radius of rs of 10mm, that the exit site of the scar is highlighted
by low values of RVI. Decreasing rs produced a more negative RV Imin with an RV Imin
of approximately -120ms being produced using the smallest radius of rs (1mm) and an
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Figure 5.14: Effect of varying calculation mesh resolution on the RVI in the scar model.
Top - RVI maps calculated from models with resolutions of 0.4mm (left) and 8mm (right)
between nodes. Middle - effect of varying resolution on RV Imin. Bottom - effect of varying
resolution on RV Iarea<50.
RV Imin of approximately 40ms being produced using the largest radius of rs (25mm). This
effect is also seen in the experimental model. However, in the experimental model, a radius
of rs of 25mm was able to produce negative values of RVI in simulations of UDB. In this
model, a radius of rs of 25mm is not able to locate the exit site of a reentrant circuit with
negative values of RVI. As such, a radius of rs of 10mm was chosen to conduct subsequent
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Figure 5.15: Effect of varying the size of rs used in the RVI calculation. Top - RVI maps
calculated using a radius of rs of 10mm (left) and 25mm (right). Middle - effect of
varying the size of rs on RV Imin. Bottom - effect of varying the size of rs on RV Iarea<50.
analysis in this section in order to be able to produce results displaying negative values of
RVI in simulations of UDB. Similarly to the results produced by the experimental model,
there is a general trend showing that the RV Iarea<50 increases as the radius increases
due to the effect of averaging larger amounts of data produced by utilising a larger rs.
However, the RV Iarea<50 decreases at the largest rs due to higher values of RVI being
produced.
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5.3.5 Investigating the Effect of Varying Arrhythmogenicity on the RVI
in the Scar Model
Figure 5.16 displays the effects of increasing the arrhythmogenicity of the simulation on
Figure 5.16: The effect of increasing arrhythmogenicity on the RVI. Graphs of RV Imin
with varying BCL (top) and BZ conductivity (bottom). Red bars indicate UDB and Green
bars show no block.
the RVI. The graph at the top of the figure displays the effect of varying BCL on RV Imin.
Decreasing the BCL increases the arrhymogenicity of the simulation due to the earlier re-
polarisation of the tissue prior to the line of block. Unlike, the scenario in the experimental
model, the pathlength of the propagation wave around the scar region remains the same
in all simulations and so does not contribute to increasing arrhythmogenicity. A negative
RV Imin value of approximately -50ms was produced by the most arrhythmogenic UDB
(red) simulation (BCL = 340ms), with the less arrhythmogenic UDB simulation (BCL
= 360ms) producing a less negative RV Imin; a trend that was also seen in the results of
the 2D experimental model. The simulation in which no block occurred (green) produced
high positive values of RV Imin of approximately 140ms.
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A similar trend was observed in simulations with varying BZ conductivity in BZcond.
Decreasing the CV in BZcond provided the tissue prior to the line of block the time to
recover from activation, before the reentrant wave propagating from the isthmus arrived
at the region. As a result of the wavefront propagating at a slow speed, increased ATs
are sampled from downstream activated nodes within the BZ, contributing to the more
negative RVI values. Decreasing CV produced more negative values of RV Imin with the
most arrhythmogenic simulation displaying an RV Imin of approximately -170ms and the
least arrhythmogenic simulation displaying an RV Imin of approximately -30ms.
The results observed in the parameter sensitivity analysis in which arrhythmogenic-
ity of the simulations was increased, suggests that the RVI algorithm can be performed
successfully in an idealised scar model geometry in a variety of different physiological con-
ditions. Moreover, results of the RVI algorithm produced in the experimental model are
substantiated in the scar model, suggesting that more arrhythmogenic simulations produce
more negative RVI values.
5.4 Discussion
5.4.1 Limitations
The 2D models utilised in this study represent highly simplified geometries. It is pos-
sible that more realistic scar geometries may produce very different RVI results and it
is unknown whether the algorithm would maintain its ability to predict susceptibility to
reentry in such models.
In addition the 2D models do not take into consideration the complex 3D wave prop-
agation that occurs in vivo. It remains to be seen how the RVI calculation performs in
3D tissue and whether the method can identify sites vulnerable to reentry throughout the
heart. The 2D models utilised in this study do not allow for such investigation which
could be vital to comment on the clinical application of this work.
In light of these limitations, the work presented in Chapter 6 aims to investigate some of
the uncertainties described above. In particular, we will simulate wave propagation around
infarct scars in a 3D ventricular model in order to test whether the RVI methodology
retains its ability to identify sites vulnerable to reentry throughout the ventricle wall,
based on 3D in silico data. The more realistic geometry will allow for the investigation
of how the RVI calculation performs in a more clinical setting. In order to study whether
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the RVI maintains its accuracy and applicability in a clinical setting, we will observe the
effect of low resolution, endocardial data sampling in the 3D ventricular model.
5.4.2 Summary
Implementing the RVI method in a 2D simple experimental model incorporating dispersion
of repolarisation showed that the method can predict regions susceptible to reentry and
display the results on a spatial map. This result suggests that the RVI methodology can
be successfully implemented and produces RVI maps which can accurately identify the
exit point of the scar, whilst utilising human electrophysiological data. Previously the
technique has only been demonstrated using porcine data (Child et al., 2015). Here we
demonstrate the method’s use on human data.
Importantly the RVI is able to locate regions susceptible to reentry in cases where both
UDB and BDB occur. Negative values of RVI are produced by UDB and BDB simulations
produce low positive values of RVI. However, in comparison to the rest of the tissue, these
values are still low and can identify the region which may be susceptible to reentry. The
low values of RVI are located at the point where initial block occurs, which also coincides
with the point at which the wave completes a reentrant circuit; the exit point of the scar.
Due to the limitations of the sampling techniques used in the clinic, both resolution
and rs parameters were varied in order to provide information about the optimal data
recording and analysis techniques which could be of use in the clinic. It was found that
increasing the resolution of the sampled data used in the algorithm produced more negative
values of RVI and in addition, produced a smaller area of lower RVI values. These results
indicate that using a higher resolution will provide a more robust and accurate indication
of the susceptibility to reentry. Decreasing rs produces more negative RVI values and a
smaller region of low values which indicates that a small rs could be more effective in
locating regions susceptible to reentry.
Increasing the arrhythmogenicity of the simulations by decreasing BCL and increasing
the heterogeneity of repolarisation across the tissue is more likely to produce UDB. Like-
wise, decreasing the CV in the lower half of the tissue increases the arrhythmogenicity due
to the increase in excitable gap. However, results showed that increasing the CV could
also facilitate reentry as the increase in CV lengthens the wavelength in the lower half
of the model during the S1 beat. As a result, the S2 beat propagating from the upper
half of the model encounters a more significant area of block which in turn increases the
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path length as the wave must travel further around the region of block, increasing the
excitable gap. These complex interactions between varying CV and reentry success have
been discussed elsewhere in the literature (Coronel et al., 2010). Importantly more ar-
rhythmogenic simulations produced more negative RVI values. This is a crucial finding as
we can deduce that the RVI algorithm can indicate the severity of the arrhythmia based
on the values of the RVI. In addition, it can be concluded that the RVI is able to locate
regions susceptible to reentry across varying physiological scenarios, an important trait if
the algorithm is to be of use in the clinic where biological variation is inherent.
The present study also validates the use of the RVI algorithm in a simplified model of
post-MI reentry. Low RVI values are produced in both UDB and BDB simulations at the
exit point of the scar. This region has previously been suggested to be the optimal location
to introduce an ablation lesion in order to terminate post-MI VT (Segal et al., 2010).
Hence, the RVI method may prove to be very useful in guiding the ablation procedure.
Due to the small region of wave block involved in the scar geometry model, less negative
values of RVI are produced by the algorithm using data from a UDB simulation. However,
in comparison to the RVI values in the rest of the tissue, the RVI is still able to locate
regions susceptible to reentry.
Testing the optimisation of the clinical recording and analysis techniques by altering
the resolution of sampled data and the rs shows that in the model with incorporated scar
region, varying the resolution of the data does not affect the result of the RVI. Similarly to
the experimental model, decreasing the rs produces more negative RVI values suggesting
again, that a smaller rs may improve the ability of the RVI to locate regions susceptible
to reentry in the clinic.
Additionally, increasing the arrhythmogenicity of the simulations by decreasing the
BCL and altering the CV in the BZ increases the likelihood of initiating reentry. Moreover,
simulations of increased arrhymthogenicity produce more negative RVI values indicating
the severity of the simulation in the scar geometry model.
Computational modelling techniques utilised in this study have provided us with the
opportunity to alter parameters which affect the arrhythmogenicity of the simulations.
These parameters are not so easily changed over a wide parameter space in animal models
and have provided important insights into the scope of the RVI method. In addition,
changing the arrhythmogenicity of the simulation has enabled the validation of the algo-
rithm under varying physiological conditions, and we can conclude that the RVI algorithm
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is robust when utilised in different physiological conditions.
It has been shown here that the RVI can predict susceptibility to reentry in cases
where both UDB and BDB occur. This finding could have great impact on the use of the
algorithm in the clinic and suggests that VT needn’t be induced in order to map the VT
substrate. Inducing VT during the ablation procedure increases the risk of the treatment
and decreases the applicability to many patients due to the difficulties in initiating the
clinical arrhythmia. Hence, a technique which could identify the exit point of the scar
without having to induce VT could be of great importance.
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Chapter 6
Modelling Clinical Data Recording
and RVI-Guided Ablation in a
Ventricular Model
In Chapter 5 we validated the RVI calculation using human in silico data, showing that
the RVI locates regions susceptible to reentry in a simplified 2D geometrical model with
incorporated idealised scar and BZ regions. Here, we wish to extend the study to investigate
the RVI in a 3D ventricular model in order to be able to draw conclusions which will
facilitate the implementation of the methodology in the clinic. In Chapter 4 we investigated
species differences in the effective electrical size of the heart and showed that, due to
species differences in effective size, the optimal approach to study post-MI VT was to
utilise human data where possible. Given that an anatomically accurate ventricular model
of the human heart is very computationally demanding, in this chapter, we required a
less computationally demanding approach. In Chapter 4 we demonstrated that the rabbit
displayed an effective size most similar to the human, therefore in this chapter, a 3D
model of rabbit ventricles is used. We investigate how low data resolution in the clinic
affects the results of the RVI, in particular, whether regions of low RVI values indicating a
susceptibility to reentry are still identifiable at low data resolutions. In addition, the RVI
map is used as a guide, as we model the ablation procedure, where regions of low RVI are





VT remains a significant, life-threatening condition due to its possible progression to VF
and SCD (Koplan and Stevenson, 2009). Treatment of VT therefore constitutes a vitally
important area of research in terms of improving life expectancy and quality of life and
reducing the economic burden of the disease.
Infarct scars occurring as a result of an MI can be a cause of VT if the scar region
alters conduction of the excitation wave in such a way that it disrupts normal propagation.
In Sections 2.6, 3.1 and 5.1 we described a classic scenario of initiation of reentry around
infarct scars. To recapitulate; non-conducting scar regions are separated by tracts of BZ
tissue which display altered ionic current and conductivity properties. Figure 5.2 shows
that on approach of a premature excitation wave, the lengthened APD in the BZ region
causes the wavefront to be blocked as the tissue remains depolarised. The wavefront
diverts around the scar regions, increasing the activation pathlength of the circuit. In
addition to the decrease in CV in the BZ, the increased pathlength results in the tissue at
the site of initial wave block having sufficient time to repolarise by the time the diverted
wave returns to the site and so the tissue is reactivated, completing the reentrant circuit.
Thus, VT as a result of ischemic heart disease is caused by this sustained reentrant wave
propagation around the MI scar region.
Current treatment strategies for MI induced VT include radiofrequency catheter ab-
lation, drug therapy and ICDs. The problems associated with drug therapy and ICD
treatment, such as having a negative impact on the quality of life, medical contraindica-
tions and application of painful shocks, contribute to catheter ablation being a common
choice of treatment for MI scar-related VT. In Sections 2.6 and 3.7, we described in detail
different approaches to the ablation procedure, as well as the limitations of current tech-
niques. We described how, during catheter ablation, mapping of the tissue is conducted
in order to locate regions within the scar and target them for ablation. Ideally, tissue
within a critical isthmus of the scar should be ablated to terminate reentry. However,
current mapping techniques identifying ablation targets are not always applicable to all
patients and are not always sufficiently accurate. As such, in some cases, the optimal site
for ablation is not identified and areas other than those within the critical isthmus are
often ablated as shown in Figure 6.1. The red, green and light blue areas on the CT scan
image show a scar region as indicated by low voltages during contact mapping. White
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Figure 6.1: Map highlighting the inaccuracy of identifying the target for ablation. White
- ablation lesions. Dark blue - healthy tissue as indicated by normal voltages during
contact mapping. Red, green and light blue - scar tissue as indicated by low voltages
during contact mapping (Tung et al., 2010).
areas show the extent and number of dispersed ablation lesions (Tung et al., 2010), indi-
cating the inaccuracy of locating ablation targets. This results in the possibility that the
procedure may not be successful in terminating reentry due to the ablation target being
incorrect. In addition, in order to ablate the correct region of tissue, more tissue than
necessary may be ablated, possibly leading to later mechanical dysfunction.
In Chapter 5 we showed that the RVI method locates regions susceptible to reentry
in a simple geometrical model utilising a model of human electrophysiology. Crucially,
the RVI calculation has a potential clinical application in guiding the ablation procedure,
by more accurately locating the exit site of the scar as the ablation target, increasing
the applicability, accuracy and success rates of the treatment. A previous study imple-
mented RVI-guided catheter ablation in a patient displaying ischemic heart disease and
VT (Child et al., 2015). Electrograms were recorded during S1S2 pacing and ATs and
RTs were derived from the data. The RVI calculation was performed on the data and the
region of low RVI indicating a susceptibility to reentry was ablated, terminating the VT.
Hence, the method has been validated in the clinic but only in one patient. Therefore,
the method requires further validation in hearts of varying geometries and with varying
electrophysiological properties. In order to calculate a map of RVI across the myocardium,
electrophysiological data need to be sampled at a number of points around the ventricular
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wall. However, in the clinic the number of recording locations is limited by the catheter
used, its manual manipulation around the ventricles and the allocated procedure time.
In addition, due to the available access via the femoral artery, data are only recorded
from the endocardial surface of the ventricles. It remains to be seen how both the low
resolution, and endocardial recording of data in the clinic affects the result of the RVI,
particularly in hearts with varying scar locations and geometries. Also difficult to quantify
in the clinical study is the accuracy and specificity of the RVI with respect to locating the
critical region of the scar. Although the clinical study provided initial validation of the
RVI-guided ablation procedure, further validation and investigation into the methodology
is required.
The following study implements the RVI method in 3D ventricular models with varying
MI scar geometries to provide further validation of the technique. Utilising a FE geomet-
rical model provides the opportunity to investigate the effects of varying data resolution
on the result of the RVI by comparing RVI maps generated using data sampled at varying
resolutions. Moreover, in the computational models, data are generated across the entire
ventricular myocardium including throughout the 3D ventricular wall and on the epicar-
dial surface. As such, it is possible to calculate the RVI throughout the 3D model and
observe how 3D RVI maps differ from endocardial RVI maps produced according to the
clinical protocol. We investigate the application of the RVI method to guide the ablation
procedure in varying geometries and observe the accuracy of the RVI map and the result-
ing wave propagation post-modelling of the ablation procedure. This investigation is vital
in order to further validate the clinical method, thoroughly investigate its application to
guide the ablation procedure and to suggest potential limitations of the clinical protocol.
In this chapter, we incorporate idealised scars into a 3D rabbit ventricular geometry
and simulate wave propagation across the model. The resulting in silico data are utilised
in the RVI calculation to produce 3D RVI maps. The ablation procedure is modelled
by creating non-conducting ablation lesions in the model in regions where RVI is less
than a threshold value. Clinical data sampling methods are replicated, sampling data
from only the endocardial surface and decreasing the resolution of the data utilised in
the calculation. The ablation procedure is also modelled utilising the RVI maps produced
from endocardial, low resolution data to replicate clinical procedure. For the purposes of
investigating how the location of the scar within the myocardial wall affects the result of
the RVI, we create a series of simple 3D models with idealised scars located at increasing
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depths beneath the surface and calculate RVI maps on the surface of the model.
6.2 Validation of the RVI Methodology in Ventricular Mod-
els
6.2.1 Ventricular Rabbit Model
Simulations in this chapter were conducted on an anatomically accurate 3D model of the
rabbit ventricles (Deo et al., 2009) described previously (Section 3.5), in order to reduce
the computational demand compared to that required by an equivalent human model.
The similarities in the effective size of the heart between the human and rabbit as pre-
viously shown by Panfilov (2006) and in Chapter 4 suggests that wave propagation and
reentry dynamics are similar in both species due to the size of the activation wavelength in
comparison to the size of the tissue. Hence, due to these similarities and considering the
computational demands of the two models, we chose to study the RVI using a 3D model of
rabbit ventricles, scaling experimentally derived conductivity values (Clerc, 1976) in order
to produce a wavelength which would produce a similar effective size to that of the human.
We were confident that the model used in this study, with the scaled conductivity values,
would produce similar RVI results as would be expected in the human, that it would repli-
cate the arrhythmia dynamics in the human and that it provided sufficient complexitity
to answer the questions posed whilst being computationally efficient. Simulations run on
the model could be performed on a PC in an acceptable time frame (approximately three
hours) and without large data storage requirements (data files were approximately 2GB).
It is also important to consider that the RVI algorithm is not species specific. It is a
metric based on ATs and RTs around a region of MI scar tissue. In fact, it has rececntly
been shown that the RVI algorithm performed in the human, pig and sheep maintains the
ability to locate regions of tissue susceptible to reentry irrespective of species differences in
wave propagation that may occur (Child et al., 2015). Whilst it is necessary to replicate
propagation dynamics in the human in order to investigate how clinical methodologies
affect the RVI, the calculation maintains its ability to identify regions susceptible to reentry
in different species.
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6.2.2 Incorportaing Infarct Scars into the 3D Model
Idealised representations of scar and surrounding BZ were incorporated into the 3D model
of rabbit ventricles in three different orientations. The conformation of the 3D scar region
used throughout this chapter is based on the scar geometry that was utilised in the 2D
study in Chapter 5. The scar geometries are based on a previously proposed reentrant
circuit mechanism (Stevenson, 2009) and incorporate regions of non-conducting fibrotic
tissue interspersed with a conducting BZ isthmus. This highly simplified geometry is used
for the purposes of thoroughly investigating the RVI result in a 3D model, in the absence
of additional complexity as would occur in vivo. The scar regions introduced into the 3D
model incorporate two ellipsoid scar-like objects separated by a cuboid slow conducting
isthmus (BZcond) and a cuboid region of slow conduction and lengthened APD (BZAPD).
The lengthened APD was located towards the exit site end of the isthmus as it has been
observed that functional block occurs at only a specific site and not throughout the BZ
region (Segal et al., 2010). The resulting anatomical models were utilised throughout
this study in order to simulate ischemic heart disease and produce reentry in the model.
Varying the location of the scar region establishes whether the RVI method was able to
identify the critical isthmus, irrespective of the location of the scar around the myocardial
wall and the depth of the scar region below the endocardial surface.
Regions of scar were modelled as non-conducting tissue and were incorporated into
the model by defining the 3D coordinates of the centres of each ellipsoid scar (centrex,











where X, Y, Z are x,y,z coordinates of all nodes within the model. Coordinates of the
centroids of elements in the model were calculated and if any centroid in the model laid
within the bounds of either ellipsoid (ie. Equation 6.1 <= 1), the corresponding element
was tagged with a number which would define scar in the simulation.
In a similar manner, BZ was created by defining central coordinates of each BZ region
and forming a cuboid around them by extending x, y and z mm in x, y and z directions.
Elements whose corresponding centroids fell within the cuboid region were tagged with
different numbers depending on whether they were included in the BZAPD or BZcond
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regions. The tags allowed for the subsequent assignment of unique parameters to each BZ
region.
In each geometrical model the diameters of the ellipsoid scar regions were 6mm x 4mm
x 3mm, the BZcond was 3mm x 3mm x 2mm and the BZAPD was 4.5mm x 3.5mm x
2mm. The apical-basal length of the scar complex covered slightly less than a third of
the length of the ventricles and the lateral width of the complex also spanned approxi-
mately a third of the width of the heart at the base. The depth of the scar measures
4mm which approximates to the depth of the interventricular septum measured at the
base, although the amount of penetration of the scar complex within the myocardial wall
depends on its location. In patients displaying VT, the size of the scar is documented to
cover approximately 12±7% of the ventricles (Alexandre et al., 2014), however the size of
MI scars is highly variable due to the severity and duration of the ischemia, and the time
elapsed and degree of healing of fibrosis since the MI. Based on approximate volumetric
comparisons, the size of the scar incorporated into the rabbit model is approximately 10%
of the ventricular model which is comparable to the reported size of MI scars in patients
displaying VT.
Figure 6.2 displays 3 different models, the anterior LV transmural scar (AntLVtrans),
the interventricular septum transmural scar (IVtrans) and the posterior LV endocardial
scar (PostLVendo), with the scar region located at varying sites across the ventricles, from
an epicardial (left), a transmural (middle) and an endocardial (right) view. The scar is
displayed in black, the BZAPD in red and the BZcond in blue.
LV Transmural Scar
The scar and BZ protrude slightly from the epicardium in the AntLVtrans model (Figure
6.2 (top)) and span most of the LV wall with only the BZ extending to the endocardial
surface. The scar is located on the anterior LV wall, roughly midway between the apex
and base. Closest to the apex of the heart is the BZAPD (red).
Interventricular Septum Transmural Scar
Panels in the middle row of Figure 6.2 show the IVtrans model with the scar region located
on the interventricular septum, in the middle of the heart in the apex-base direction. The
scar protrudes slightly at both surfaces of the myocardium, again with the BZAPD located
closest to the apex.
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Figure 6.2: 3D models with incorporated scar and BZ regions. Scars are displayed from
different angles; left - epicardial, middle - transmural and right - endocardial.
LV Endocardial Scar
The scar region in the final model, the posterior LV endocardial model (PostLVendo)
(Figure 6.2 (bottom)) is located towards the apex at the junction between the LV posterior
wall and the interventricular septum. As can be seen in the figure, the BZAPD (red) is
located nearer the base of the heart, contrary to the location of theBZAPD in the other two
models. This geometry is also unique as the scar region is incorporated on the endocardial
surface and extends transmurally to roughly half the depth of the wall so there is no
protrusion of the scar region at the epicardium.
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6.2.3 Simulation of Electrical Activation
Simulations were run in CARP (Section 2.5) using the previously described computational
set-up (Section 4.2). The Mahajan et al. (2008) rabbit model of ventricular AP was used
to model the electrophysiology in the healthy tissue. Anisotropic conductivity values were
assigned to the model’s existing fibre architecture. In order to be able to sustain reentry,
and in accordance with previous studies (Li et al., 2009; Ripplinger et al., 2009; Rantner
et al., 2012), conductivity was reduced in the healthy tissue, replicating a 25% slowing of
conduction velocity to reduce the activation wavelength of the rabbit model, mimicking
the effective size of the human heart.
Modelling BZ Tissue
Ionic changes in the BZAPD were based on previously described methods of modelling BZ
changes in rabbit, human and canine models (Decker and Rudy, 2010; McDowell et al.,
2011; Rantner et al., 2012; Ashikaga et al., 2013) where the maximal conductance value
of INa was reduced to 70% of normal, IKr to 30% and IKs to 5% and the strength of ICaL
flux was increased to 150% of normal. Figure 6.3 displays APs for both healthy (left)
Figure 6.3: APs produced from simulations in the 3D geometry using a model of rabbit
electrophysiology. Left - AP from healthy tissue. Right - AP from BZAPD.
and BZAPD tissue (right). The APD in the healthy tissue measures approximately 170ms
compared to the APD in the BZAPD measuring approximately 230ms.
Conductivities in both the BZcond and BZAPD regions were decreased to model the
CV slowing observed in BZ tissue (Luke and Saffitz, 1991). Conductivities were reduced
by 30% compared to healthy tissue, a protocol which has previously been utilised to model
BZ conductivity remodelling in rabbit, human and canine studies (Decker and Rudy, 2010;
McDowell et al., 2011; Rantner et al., 2012; Ashikaga et al., 2013).
Although the geometry and size of the scar regions incorporated in to the rabbit model
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and the ionic and conductivity parameters used in this study were motivated in part by
previous studies and clinical observations, the choices were also made to ensure that the
model produced reentry. The present study of quantifying the likelihood of reentry in
structural heart disease requires that the models used here are able to sustain a figure-
of-eight reentrant circuit around the scar region as occurs in patients with a history of
MI. The two non-conducting fibrotic scars separated by a conducting isthmus and the
altered BZAPD and BZcond parameters ensured that the model displayed the required
figure-of-eight reentry with propagation through the BZ isthmus.
Implementing the S1S2 Pacing Protocol
The heart was paced at the apex, with a strength of 400µA for a duration of 3ms in
all simulations. Cell models were pre-conditioned to reach a steady state by pacing the
models at 340ms, a frequency slighty faster than sinus rhythm (400ms), for 10 beats.
The S1S2 protocol was then implemented with the S2 beat being initiated 200ms after
S1 for both AntLVtrans and IVtrans models and 190ms for the PostLVendo model in order
to produce reentry. Reentry was defined as an episode in which the wavefront blocked
at the BZAPD, circumvented the scar region, returned to the region of initial block and
continued propagation (as shown in Figure 6.4).
Figure 6.4: Time series of electrical activation illustrating reentry. Times are stated
above. Wavefront of S2 is blocked by delayed S1 repolarisation in the BZ (T = 320ms).
The wavefront of S2 travels around the region of block and scar tissue (T = 370ms) and
propagates back through the isthmus (T = 470ms). Reentry is defined as occuring when
the activation wave propagates out of the exit site of the scar, past the point of initial
wave block (T = 520ms).
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6.2.4 Calculating the RVI in 3D Models
The principles of calculating the RVI are similar to that described in the 2D model in
the previous chapter. Initially, ATs and RTs are calculated at each node in the model
to provide the data used in the RVI calculation. The calculation is performed using AT
and RT data from two nodes in the model to determine the extent of the excitable gap
between the nodes. The RVI values calculated between node pairs are then plotted at a
midpoint between the node pair to create a spatial map of RVIs across the tissue.
Data Acquisition
ATs and RTs were calculated at each node for only the S2 beat using a linear interpolation
algorithm to find the time points at which Vm crosses -40mV on the upstroke and -70mV
during the repolarisation phase respectively, and the APDs were calculated by subtracting
the AT from the RT at each node. The data from a particular node were only utilised in
the RVI calculation if the APD was shorter than 250ms, a plausible APD length. Very long
APDs can occur at the border of the fibrotic scar region, due to the wavefront anchoring
around the scar. As the wave propagates around the non-conducting scar, the lack of an
electrical sink causes the prolongation of the APD. In fact, in the clinic, low amplitude
electrograms sometimes displaying long APDs may be recorded from dense fibrotic regions
within the scar. If this occurs, data displaying long APDs or low amplitude electrograms
are not used in the calculation of the RVI (Child et al., 2015) in order for the RVI result
not to be affected by such data. Hence, data with long APDs in the vicinity of the scar
are discounted here.
Determining Node Pairs
The RVI is calculated between pairs of nodes throughout the model in order to calculate
the excitable gap, the RVI, between each node pair. The following section describes the
method of determining the calculation node pairs.
As described in Section 5.2, it is essential that the calculation node pair lie within close
proximitiy of each other. The RVI algorithm calculates a time difference between the wave
tail (RT) and the wave head (AT) in a reentrant circuit. If the RT and AT are sampled
within close proximity of each other, it is accepted that the time difference between the
wave head and tail, calculated by the RVI, can infer whether or not reentry can occur.
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However, if the RT and AT are sampled from two points which are far apart, the calculated
time difference between the wave head and tail becomes meaningless. Consider that the
RT and AT of an excitation wave are sampled from two points which are located some
distance away from each other. The AT sampled at nodei occurs before the RT sampled
at nodej suggesting that the wavefront would be blocked by the wave tail. However, the
wave continues to propagate towards nodej from which the RT is sampled and by the time
the wavefront reaches nodej , the tissue here has in fact had sufficient time to repolarise
and so the wavefront can propagate and reenter. Hence, it is necessary to sample points
which lie within close proximity to each other.
Node pairs are defined from within a spatial radius, rs in order to ensure that the
AT and RT data are within a short distance of each other, as in the protocol described
in Section 5.2. Due to the large number of nodes in the 3D model, previous methods of
creating rs based on distances between Cartesian coordinates proved too computationally
demanding and so an alternative method was used. A 3D grid of 0.1mm resolution was
imposed over the nodes of the 3D ventricular model. For each subsequent node in the
model (nodei), nodes within a certain distance are found by extending 1000 voxels in
each dimension from nodei. It is determined whether the nodes within this boundary are
downstream nodes (activated after nodei) and if they are, they are deemed nodej .
The RVI Equation
The RVI calculation is performed as described in Section 5.2. In short, each nodei forms
a calculation node pair with multiple nodej , as nodej is defined as any downstream node
which falls within rs of nodei. The RVI calculation is performed between nodei and each
nodej and in turn, the calculation is repeated for each nodei in the model, according to
Equation 5.3. The RVI calculation subtracts the AT from nodej from the RT of nodei in
order to calculate the excitable gap.
Plotting the RVI Results on the 3D Model
The 3D grid is also utilised in determing a spatial midpoint between node pairs for the
purposes of plotting the RVI. A grid voxel at the midpoint between nodes i and j is
determined. If the voxel contains a node, the RVI is stored on that node. If the voxel
contains no node point, the RVI is stored on a node within the next nearest voxel which
contains a node. An average of RVI values stored on each node is taken to produce the
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RVI map.
6.2.5 Results of the RVI in 3D Models
Simulations using each 3D model produced reentry as can be seen from the time series
images in Figure 6.5. The series diplays the wavefront of the S2 beat being blocked by the
BZAPD which has not had time to repolarise because of its altered ionic current properties
(T1). Due to this region of block, the wavefront is diverted around the scar (T2 and T3)
and propagates through the isthmus, contrary to the direction of the wavefront which had
emanated from the pacing location (apex) (T4). Slow conductivity in the BZcond causes
the wavefront to propagate slowly through the isthmus and so as the wavefront reaches
the exit point of the scar, the tissue at the exit site has had time to repolarise and is ready
for reactivation. This phenomenon allows the wave to propagate out of the scar region
and form a reentrant wave (T5).
The AT and RT maps reiterate that the propagation wave is able to form a reentrant
circuit. The region prior to the initial block displays a low RT (dark blue) of around
400ms and the region which caused the initial wave block displays a high AT (red) of
around 500ms, due to the circumnavigation of the wave around the scar before activation.
Implementing the RVI calculation (RVI = RT - AT) at this region gives 400ms - 500ms
= -100ms. This suggests that there is an excitable gap of 100ms, easily facilitating reen-
trant wave propagation. The RVI map indicates that this is the case as low RVI values
(dark blue) occur in the same region, the region of initial block.
The magnitude of the RVI, although low, does not directly correspond to the specu-
lative calculation described giving an RVI of -100ms, instead the map shows an RVI of
around 0ms in the same region. This result is a consequence of the methodology of plotting
the RVI. An average of the RVI values that had been associated with their corresponding
midpoints was taken, resulting in an average RVI being displayed which incorporates AT
and RT data from the immediate area either side of the line of block, in addition to AT and
RT data from elsewhere in the model with a midpoint in the region of interest. Averaging
the RVI in this manner produces the effect of lessening the magnitude of the low RVI in
the critical region. However, the region at the exit point of the scar, the region of initial
block is still accurately identified by a specific area displaying RVI values considerably
lower than the remainder of the model. Moreover, this ability of the RVI to locate a
region of interest occurs in each of the 3D geometries suggesting that the algorithm works
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Figure 6.5: Results of the RVI protocol producing UDB in three, 3D geometries. For
each geometry; five top-most images - Time sequence displaying S2 propagation wave
approaching (T1) and blocking (T2) at the line of heterogeneity, circumventing the scar
regions (T3), entering the isthmus (T4) and reentering (T5). Three bottom-most images
- Corresponding AT, RT and RVI maps.
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independent of scar location in the heart and depth within the myocardial wall.
The RVI calculation, implemented in a 3D model, displays a very similar result to that
which occurs in 2D simulations and analysis, confirming the validity of the fundamental
concepts of the RVI due to the result remaining consistent in varying 2D and 3D models.
In addition, the result of the RVI calculated in 3D suggests that the method is able to
accurately locate regions susceptible to reentry which could prove important for future
clinical applications.
An interesting finding appears when the scale of the RVI maps are optimised to show
the whole range of data within the map as shown in Figure 6.6. In addition to the region
Figure 6.6: RVI map displayed with optimised scale.
of low RVI, apparent in the image as a region of light blue beneath the scar, is a relatively
large region of high RVI (∼200ms). A high RVI value is produced by subtracting a small
AT from a large RT. Referring to Figure 6.5 (AntLVtrans (AT and RT maps)), it might
be considered that a high RVI value could be produced by subtracting an AT from the
light blue region just below the line of block (300ms) from an RT from the red region
just above the line of block (700ms). Indeed, 700 − 300 produces RV I = 400ms. This
value of RVI is in excess of the highest value seen in the RVI map in Figure 6.6, but
additionally this described scenario could not contribute to the high RVI value because
nodei (RT data node) must be activated before nodej (AT data node); not the case in
this scenario. Considering the red regions in the AT and RT maps in Figure 6.5, they
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correspond to the location of the BZAPD, a region of lengthened APD. It is in fact an RVI
produced by subtracting an AT from the bottom of the red region (500ms) from an RT
at the top of the red region (700ms), which constitutes the region of high RVI in Figure
6.6 (200ms). Notably, the value of high RVI in the region (∼230ms) is comparable to
the APD in the region due to the fact that the RVI is calculated over a small distance
where normal wave propagation occurs. This results in the ATs and RTs of the region
remaining relatively consistent and therefore RVI ≈ APD (RT − AT ). In fact, where
normal wave propagation occurs over a small distance regardless of the location within
the tissue, RVI ≈ APD. Due to the lengthened APD in BZAPD, the RVI produced in
this region is larger than in the rest of the tissue which displays a shorter APD. Whilst
it is understood that these regions of high RVI which border the region of low RVI are
produced as an approximation of the APD, it is possible that the high RVI values may
interfere with clinical analysis, particularly in cases where data resolution is decreased.
6.3 Utilisation of the RVI Map to Guide the Ablation Pro-
cedure
6.3.1 Creating an Ablation Model
Modelling the ablation procedure in 3D was conducted on the AntLVtrans model. Using
the previously produced RVI map, all values of RVI below a threshold value were consid-
ered ablation targets. In practice, the elements of the model whose connected nodes all
displayed an RVI of less than the threshold value were designated as ablation scars. Figure
6.7 shows on the left, an element whose nodes all display an RVI less than the threshold
(blue) and so the properties of that element would be altered to create a non-conducting
ablation scar by assigning no fibre direction to the element. On the right hand side of
the figure, 3 out of the 4 nodes display an RVI less than the threshold (blue), but one has
an RVI which is greater than the threshold (red) and so this element is not ’ablated’; its
ionic and conductivity properties remain the same.
A parameter sensitivity analysis of threshold values was conducted for the purposes of
determining a threshold limit that would terminate a reentrant circuit. The area of the
resulting ablation lesion was calculated for each model.
Figure 6.8 displays RVI maps (top), at cross sections throughout the myocardium,
highlighting RVI below a threshold (30ms on the left, 40ms on the right) apparent as a
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Figure 6.7: Methodology for creating an ablation model. Element on left is a target for
ablation (all nodes have RVI < threshold (blue)). Element on right is not a target for
ablation as one node has RVI > threshold (red).
Figure 6.8: Modelling the ablation procedure, guided by the RVI. Left - ablation of the
myocardium where RVI < 30ms. Right - ablation of the myocardium where RVI < 40ms.
Top - RVI maps at sections through the myocardium, displaying regions below threshold.
Middle - sections through the model resulting from ablation of regions below threshold.
Bottom - time series displaying wave propagation in a simulation using the ablation model.
blue region just below the scar. It is evident that the maps resulting from the detection of
the 2 different threshold values are very similar; the area of RVI less than each threshold
value is virtually the same. In fact, the percentage of the mesh with an RVI less than 30ms
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is 0.12% and the percentage of the mesh with an RVI less than 40ms is 0.15%. The areas
less than the respective threshold values (blue on the RVI map) were then established as
non-conducting regions to model an ablation lesion. These geometrical ablation models
can be seen in the second row of Figure 6.8 in which cross sections across the myocardium
are displayed. Again, the resulting geometrical models appear very similar.
Simulations modelling the ablation procedure were conducted on the geometrical mod-
els including the ablation scars using the protocol previously described (Section 6.2) be-
cause of its known ability to elicit reentry. The model was paced from the apex to a steady
state at a BCL of 340ms for 10 beats, before proceeding with the S1S2 protocol paced at
200ms.
6.3.2 Wave Propagation Post-Ablation
The RVI algorithm specifically highlights the critical region with low values of RVI and the
validity of the algorithm to detect these regions is emphasised by the success of modelling
ablation guided by the RVI map. Despite the ablation models appearing very similar in
terms of lesion size and location, the result of the simulation run on the respective models
is very different. Ablating the region of RVI below 30ms still elicits a reentrant wave due
to the wavefront propagating out of a gap between the scar and ablation lesion (Figure
6.8, bottom, left). This gap is not present when all regions of the model with an RVI
below 40ms is ablated and so the wave terminates at the lesion and halts the reentrant
wave pattern (bottom, right).
This study substantiates the result observed in the clinic, that the ablation procedure
can be informed by the result of the RVI algorithm. The RVI locates, accurately enough,
a region susceptible to reentry so that an ablation lesion created at that area is able to
terminate post-MI reentry. In the clinic, the ablation lesions created by radiofrequency
catheter ablation are much larger and all tissue within a certain radius of the ablation
catheter is ablated. However here, we aim to determine the accuracy of the RVI algorithm
in ablating the VT circuit. Therefore we investigate the minimum size of the ablation
lesion necessary to terminate the arrhythmia by only ablating a very specific region of
tissue which displays an RVI less than a threshold value. Such small ablation lesions are
unable to be produced in the clinic due to the nature of the ablation catheters but the
technique applied in these models can illustrate the accuracy of the RVI algorithm in
guiding the ablation procedure.
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6.4 Modelling the Clinical Application of the RVI Method-
ology
The clinical method differs from the method of calculating RVI in the 3D model in this
study in two major ways. Firstly, clinical AT and RT data are only obtained at the
endocardial surface. In addition, ablation catheters which administer the radiofrequency
to produce an ablation lesion, ablate the tissue from only the endocardium. Secondly, the
quantity of AT and RT data is greatly reduced (Child et al., 2015). In order to validate
the use of the methodology in the clinic and to understand its potential drawbacks, the
clinical method is replicated in the model here.
6.4.1 Creating an Endocardial RVI map
Clinical RVI analysis only takes into account data from endocardial nodes because elec-
trophysiological data from catheter recordings are only acquired there and hence, the RVI
is only calculated and plotted on the endocardium. In order to obtain data only from the
endocardial surface, a list of all LV endocardial nodes is obtained, discounting those which
pertain to endocardial scar. Only AT and RT data from the LV endocardial nodes and
their coordinates are used in further analysis.
In this analysis the AntLVtrans and the PostLVendo models were used. Simulations
run previously for 3D analysis (Section 6.2) provided AT and RT data, and RVI analysis
proceeded as described in the 2D RVI analysis (Section 5.2) due to the vastly reduced
number of calculation nodes.
At each nodei on the endocardium, endocardial nodes within a 5mm radius (in 3D
space) of nodei were identified to match the clinical approach (Child et al., 2015). Of
those nodes within the sphere, downstream endocardial nodes (those activated after nodei
on the S2 beat) were found and denoted nodej . The RVI was calculated between the
RT at nodei and the AT of each nodej individually. In order to plot the RVI on the
endocardial surface, a midpoint between the two calculation nodes was determined and
the RVI plotted on the nearest node to the midpoint. An average of RVI on each node
was then taken and these data were used to produce the RVI map.
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6.4.2 Endocardial RVI Maps
Due to the relatively small amount of data on the endocardial surface being analysed in
this study, the resulting RVI map displayed nodes which had no RVI result associated
with them because the node was never indicated as a midpoint between calculation nodes.
This can be seen in Figure 6.9 where, on the left hand side, small specks of dark blue
Figure 6.9: Smoothing the RVI result. Left - non smoothed RVI map. Right - smoothed
RVI map.
appear throughout the model. Approximately 10 nodes out of 13000 non-scar endocardial
nodes in the model displayed no RVI result. In addition, the RVI did not appear to be
smooth as seen in the full 3D analysis but rather that low RVI, although clustered around
the exit point of the scar, appeared sporadically in the model (left) because less data were
averaged to produce a smooth RVI map. For the purposes of presenting a more coherent
result, an additional analysis step was required to smooth the data, the result of which
is presented on the right hand side of the figure. To ensure all endocardial nodes display
RVI data, nodes with no associated RVI value were found and for each of these nodes, an
average of the RVI data from their element-connected nodes was taken and the average,
plotted on the node in question. In order to smooth all RVI data across the endocardial
surface, a similar technique was utilised. For each node on the endocardium, an average
of its element-connected nodes was taken and the average stored on that node. This step
was included in all further endocardial RVI analysis.
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Figure 6.10 displays the AT and RT maps (first and second images) of the data on
Figure 6.10: Endocardial RVI produced from endocardial data for the 3D models: top
- AntLVtrans, bottom - PostLVendo. Left and Middle - endocardial AT and RT maps
respectively. Two right-most images compare the endocardial RVI map produced by en-
docardial data and the RVI map produced by complete 3D data with only the endocardial
surface displayed.
only the endocardial surface of the AntLVtrans (top) and the PostLVendo (bottom) models.
Again, it is possible to see from the AT maps illustrating the wave block and subsequent
circumnavigation of the scar, that wave block occurs shown by the sharp delineation
between a relatively short AT and a long AT. The RT maps show the BZAPD with
colours in the red spectrum denoting a long APD which causes the initial wave block and
contributes to the low values of RVI around the region of block which can be seen in the
RVI maps (third image).
For comparison, the endocardial RVI map (third image) and the 3D RVI map (fourth
image) are shown side-by-side. It is evident that the region of low RVI in the endocardial
RVI map is considerably more dispersed and less negative than can be seen in the 3D RVI
map. There are considerably less data used in the calculation of the endocardial RVI map
which produces a less accurate result. However, it is still possible to identify a region of
RVI that is lower than that of the rest of the model and identify this as a critical region.
Interestingly, the region of interest in the endocardial RVI map of the PostLVendo
model, whilst still being diffuse, seems to be more accurate and displays lower RVI values
than the RVI map of the AntLVtrans model. Of note in this case, is the fact that the
scar region protrudes from the endocardial surface of the PostLVendo model whereas the
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scar region of the AntLVtrans model is transmural. This disparity between the results of
the two models leads to an important conclusion; that the depth of the scar within the
myocardium, and more specifically, the depth at which the critical site of initial block
occurs, may well affect the accuracy of the RVI algorithm.
6.4.3 Guiding Ablation Utilising an Endocardial Map of the RVI
Creating Ablation Lesions
Nodes on the endocardial surface which display an RVI less than a threshold value are
targets for ablation. However, the ablation lesion must penetrate into the 3D model
in order to replicate the clinical procedure and for successful termination of a reentrant
circuit. Here, contrary to the protocol described in the previous section, we model the
clinical ablation protocol in which tissue within a radius of a region of low RVI on the
endocardium is ablated.
After determining an area of RVI below a threshold value on an endocardial RVI map,
a centre point of the region was determined by estimating its location and the coordinates
obtained. Nodes on the endocardium, within a radius of 2.25mm of the centre point which
display an RVI less than the threshold value were determined. A lesion with a radius of
2.25mm was chosen by scaling the size of ablation lesions created in a human heart, to
the size of the rabbit heart. The myocardial wall in the human, measures approximately
14mm from the endocardium to the epicardium (Ho, 2009) and ablation lesions created
in patients measure approximately 7mm, half the depth of the myocardium (Lai et al.,
2004). The rabbit myocardial wall is approximately 4.45mm thick (Mahaffey et al., 1995)
and so we assumed the lesion size in the rabbit to measure half of the depth of the rabbit
myocardial wall. For each of these specified nodes, the surrounding nodes in a 3D radius
of either 2.25mm or 5mm were found and each element containing that node was tagged
to identify it in order to be able to assign non-conducting tissue properties to the element
for the purposes of modelling an ablation lesion. Parameter sensitivity analyses were
conducted to determine the threshold values.
The Success of the Ablation Procedure
It was predicted that using the endocardial RVI to guide the modelled ablation procedure
may be less successful than using the whole 3D RVI map due to the lack of accuracy of the
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endocardial analysis. It can be seen from the endocardial RVI maps (left) in Figure 6.11
that setting a threshold value of RVI less than 60ms defines a very small portion of the
Figure 6.11: Modelling ablation utilising the endocardial RVI map. Endocardial RVI maps
showing regions of the model with an RVI less than 60ms (left) for both the AntLVtrans
and PostLVendo, were used to produce the ablation models (second image from left) with
either 2.25mm or 5mm lesion radii. Ablation lesion is shown in black, the ischemic scar
in white, the BZAPD in red and the BZcond in blue. A series of images in time for each
ablation model shows the outcomes of simulations conducted using the models.
model, particularly in the transmural AntLVtrans model. However, a distinct region of the
model can be determined when setting this threshold; the values of RVI less than 60ms
are gathered in a specific area. An ablation model was produced by modelling the regions
with an RVI less than 60ms as non-conducting tissue. The ablation lesion of this radius
produced in the AntLVtrans model did not extend far enough into the myocardial wall to
stem the propagation wave from reentering around the ischemic scar (second image from
left) and this is evident in respective time series images (top) where the wave propagates
out of the isthmus after initial block. It could be thought that increasing the threshold
value could result in the termination of reentry. However, increasing the threshold value,
and ablating nodes which displayed values less than 100ms, whilst increasing the size of
the ablation lesion on the endocardial surface, still did not terminate reentry due to the
lesion not penetrating deep enough into the myocardium to stem the wave propagating
around the scar transmurally. If the radius of the ablation lesion is increased to 5mm in
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the AntLVtrans model, the lesion extends far enough into the LV wall (middle) to halt
the propagation wave around the ischemic scar and stop reentry occurring (middle, time
series images). In comparison, a lesion produced using the smaller 2.25mm radius, in the
endocardial PostLVendo model, was able to halt a reentrant circuit due to the depth of the
scar within the LV wall. The extent of the ablation lesion (black) can be seen in conjuction
with the depth of the ischemic scar (white) in the second image from the left (bottom).
The time series images of the simulation (bottom) show that the propagation wave was
halted at the ablation lesion. Regardless of the depth of the ablation lesion, it is evident
that the endocardial RVI may be used to guide the ablation procedure and successfully
terminate reentrant circuits. It is important to note that whilst an appropriate guide to
the diameter of the ablation lesion was determined, in the clinic, the lesion radius varies
and if the scar is particularly transmural, radiofrequency is applied through the ablation
catheter for a longer period of time, forming a larger lesion to halt the arrhythmia. This is
similar to what has been modelled here by extending the diameter of the ablation lesion.
6.4.4 Guiding the Ablation Procedure with Low Resolution RVI Maps
Varying the Data Resolution and Search Radius Size
The clinical recording catheter has 10 electrodes spaced evenly along its length and is
relocated around the endocardium approximately 20 times (Child et al., 2015) resulting in
200 recording sites. In contrast, the endocardial surface of the 3D model has approximately
13000 node points, all of which can provide data to be used in the RVI calculation. In
order to more closely replicate the clinical method, the sampling points used in the model
are reduced by taking a subset of endocardial nodes to use in analysis.
To reduce the number of data points in the model, AT and RT data were calculated
as normal but only a subset of the data was used by utilising every nth data point. The
endocardial RVI algorithm was then performed as described in Section 6.4, calculating the
RVI using only the low resolution subset of AT and RT data to produce a low resolution
endocardial RVI map. A parameter sensitivity analysis was conducted, reducing the data
points to every 5th, 10th and 20th node, to divulge the effect of reducing the number of
data points on the RVI.
The size of rs used to search for downstream nodes was also altered in a parameter
sensitivity analysis. We varied rs between 1mm and 5mm for the purpose of observing the
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effect that both rs in conjunction with the resolution of the sampling points has on the
RVI.
A parameter sensitivity analysis altering the size of rs used in the RVI algorithm was
performed on a model with a resolution of every 20th node. Figure 6.12 displays the results
Figure 6.12: Effect of varying rs on 3D RVI when using data only from every 20th node
on the endocardium of the AntLVtrans model. Top - RVI maps calculated using a radius
of rs of 1mm (left), 2mm (middle) and 5mm (right). Middle - effect of varying size of rs
on RV Imin. Bottom - effect of varying the size of rs on the RV Iarea<50.
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of varying the size of rs. The RVI maps at the top of the figure show that a critical region
of low RVI values is located by the RVI algorithm, indicating a susceptibility to reentry.
It appears that lower values of RVI are produced by the calculation using a smaller rs and
that a larger area of lower RVI values is produced in calculations using a larger rs.
The graph of RV Imin (middle) illustrates that using a 2mm radius of rs produces
the most negative RV Imin of approximately -40ms, as can be observed by the dark blue
regions of the RVI map (top). Using a larger rs of 5mm in the RVI calculation produces
a less negative RV Imin of approximately -5ms and the regions of green in the RVI map
(top, right) also illustrate this result. This is due to the fact that, with a smaller rs, fewer
values of RVI are produced and therefore, fewer values are averaged in order to plot the
RVI map resulting in greater variation in the data being displayed.
As the RVI map produced using a radius of rs of 2mm shows (top,middle), utilising rs
with a radius of 2mm produces the largest region of RV Iarea<50. The smallest rs produces
a smaller RV Iarea<50 due to fewer very low RVI values being produced and averaged to
create the RVI map. The RVI map on the left illustrates that only a very few values
of low RVI and hence, a low RV Iarea<50 are produced. Whilst the RVI map on the
right, displaying the results produced by using an rs with a radius of 5mm in the RVI
calculation, indicates that the low RVI values are more diffuse, the graph of RV Iarea<50
(bottom) shows that only a small RV Iarea<50 is actually produced. This is due to the
fact that the less negative values of RVI are produced when an rs with a radius of 5mm
is used, as can be seen in the graph of RV Imin (middle). As a result of these combined
findings, an intermediary rs was chosen in order to proceed with the resolution parameter
sensitivity analysis.
Figure 6.13 displays the results of varying the resolution of the model on the RVI.
Observing the RVI maps; compared to the RVI map of the full resolution model (left),
the lower resolution models determine approximately the same region of interest as flagged
by the lower RVI values in both AntLVtrans and PostLVendo models.
The graph of the RV Imin produced by the AntLVtrans model (middle) shows that the
RV Imin remains relatively constant at approximately -35ms irrespective of whether the
RVI is calculated utilising a lower or higher resolution model. This is relatively surprising
as it would be expected that sampling the AT and RT data immediately from either side
of the line of block, potentially more likely to occur in higher resolution models, would give
the lowest value of RVI and that this may be missed as the resolution decreases. However,
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Figure 6.13: Effect of varying data resolution on 3D RVI, analysed with a search radius size
of 2mm. Top - The AntLVtrans model and PostLVendo results are shown. Full resolution
RVI maps are shown on the left for comparison between RVI maps which display data
analysed from every 5th, 10th and 20th node. Middle - effect of varying resolution on
RV Imin in the AntLVtrans model. Bottom - effect of varying resolution on the RV Iarea<50
in the AntLVtrans model.
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the results do not reflect this.
The RV Iarea<50 increases from approximately 1% to 2% as the resolution is decreased
from using every fifth node in the model in the RVI calculation to using every 20th node as
shown by the graph of RV Iarea<50 (bottom) produced by the AntLVtrans model. Again, a
more diffuse region of low RVI values is expected when using a lower resolution model due
to the method of taking an average of the RVI values to create the RVI map. In the clinical
setting, a decapole catheter acquires the data and is moved around the myocardium 20
times, this gives 200 sites which data can be recorded from. Using every 20th node in
the model also gives approximately 600 data points. This similarity, in conjuction with
the fact that using a model with a resolution of every 20th node indicates a larger critical
region, was motivation for using the resolution model of every 20th node in order to model
the ablation procedure using this RVI map in the following study.
6.4.5 Guiding Ablation with Low Resolution Endocardial RVI Maps
The low resolution endocardial RVI map was used to guide the ablation procedure ac-
cording to the method described in detail in Section 6.4 in the AntLVtrans model, by
identifying nodes on the low resolution endocardial RVI map with an RVI less than the
threshold value. A parameter sensitivity analysis was conducted in order to derive thresh-
old values which would either produce reentry or no reentry following ablation. Ablation
lesions penetrated 5mm into the full resolution model myocardium and was modelled as
non-conducting tissue. A smaller ablation lesion was not able to terminate reentry in
this model due to the location of the scar complex within the myocardial wall, as seen in
previous results in this section.
Surprisingly, very low threshold values of RVI could terminate reentry as shown in
Figure 6.14. Ablation of nodes displaying an RVI less than -20ms resulted in termination
of the reentrant circuit (top, right) whereas ablation of nodes displaying an RVI less than
-30ms could not terminate reentry (bottom, right) depicted by the continued propagation
of the activation wave past the site of initial block after circumventing the scar region.
Again, there is very little difference in the area that is ablated between the models of
different threshold values but the outcomes of the simulations are vastly different. The
magnitude of the threshold value which can terminate reentry suggests that only a small
portion of the very low RVI values is required for use in the ablation procedure. Impor-
tantly, this substantiates the accuracy of the RVI algorithm and proves that it accurately
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Figure 6.14: Utilising the reduced resolution endocardial RVI map to guide ablation. Top
- RVI threshold -20ms, bottom - RVI threshold -30ms. Left - RVI maps displaying nodes
below threshold. Middle - Resulting ablation models. Right - Time series of simulation
displaying wave propagation outcome of ablation modelling.
locates regions susceptible to reentry. Moreover, the algorithm is validated even when
limitations are imposed such as reduced resolution. Although reducing the resolution of
the endocardial RVI seemed to produce a less accurate RVI map, utilising it in ablation
modelling still provided the desired result; termination of reentry.
6.5 Investigating the Effect of the Depth of the Scar on the
RVI
A study was performed in order to determine the effect of the depth of the scar within the
myocardial wall on the result of the RVI algorithm. Clinical data are only obtained from
the endocardial surface as described in Section 2.4 but scars may occur anywhere in the
myocardium from endocardial, transmural or epicardial locations although endocardial
scars are more commonly seen. Here, we investigate whether the endocardial RVI, as per-
formed in the clinic, can accurately determine a location susceptible to reentry irrespective
of depth within the myocardial wall.
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6.5.1 Incorporating Scar at Varying Depths Below the Surface
In this section, we return to utilising a simplified model in order to investigate the effect
that scar location within the myocardial wall has on the RVI. Section 1.3 describes the
importance of computational models in the study of post-MI arrhythmias. Here we wish
to investigate a particular parameter; depth of the scar underneath the surface of the
endocardium, and its effect on the RVI. Therefore, we utilise a simplified model in order
to reduce the complex dynamics which may obscure the result. A 2cm x 2cm x 1cm model
was created with a resolution of 200µm between nodes, resulting in a model containing
520250 node points and 2500000 tetrahedral elements. The depth of the model (1cm) was
chosen as it lay within the bounds of the average thickness of a healthy myocardial wall.
The uppermost 2cm x 2cm surface was denoted the endocardium as depicted in red in
the top image of Figure 6.15. 3D scar regions were incorporated into the models using the
Figure 6.15: Models used in investigating the effect of scar depth on the RVI. Top - endo-
cardial surface for which RVI is calculated. Bottom - Geometrical models with increasing
scar depth (left to right).
same method as previously described in Section 6.2. Again, the scar regions contained
2 ellipsoid non-conducting scars (black) separated by an isthmus of BZcond (blue) and
BZAPD (red). Scars were placed in the middle of the plane parallel to the endocardium
in each model, but models differed in the depth of the scar from the endocardial surface.
Figure 6.15 also displays the geometrical models used in this study, showing the depth of
the scar regions from the endocardial surface. Model D0 possessed the scar region lying
on the endocardial surface, so that exactly half of the scar region lay within the model
whilst the other half protruded from the endocardial surface. The centre of model D2.2
lies 2.2mm from the endocardial surface with some scar protruding from the endocardium,
D2.6 contains the scar region 2.6mm away from the endocardial surface with the scar just
touching the surface, the scar in D3 lies just below the surface with the centre of the scar
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lying 3mm away from the endocardium and in model D3.6, the scar lies 3.6mm away from
the endocardial surface.
Model Parameterisation
The human model of ventricular AP (Ten Tusscher and Panfilov, 2006) was used to simu-
late electrophysiological membrane dynamics in healthy tissue. In the BZAPD, the APD
was lengthened by altering the model parameters based on previously described protocols
(Rantner et al., 2012; Ashikaga et al., 2013). The maximal conductance value of INa was
reduced to 38% of normal, ICaL to 69%, IKr to 30% and IKs to 60% and the maximal
value of INaCa was increased to 132% of normal.
Isotropic fibre orientations were assigned to the healthy tissue as described in the 2D
experimental model (Chapter 5) in order to observe the effect of the depth of the scar
within the myocardial wall on the RVI algorithm without introducing further complex-
ity to the model. Conductivities were reduced by 50% in the BZcond to represent slow
conduction.
Whilst the parameterisation of the model is based upon previously described protocols,
it was essential that the reentry could be initiated in the models in order to study the
RVI. The protocol described here produced reentry in all of the models.
Implementation of the S1S2 Pacing Protocol
Plane activation waves were produced by stimulating the entire 2cm x 1cm side of the
cuboid in order to simulate the shape of an activation wave after having possibly travelled
a distance from the clinical pacing location (most often the apex) to the site of infarction.
The models were paced to a steady state at 480ms for 10 beats with a stimulus duration of
3ms. Subsequently, the S1S2 protocol was performed with a BCL of 300ms and a stimulus
duration of 3ms, producing reentry in each model.
6.5.2 The Effect of the Depth of the Scar Within the Myocardium on
the RVI
ATs and RTs were calculated as described previously (Section 6.2) and the RVI map was
created using only data on the endocardial surface (Section 6.4), to produce an endocardial
RVI map.
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Important conclusions can be drawn from the results, displaying the effect that the
depth of the scar region within the myocardial wall has upon the RVI. Figure 6.16 displays
Figure 6.16: The effect of depth of scar region on the RVI. AT (top), RT (middle) and
RVI (bottom) maps are displayed for models with the scar region lying 0mm (D0), 2.2mm
(D2.2), 2.6mm (D2.6), 3mm (D3) and 3.6mm (D3.6) underneath from the endocardial
surface (left to right).
AT (top), RT (middle) and RVI maps (bottom) for models with the scar region incorpo-
rated at increasing depths beneath the endocardial surface (left to right). The black
regions in the first 3 models are the area of the scars protruding at the endocardial sur-
face. The nature of the wave propagation around the scar complex can be seen in the
AT and RT maps. It is evident from the RT map of D3.6 (middle, right) that although
the scar and BZ complex lie underneath the endocardial surface, regions of late RTs com-
pared to the rest of the tissue can be seen around the scar complex. This is possibly due to
electrotonic effects of the scar and BZ which lie just underneath the endocardial surface,
causing the prolongation of the APD in nearby tissue.
In each model, a region of low RVI can be defined, compared to the RVI in the rest
of the model, which corresponds to the regions susceptible to reenty. It appears that the
closer the scar region to the endocardial surface, the more precise the RVI algorithm is at
locating regions susceptible to reentry. This could be due to the AT and RT information
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at the surface of the model representing the exact line of block and reentry. When the
scar regions lie beneath the surface of the model, the AT and RT maps are less accurate
at portraying that critical event because the abrupt block occurs at the exit point of the
scar, which no longer lies on the surface of the model. The effect on the RVI is that as
the scar becomes more intramural and less evident on the endocardium, the RVI becomes
less precise but importantly, critical regions are still able to be resolved.
These findings are quantified in Figure 6.17 which displays the RV Imin (top) and
Figure 6.17: Graphs showing how the depth of the scar under the endocardial surface
affects the RVI. Top - effect of varying scar depth on RV Imin. Bottom - effect of varying
scar depth on the RV Iarea<50.
RV Iarea<50 (bottom) for each model. Interestingly, as the scar is located further away from
the endocardium, the RV Imin becomes more negative, increasing from approximately -
50ms to -100ms. A possible explanation for this trend is that as the fibrotic scars disappear
below the endocardium, more BZ regions are displayed on the endocardium. It is the
heterogeneity between the healthy and BZ tissue which causes the initial wave block and
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determines subsequent reentrant success and so it is plausible to think that an increased
region of BZ tissue could contribute to more negative RVI values. As both the scar and
BZ regions disappear from the endocardial surface in D3.6, the RVI algorithm is no longer
able to predict a region susceptible to reentry with very low RVI values despite UDB
occurring.
The graph of RV Iarea<50 shows that as the depth of the scar beneath the surface of
the endocardium increases, the RV Iarea<50 increases also. Again, this is possibly due to
the increasing region of BZ tissue contributing to producing lower RVI values as the scar
region disappears below the surface of the endocardium. However, when the scar is located
3.6mm below the endocardial surface in this model, although a region of low RVI can be
located in comparison with the remainder of the RVI values, the values are very high and




Idealised scar geometries were used in this study to investigate the potential use of the RVI
in the clinic to guide the ablation procedure. Although unlikely, it is possible that utilising
such simplistic scar models could alter the efficacy of the RVI algorithm due to much more
complex wave propagation patterns, which would occur around more realistic complex scar
geometries. The models that we used ultimately were capable of producing reentry which
was required for the investigation. However, a large BZAPD region was required in order
to initiate reentry which may not be physiologically accurate. In addition, the previously
reported methodologies for modelling BZ tissue (McDowell et al., 2011; Rantner et al.,
2012; Ashikaga et al., 2013) were altered in order for the models to produce reentry. The
alterations of the BZ remodelling protocol could potentially affect the magnitude of the
RVI but shouldn’t affect its ability to locate regions susceptible to reentry, as simulated
by the models.
Realistic scar geometries may incorporate multiple exit sites whereas the models used
here only displayed one exit site. It is unknown whether the RVI could indicate multiple
exit sites which would be of benefit in the clinic, ensuring that no further VTs produced
by different physiological circuits could ensue after the ablation of the clinical VT.
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In order to test the results of the ablation modelling and observe whether the protocol
was able to terminate reentry, the same S1S2 protocol was conducted which was initially
conducted to produce reentry in the model. A more robust protocol to test the success of
the ablation procedure may be to implement multiple stimulation protocols, for example;
pacing from different locations or with different pacing frequencies. A different stimulation
protocol may be able to elicit reentry in the ablation model which was not possible with
the S1S2 protocol performed in this study.
6.7 Summary
This study verifies that the RVI can locate regions suscpetible to reentry throughout the
myocardial wall in a 3D model of rabbit ventricles. The region of low RVI which indicates
the susceptibility to reentry is again located around the region of the exit site of the scar
which has been noted to be an optimal ablation target. This conclusion is vital in order
to display that the RVI algorithm may be of use in a clinical scenario. In addition, it is
shown here that the RVI maintains its ability to identify a location which is susceptible to
reentry in varying geometrical models, suggesting that the RVI algorithm may be robust in
different patients who will certainly have varying heart shapes and sizes as well as varying
scar locations and geometries.
Crucially, it has been shown in this study that it is possible to utilise the RVI map
to guide ablation. Based on RVI maps, identified regions of low RVI values were targeted
for ablation which effectively removed the conductive tissue from the target region. On
induction of a S1S2 pacing protocol after ablation, depending on the threshold of RVI
set as the target for ablation, the reentrant circuit was terminated. This, in the clinic
would be a positive outcome of the ablation procedure. Indicating that the RVI algorithm
could be of use in the clinic is of great interest as it could potentially provide a novel
methodology which could accurately map the exit point of the scar without inducing VT,
something which current ablation treatments fail to do very effectively.
In the clinic, data are only sampled from the endocardium which could have rendered
the RVI algorithm, which depends on AT and RT data sampled near to the exit site,
useless. However, after performing the RVI algorithm on only endocardial data and pro-
ducing endocardial RVI maps, it is evident that, although slightly less accurate, the RVI
is still able to predict regions susceptible to reentry with low RVI values. Moreover, the
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algorithm performed on endocardial data is effective whether the scar is located endo-
cardially or transmurally. On utilising the endocardial RVI maps to guide the ablation
simulation, it was found that it was possible to terminate reentry by ablating regions of
low RVI. However, the success was dependent on the depth of the exit site within the
myocardial wall and the size of the ablation lesion that was created. A more transmural
scar required a larger ablation lesion performed from the endocardium to be created, a
scenario that also presents in the clinic.
The vast reduction in data sampling resolution which is inherent in clinical data record-
ing could result in the algorithm being less able to locate the regions susceptible to reentry,
a result which was indicated in the previous chapter. The decrease in endocardial sam-
pling resolution was modelled here and it was found that despite loss of accuracy of the
RVI result, the calculation was still able to locate regions susceptible to reentry. This is
a major finding which validates the use of the RVI algorithm in the clinic. The result is
further supported by the ability to terminate reentry by modelling ablation of the regions
indicated by low RVI values on the low resolution endocardial RVI map.
Lastly, the study investigated the effect of the depth of the substrate within the my-
ocardial wall on the RVI map. It was assumed that the RVI map would become less able
to identify susceptibility to reentry when the substrate is deep within the myocardial wall.
However, results indicate that the RVI algorithm can identify regions susceptible to reentry
even when the substrate is located underneath the surface of the tissue, suggesting that
RVI guided ablation could be of use in ablating transmural MI-scars involved in VT cir-
cuits. Moreover, we have shown here that the RVI technique is successful when performed
on the endocardium but the technique could also be applied to the epicardium, acquiring
and utilising epicardial data in the calculation of the RVI. Hence, the RVI algorithm could
provide a technique with which to treat both endocardial and epicardial infarct scars.
Computational modelling has enabled the study of many factors such as endocardial
data sampling and low resolution data sampling which could impact the results of the RVI.
The techniques used here have enabled questions to be answered that can not currently





Reentrant arrhythmias are a cause of hundreds of thousands of deaths each year due to
the loss of cardiac function and blood supply to vital tissues, the treatment of which is
exceptionally costly to the Health Services. As such, much research has been performed to
study the causes, initiation, maintenance and treatment of arrhythmias but despite this,
death rates remain high. As the incidence of risk factors such as obesity, diabetes and high
cholesterol increase, it is likely that arrhythmias will continue to be a significant cause of
death. Ischemic damage to the tissue as a result of an MI can cause reentrant arrhythmias
to occur around infarct scars, which if untreated, can lead to VF and SCD. Research is
targeted at understanding the mechanisms of reentrant propagation to enhance treatment
strategies, halting the arrhythmia and returning the heart to normal rhythm.
Throughout the thesis we adopt a computational modelling approach to simulate wave
propagation across the heart and use simple measures of wavelength to determine the
dynamics of reentrant propagation. Computational models are used here to provide novel
insight into real-time intramural wave propagation which is currently unattainable in the
clinic due to ethical restrictions and the limitations of clinical data recording. At present,
clinical recording techniques are unable to provide the high-resolution, 3D data that can
be produced by models. The low financial burden of computational models and the lack
of ethical restrictions permits us to study wave propagation over large sets of physiological
parameters quickly and with relative ease. Potentially one of the most important benefits
of using in silico models is that it is possible to study wave propagation with varying
degrees of complexity, by altering single electrophysiological parameters or increasing the
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complexity of geometrical models, in order to provide detailed insight into the mechanisms
of reentry.
The investigations conducted in this Thesis were fundamentally rooted in a concept
highlighted in the leading circle theory of reentry. This theory states that if wavefront-wave
back interactions occur as a wave propagates around a circuit, reentry will be terminated.
However, if an excitable gap is present between the wavefront and the wave back, the
wavefront will be able to continue to propagate into the gap, facilitating reentry.
The first research chapter in this Thesis, Chapter 4, begins by determining the similar-
ity of reentry dynamics between species. Many small animal models are used to investigate
arrhythmias in order to draw conclusions which may be of clinical use. However, in or-
der to provide clincally relevant conclusions, small animal models should replicate the
wave propagation dynamics of the human, particularly in terms of the disrupted wave
propagation and arrhythmia dynamics which occur around infarct scars. Importantly,
species differences such as the size of the heart and the electrophysiological properties of
the myocardium can affect wave propagation. Here we investigated which species model
most closely replicates the wave propagation dynamics observed in the human, in order
to be able to suggest the optimal model to use in further research pertaining to reen-
trant arrhythmias. To do this we compared the effective electrical size of the heart, which
compared the wavelength to the size of the heart, to determine the likelihood of reentry
occurring. Importantly, we studied the restitution profiles of the effective size of the hearts
of each species to observe whether the models became equally more susceptible to reentry
at faster cycle lengths, indicative of those which occur during VT arrhythmias. Alterations
to ionic currents and conductivity properties occur in the BZ tissue surrounding the scar.
As such, we investigated the effect of BZ remodelling on the effective size, in addition to
observing whether BZ remodelling would serve to increase the species differences in wave
propagation dynamics. The results of Chapter 4 motivated the use of the models utilised
in Chapters 5 and 6.
In Chapters 5 and 6, we studied reentrant wave propagation by quantifying whether
or not reentry could occur based on AT and RT data using the RVI calculation. In other
words, we observed whether or not the wavefront may collide with the wave back. Cru-
cially this work has significant clinical impact in treating post-MI arrhythmias. Currrent
ablation treatment has relatively low success rates due to the difficulties in accurately
locating the scar region and in particular, locating the exit point of the scar which has
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been suggested as the optimal ablation target. In some cases the treatment is potentially
dangerous due to the need to induce VT in order to locate the scar. Therefore, we in-
vestigated the RVI methodology and in particular, its application for use in the clinic.
Firstly, we validated the method in simple 2D models, producing a spatial map of RVI
values to locate regions susceptible to reentry and observed how increasing arrhythmo-
genicity affected the results. We progressed the study by using 3D models to research
how accurate the RVI is at locating the exit point, utilising 3D data to produce 3D RVI
maps. In addition, we modelled the clinical method used to produce RVI maps, taking
into consideration the low resolution, endocardial data that are recorded in the clinic for
the purposes of observing how the clinical method may affect the RVI results. Finally we
modelled the ablation procedure using the RVI maps to demonstrate the efficacy of the
RVI method in guiding the ablation procedure.
7.2 Important Findings and Key Contributions
The species differences in effective size between small animal models were tested at frequen-
cies indicative of VT for the first time in Chapter 4 due to the large amounts of literature
studying reentrant arrhythmias, utilising small animal models. Restitution curves of APD
and CV in both the single cell and tissue models illustrated that the parameters decreased
with increasing frequency. This finding supports the evidence that as pacing frequency
increases, slow recovery from inactivation of the ionic channel gating mechanism causes
the decrease in APD and CV. Interestingly, as a result of the wavelength being calculated
as the product of APD and CV, wavelength also decreases with increasing cycle length.
Moreover, we show that although the wavelength restitution graphs of different species
share the same trend, differences occur in the magnitude of the change in wavelength as
pacing frequency increases. Specifically, we have shown that the human model displays
the steepest wavelength restitution curve, with wavelength decreasing considerably as the
pacing frequency decreases. By the leading-circle theory of reentry, decreasing the APD,
CV and wavelength, all increase the excitable gap, suggesting that reentry is more likely
to occur at faster pacing frequencies. Due to the species differences in the magnitude of
the restitution curve, we can suggest that as pacing frequency increases, reentry is more
likely to occur in the models as a result of the increase in excitable gap. But crucially,
due to the largest change in wavelength with pacing frequency, we can speculate that
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the human model is more susceptible to reentry at fast pacing rates than the other small
animal models tested here.
The one exception displaying negative restitution graphs of APD, CV and wavelength
was the rat model (Pandit et al., 2001). Negative restitution of the rat model has been
reported in the literature at the both the single cell and tissue levels (Kondratyev et al.,
2007; Fenton and Cherry, 2008; Salle´ et al., 2008). This phenomenon is not physiologically
possible, for if the APD continued to increase whilst the heart rate increased, there would
become a point when the myocardium would no longer be able to contract fast enough to
maintain the required CO. It is possible that such restitution reported in the literature, is
due to the nature of data acquisition and the use of EGTA in patch clamp recordings and
optical mapping dyes and mechanical uncoupling agents at the tissue level. Therefore,
we can suggest that the rat model requires reformulation with newly acquired data which
do not display the negative restitution artefact, if the model is to be useful in studying
arrhythmia mechanisms.
Observing the effective electrical size of the hearts of the human, rabbit, guinea pig
and rat models, it is possible to suggest that the rabbit model displays the most similar
effective size to the human model. In fact the human model displays a greater effective
size than the rabbit and yet a greater effective size still, than the guinea pig model.
These results suggest that the human is more likely to be susceptible to reentry than the
other models. Although there is a difference in magnitude of effective size between the
human and rabbit models, the restitution properties of the effective size are most similar.
This is due to the similarity in wavelength restitution between the models which showed
that the steepness of the wavelength restitution graphs of the human was most similar
to the rabbit model in both the single cell and tissue models. Therefore, the increase in
effective size as pacing frequency increases in the human model is also seen in the rabbit
model, illustrating the fact that the tissue becomes more susceptible to reentry as the
pacing frequency increases. This similarity in effective size between the human and rabbit
models suggests that, although species differences occur, the rabbit model may be the
most useful model to study clinical arrhythmia dynamics.
Incorporating ionic current and conductivity BZ remodelling into both the human and
rabbit models resulted in an increase in APD and a decrease in CV respectively. The
effects of BZ remodelling on the effective size of both species, illustrates that despite the
rabbit model displaying an effective size most similar to the human model, important
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species differences in both the magnitude and restitution remain and could be enhanced
in BZ regions, through which reentry may occur. Thus we propose that in order to model
reentrant arrhythmias to draw conclusions which may be applicable to the clinic, a human
in silico model should be used. However if, due to the computational demands of human
model simulation, this is impractical, or indeed if the most suitable animal model is being
sought for in vivo research, the rabbit model proves to be the most suitable animal model
to study reentrant arrhythmias. The rabbit model does display a similar effective size and
response to BZ remodelling to the human, which is crucial to the study of post-MI reentry.
Results from Chapters 5 and 6 suggest that studying the wavelength to determine
whether reentry can occur or not, may prove useful in guiding the clinical ablation pro-
cedure. The RVI algorthim was proposed to create a spatial map which can predict a
susceptibility to reentry (Child et al., 2015). The method works by comparing the times
at which the wavefront and wave back reach nearby points in a circuit to determine whether
an excitable gap exists and whether reentry is likely to occur there. The results of these
chapters indicate that regions highlighting a susceptibility to reentry may provide accurate
targets for ablation which could improve the success rates of the ablation procedure.
When implemented in simple 2D models, the results of the RVI calculation showed that
regions susceptible to reentry could be located across a 2D surface by the presence of neg-
ative values of RVI in cases where UDB occurs and low positive values where BDB occurs.
We further tested the methodology by producing data from many simulations ranging in
arrhythmogenicity. For example, increasing the prematurity of the S2 beat increased the
arrhythmogenicity of the simulation as expected, resulting in reentry and interestingly,
produced a greater area of more negative RVI values. Not only do these results suggest
that the RVI can indicate the severity of the arrhythmia but they also support the idea
that the RVI algorithm can predict regions susceptible to reentry over a wide variety of
physiological conditions. This validation was necessary due to the methodology previously
only being tested on one patient. In addition, we were able to use computational models
to observe how varying parameters such as the resolution of the data being used and the
rs implemented to determine calculation node pairs, affects the RVI results. In the clinic,
sampling of data is limited due to the number of recording electrodes on the catheter,
the manual manipulation of the catheter and the time constraints of the procedure. As
such, low resolution data sets, compared to data produced by computational models, are
collected and used for analysis in the clinic. The rs is a parameter utilised in the calcu-
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lation of the RVI to determine calculation node pairs in order to ensure that the RVI is
calculated between two nearby points. We found that the RVI highlights regions of low
RVI even when low resolution AT and RT data are used in the calculation. However, RVI
calculated from low resolution data has a tendency to be less accurate due to plotting
the result on a low resolution model. The RVI calculated from low resolution data also
indicates critical regions with less negative RVI values. This methodology replicates the
clinical scenario and results suggest that the limitations of clinical data recording affect
the results of the RVI only minimally and that the RVI calculation is still of significant
use in the clinic. Likewise, increasing rs to a size which is comparable to that used in the
clinic, also results in a less accurate RVI map of the critical region, due to large numbers
of RVI values being calculated and averaged in order to produce the RVI map. Despite
these parameters resulting in less accurate RVI maps being produced, the calculation is
still able to locate critical regions of the tissue.
Integrating a simplified scar geometry into the model allowed us to visually verify
whether or not the RVI was able to locate the exit point of the scar and determine
the accuracy of the RVI. Incorporating the scar and simulating wave propagation in the
model produced figure-of-eight reentry patterns comparable to those which may cause
clinical VT. Indeed, results showed that the RVI calculation located the exit point with
low values when either UDB or BDB occurred. Similar results to those of the experimental
model were reported suggesting that more negative values of RVI were produced in more
arrhythmogenic simulations. In addition, higher resolution data which are possible to
obtain from computational models increase the accuracy of the RVI results. In addition,
using a smaller rs in the RVI calculation to determine calculation node pairs also increased
the accuracy of the RVI results. Importantly, even using low resolution data and large rs
sizes in the calculation of the RVI, areas susceptible to reentry, namely the exit point, are
still able to be distinguished from the rest of the tissue, in a similar manner to the results
produced by the simple experimental model.
The aim of Chapter 6 was to thoroughly investigate how the clinical recording pro-
cedure may affect the results of the RVI algorithm and demonstrate that RVI maps can
improve the ablation procedure. Current problems with ablation treatment include the
inaccuracy of locating the ablation target, resulting either in multiple sites being ablated
which may have a negative impact on cardiac function, or VT recurring at a later date. In
addition, in some cases VT is induced to map the scar region which increases the danger
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of the procedure. We suggest that the RVI algorithm can improve the ablation treatment
by addressing both of these issues by accurately locating the exit point of the scar without
having to induce VT. Moreover, the RVI technique only requires AT and RT data from
sites across the endocardial surface, data which are acquired with relative ease. Currently,
techniques to map the substrate involve skillful catheter manipulation to record data from
sites within the scar and expert opinion to analyse the electrograms. In addition, recording
voltages from the scar and BZ region can result in either false positive or false negative
indication of the correct target location. In order to investigate the clinical application
of the technique, we employed a detailed model of 3D rabbit ventricles to be able to in-
vestigate transmural propagation and reentry. A rabbit model was used here based on
the results of Chapter 4 in which we showed that the rabbit model displayed the most
similar effective size, in terms of magnitude and restitution effects, to the human in both
health and BZ remodelled tissue. Here we utilised the rabbit model in order to reduce the
computational demand that a 3D human model would require. Important to note is that
the RVI technique is not species specific and that the quantification of wavefront-back
interactions using AT and RT data is the same across species.
We began the Chapter by implementing the RVI algorithm in three 3D models each
incorporating scar at different locations around the ventricular wall and at different depths
within the myocardium. Performing the RVI calculation on the 3D data showed that low
values of RVI highlight the exit point of the scar irrespective of the scar’s location. Again,
the use of different models here provided extra validation of the technique and showed
that it is robust enough to be used in the clinic where biological variation is inherent.
The effects of clinical data recording were investigated by calculating the RVI using
only endocardial data to produce an endocardial RVI map. Recording data in this manner
replicated the collection of data in the clinic. Our simulations predicted that exit points
would be less accurately located by the RVI if they were located more transmurally and
we found this to be the case, although the RVI could still indicate the critical region but
less accurately and with less negative RVI values. We modelled the ablation procedure by
simulating ablation of the regions of low RVI values and found that ablation of even very
small regions highlighted by the RVI map could terminate reentry. To further investigate
the potential to guide the ablation procedure using RVI maps, areas of the model displaying
RVI values below varying threshold values were ablated in order to investigate the accuracy
of the RVI map. Previously, we showed that endocardial RVI maps are less accurate at
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locating regions suscpetible to reentry with low values of RVI and so it was predicted that
guiding the ablation procedure with endocardial maps would be less successful. However,
using these maps to suggest ablation targets still resulted in termination of the arrhythmia.
We further investigated clinical procedure by reducing the resolution of the endocardial
data which resulted in yet less accurate and precise location of regions susceptible to
reentry by the RVI map, however identification of the critical exit point was still possible.
Therefore, we can suggest that the low resolution endocardial RVI maps produced in the
clinic remain effective at locating the optimal ablation lesion targets. What remains a
problem, is that if the scar is transmural and catheter ablation is performed from the
endocardium, the ablation lesion has to penetrate transmurally to reach the exit point to
be successful in terminating VT. It should be considered that the RVI technique could be
implemented on the epicardium and so transmural and epicardial scars may still be able
to be treated with success rates similar to those achieved for endocardial scars.
Simplified models of scar regions embedded at different depths in the myocardium
were used to observe how the transmural depth of the scar affected the RVI result. RVI
maps created on the endocardial surface showed that the RVI was less accurate at locating
critical regions as the depth of the scar below the endocardium increased. However, it was
also shown that as the depth of the scar beneath the surface increased, the values of RVI
became more negative and the area of the lowest RVI values increased. These results
suggest that it is still possible to detect regions of low RVI values even when the scar was
located transmurally.
7.3 Future work
The research in this Thesis has suggested the optimal animal model to study reentrant
arrhythmias and therefore can inform methodological practise. In addition, the research
has provided important validation for the use of the RVI in the clinic. However, if the
RVI is to be implemented routinely in clinical procedures, further investigation could
be performed to validate and optimise its use. Suggestions of potential future research
avenues are presented here.
In the clinic, opinions on the desired end point of the ablation procedure are divided
(Aliot et al., 2009). In Chapter 6, we assumed that the ablation procedure which we
modelled had been successful if, on performing the same stimulation protocol which was
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used to initiate reentry in the model before ablation, the activation wave was blocked by
the ablation lesion, terminating the reentrant circuit. In a patient, scar geometries are
both complex and varied. In fact, it has been reported that multiple potential reentrant
circuits exist within a patient, which can act as a substrate for VT. Indeed, the cause of
many recurring arrhythmias post-ablation treatment occur as a result of reentrant waves
propagating around other VT circuits. Current ablation techniques aim to terminate the
clinical VT without taking into account that multiple potential VT circuits can occur in a
patient, therefore, another VT may occur at a later date. In Chapter 6 we investigate the
RVI method in a simplified model with one possible reentrant circuit. However, the RVI
method should be able to detect multiple circuits based on the wave propagation dynamics
around the scar. In order to do this, either UDB or BDB around the other VT circuits
needs to be induced in order for the RVI to be able to indicate each exit point of the
scar. Therefore, rigorous pacing protocols which can elicit UDB or BDB in each possible
reentrant circuit around the scar need to be performed. At present, such a protocol does
not exist. We propose that computational models displaying more anatomically realistic
scar geometries with multiple potential circuits, can be utilised to perform parameter
sensitivity analyses, varying both the pacing rate and the pacing location in order to
determine a protocol which enables detection of all VT circuit exit points in the scar
region. If all exit sites of the scar which are involved in potential reentrant circuits can
be detected by the RVI method and ablated, the long-term success rates of the ablation
treatment should increase.
Regarding the well-documented complexity and vast variation in infarct scars observed
in patients, it would be of signifcant use to observe the effect of such complexity on the
results of the RVI. In Chapters 5 and 6, very simplified scar geometries were incorporated
into the models. A vital next step to this research in order to further validate the RVI
would be to integrate multiple different realistic scar geometries into the computational
models at multiple locations replicating the biological variation observed in patients. Ini-
tially, anatomically realistic scars could be incorporated into the model of rabbit ventricles
used in Chapter 6 in order to reduce computational demand as a large number of scar
geometries are tested. Again, the results of Chapter 4 indicate that the rabbit model is
the most suitable small animal model to use in investigating VT arrhythmias and is the
model which is most able to replicate wave propagation dynamics of the human in healthy
and BZ tissue. The next stage would be to integrate realistic scar geometries into patient
187
7.4. CONCLUDING REMARKS
models in order to test whether the RVI maintains its ability to locate the exit points in
the scar in anatomically realistic models of the human infarcted heart. We would however,
expect the RVI results produced in humans to be similar to those produced by a rabbit
model.
In addition to the simplified geometries used in Chapters 4, 5 and 6, BZ remodelling was
implemented in these models based on previous protocols which were in turn based upon
canine and rabbit data due to the lack of data regarding ionic current and conductivity
remodelling in the human. As BZ remodelling data of the human becomes available, util-
ising the data to investigate wave propagation around infarct scars such as in the research
presented in this Thesis, could improve the accuracy of modelling BZ wave propagation.
However, the RVI algorithm is validated based upon AT and RT data irrespective of the
nature of wave propagation.
7.4 Concluding Remarks
In this Thesis, we showed that species differences occur, between human and small an-
imal models, in the effective size of the heart. We suggested that due to these species
differences in magnitude of the effective size and the restitution properties of the effective
size, that the optimal approach to modelling VT arrhythmias would be to study wave
propagation in the clinic or in a computational model of human data. However, if the
required investigation is not possible in the clinic or if computational demand of a human
model is too high, the results in Chapter 4 show that the rabbit most closely replicates the
effective size and its restitution properties of the human and hence, is the best model for
investigating VT arrhythmia wave propagation dynamics. In Chapters 5 and 6 we utilised
the methodological conclusions drawn from Chapter 4 to validate the proposed RVI algo-
rithm, which aims to identify regions of tissue susceptible to reentry, utilising AT and RT
data, for the purposes of guiding the ablation procedure. We showed that the exit point
of the scar could be located by low values of RVI during both UDB and BDB and that the
highlighted regions of low RVI values could be used as ablation lesion targets. In doing
so, the accurate location of the exit point by the RVI required only small areas of tissue
to be ablated to result in successful termination of the VT. We tested the method over
a variety of varying physiological parameters and geometries to conclude that the RVI
would be of use in a clinical setting for many patients even considering the limitations
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imposed by clinical data recording. From the results of this Thesis we can conclude that
the RVI calculation can improve the safety of the treatment, as well as the accuracy and
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